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Propositions	
	
1. When	comparing	chromatographic	media	or	configurations,	at	least	one	will	
perform	suboptimal.	(this	thesis)	
2. A	chromatographic	monolith	has	advantages	over	a	packed	bed	of	porous	
particles	only	when	very	small	or	very	large	molecules	are	to	be	adsorbed.	
(this	thesis)	
3. More	precise	measurements	do	not	always	produce	more	precise	results.	
4. The	word	‘science’	suggests	a	certainty	that	often	does	not	exist.	
5. You	only	truly	understand	something	if	you	can	explain	it	to	others.	
6. On‐line	social	media	often	result	in	asocial	behaviour	in	real‐life.	
7. Flexible	working	hours,	especially	when	working	from	home,	make	it	harder	
to	balance	work	and	private	life.	
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Chapter	1	
Introduction	
	
1.1 A	short	history	of	chromatography	
According	to	IUPAC	(International	Union	of	Pure	and	Applied	Chemistry)	the	official	
definition	 of	 chromatography	 is	 “a	 physical	 method	 of	 separation	 in	 which	 the	
components	 to	 be	 separated	 are	 distributed	 between	 two	 phases,	 one	 of	 which	 is	
stationary	(stationary	phase)	while	the	other	(the	mobile	phase)	moves	 in	a	definite	
direction”	 [1].	 Literally,	 the	word	 chromatography	means	 ‘colour	writing’	 and	dates	
back	to	1906.	The	Russian	botanist	Mikhail	Tswett	(his	last	name	meaning	‘colour’	or	
‘flowering’	 in	 Russian)	 separated	 colourful	 plant	 pigments	 from	 each	 other	 using	 a	
column	packed	with	an	adsorbent	[2].	Tswett	investigated	many	different	adsorbents	
(stationary	 phases)	 and	 solvents	 (mobile	 phases)	 to	 find	 an	 optimal	 separation	
method.	It	took	over	thirty	years	before	the	value	of	Tswetts	work	was	recognized	[3].	
This	was	mainly	due	to	the	work	of	Nobel	Prize	winners	A.J.P.	Martin	and	R.L.M.	Synge	
who	 described	 the	 chromatography	 process	 theoretically.	 From	 there	 gas	
chromatography	and	new	types	of	liquid	chromatography	were	developed.	For	a	long	
time,	chromatography	was	mainly	used	as	an	analytical	tool	using	small	sample	sizes.	
Later	on,	the	preparative	use	of	chromatography	was	rediscovered	(e.g.,	[4]),	with	its	
main	 applications	 in	 the	 pharmaceutical	 industry.	 The	 challenges	 in	 scale‐up	 of	
chromatography	 processes,	 the	 batch‐wise	 nature	 of	 the	 process,	 the	 amount	 of	
solvents	 (buffers)	 required,	 and	 the	 high	 costs	 of	 target‐specific	 chromatography	
adsorbents	are	 the	main	reasons	why	chromatography	 is	not	more	widely	used.	For	
pharmaceuticals,	purity	is	crucial	and	high	separation	costs	can	be	acceptable	in	this	
field.	 A	 picture	 of	 a	 contemporary	 lab‐scale	 preparative	 chromatography	 system	 is	
shown	in	Figure	1.1.	
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Figure	1.1.	Example	of	a	lab	scale	preparative	chromatography	setup	with	an	Äkta	Purifier	(GE	Healthcare,	
Uppsala,	Sweden).		
1.2 Chromatography	adsorbents	and	ligands	
Chromatography	can	be	used	to	separate	a	mixture	into	its	components.	Two	phases	
can	 be	 distinguished:	 the	 mobile	 phase,	 which	 can	 be	 a	 solvent	 but	 also	 the	 feed	
mixture	itself,	and	the	stationary	phase,	the	adsorbent.	The	adsorbent	or	resin	usually	
consists	of	spherical	particles	made	of	agarose,	cellulose,	polymethacrylate,	silica	and	
many	other	materials	which	are	packed	in	a	cylindrical	column.	The	particles	may	be	
porous	 or	 non‐porous.	 Membranes	 and	monoliths	 can	 also	 be	 used	 as	 a	 stationary	
phase	[5].	
Several	 methods	 of	 separation	 exist	 in	 chromatography.	 In	 size‐exclusion	
chromatography,	 also	 known	 as	 gel	 filtration	 chromatography,	 components	 are	
separated	based	on	size.	This	method	 is	mainly	 suitable	 for	analytical	purposes	and	
final	polishing,	because	the	column	cannot	be	loaded	with	the	mixture	to	be	separated	
for	more	than	~5%	of	the	column	volume.	
Another	possibility	is	to	adsorb	components	to	the	stationary	phase.	This	means	that	
after	 adsorption,	 a	 change	 in	 buffer	 is	 required	 to	 desorb	 the	 components	 from	 the	
stationary	 phase.	 As	 an	 example,	 charged	 components	 can	 be	 separated	 using	 ion	
exchange,	a	method	that	is	frequently	applied	in	the	pharmaceutical	industry,	and	for	
example	in	the	desalting	of	whey.	To	remove	the	adsorbed	components,	a	salt	gradient	
is	used.	On	small	scales,	it	is	used	in	mechanical	dish	washers	to	remove	multivalent	
ions	from	water.		
The	most	specific	method	in	chromatography	is	affinity	chromatography.	This	type	of	
chromatography	 relies	 on	 specific	 interaction	 between	 the	 target	 component	 and	 a	
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ligand	immobilized	onto	the	surface	of	the	adsorbent.	Many	different	ligands	exist,	for	
example	synthetic	dyes	like	Cibacron	Blue,	which	can	bind	certain	proteins;	metal	ions	
like	nickel	for	the	binding	of	His‐tagged	proteins;	or	Protein	A	for	binding	monoclonal	
antibodies;	and	antibodies	 themselves	 for	binding	their	specific	antigen	(e.g.,	 [6,	7]).	
Using	 antibodies	 for	 chromatography	 is	 called	 immunoaffinity	 chromatography	 [8].	
This	method	is	very	costly	and	antibodies	are	not	very	stable,	which	restricts	the	use	
to	smaller‐scale	analytical,	pharmaceutical	and	medical	applications.	
Instead	 of	 using	 a	 complete	 antibody	 molecule,	 only	 the	 binding	 domain	 of	 the	
antibody	can	be	used.	Llamas	produce	antibodies	lacking	so‐called	light	chains,	so	only	
the	heavy	chains	remain	(see	Figure	1.2).	From	these	chains,	the	binding	region,	called	
the	variable	heavy‐chain	region	of	the	heavy‐chain	antibody,	or	VHH,	can	be	isolated.	
These	antibody	fragments	are	much	more	stable	than	the	full‐size	antibodies,	but	have	
similar	binding	strengths	and	specificities.	Because	of	the	approximately	10‐fold	lower	
molecular	weight	compared	to	normal,	full‐size	antibodies,	the	VHH	ligands	are	more	
efficient	in	terms	of	mass	of	target	component	adsorbed	relative	to	the	mass	of	ligands	
required	 for	 the	 separation.	Moreover,	 the	 fragments	can	be	produced	on	 industrial	
scale	 by	 recombinant	 Saccharomyces	 cerevisiae.	 These	 properties	 make	 the	 VHH	
ligands	promising	for	large‐scale	affinity	chromatography	[9‐14].	
	
Figure	1.2.	Schematic	 representation	of	a	 regular	antibody	(left)	and	a	camelid	antibody	(right)	with	 the	
individual	domains:	CH1‐3	and	CL	are	the	constant	regions	and	VH/VHH	and	VL	the	variable	regions	of	the		
heavy	 (H),	 and	 light	 (L)	 chains	 of	 the	 antibody	 (reproduced	 with	 permission	 from	 BAC	 (Naarden,	 The	
Netherlands)).	
Because	 of	 the	 strength	 of	 binding	 in	 affinity	 chromatography,	 an	 appropriate	
desorption	 strategy	 needs	 to	 be	 developed	 for	 product	 recovery	 and	 adsorbent	
regeneration.	Desorption	can	be	achieved	by	a	change	in	solvent	composition,	such	as	
salt	concentration	or	acidity.	
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1.3 Configurations	in	chromatography	
Packed	 bed	 chromatography	 with	 axial	 flow	 is	 the	 conventional	 configuration	 for	
chromatography.	In	most	cases	porous	adsorbent	particles	are	used	which	are	poured	
into	 an	 axial	 column	 to	 form	 a	 more	 or	 less	 uniform	 bed	 (see	 Figure	 1.3b).	 The	
interstitial	liquid	volume	typically	comprises	about	40%	of	the	total	volume,	since	the	
particles	are	packed	quite	 closely.	 In	most	 cases,	 the	 feed	 stream	 is	 led	 through	 the	
column	from	top	 to	bottom	to	avoid	disturbance	of	 the	bed	packing.	Because	of	 this	
liquid	 flow,	 a	 pressure	 drop	 is	 developed	 over	 the	 column.	 Besides	 the	 difficulty	 of	
handling	 large	 pressure	 drops,	 softer	 particles	 may	 be	 compressed	 and	 deformed,	
thus	deteriorating	the	separation.	To	avoid	large	pressure	drops	on	an	industrial	scale,	
the	columns	should	be	short	and	wide	 instead	of	 tall	and	narrow.	 In	addition,	 fluids	
that	 contain	 particulate	 matter	 or	 components	 prone	 to	 cause	 fouling	 (such	 as	
proteins),	may	induce	clogging	of	the	interstitial	pores	between	the	stationary	phase	
particles,	 thus	 leading	 to	 reduction	of	 the	 flow,	 or	 an	 increase	 of	 the	 pressure	drop	
required	for	maintaining	the	same	flow	rate.		
A	variation	of	the	axial	flow	column	for	packed	bed	chromatography	is	the	radial	flow	
column	 (see	 Figure	 1.3c).	 In	 this	 column	 the	 particles	 are	 poured	 in	 between	 two	
concentric	cylinders.	Flow	is	usually	directed	from	the	outside	 inwards,	but	can	also	
be	directed	from	the	inside	outwards.	The	bed	length	is	in	this	case	horizontal	and	can	
be	 quite	 short,	 resulting	 in	 a	 low	 pressure	 drop.	 The	 column	 can	 be	 scaled	 up	
vertically	 by	using	 longer	 concentric	 cylinders	 as	opposed	 to	 the	 axial	 flow	 column,	
which	needs	to	be	scaled	up	horizontally.	
Because	 the	 fluid	 flow	 in	 the	 packed	 bed	 is	 almost	 plug	 flow,	 the	 dispersion	 in	 the	
direction	 of	 the	 flow	 is	 small,	 and	 the	 number	 of	 theoretical	 equilibrium	 stages	 is	
large.	 The	 separation	 of	 target	 components	 from	 the	 feed	 is	 therefore	 efficient.	
However,	because	of	the	narrow	channels	between	the	particles,	packed	beds	cannot	
be	used	directly	with	a	feed	that	contains	a	significant	amount	of	particulate	material,	
or	other	material	that	may	stick	to	the	particles,	like	fat	globules.	
Adsorbent	 particles	 can	 also	 be	 used	 in	 a	 stirred	 tank	 for	 batch	 or	 finite	 bath	
adsorption	 (see	 Figure	 1.3a).	 Batch	 adsorption	 is	 often	 used	 to	 determine	 the	
equilibrium	 behaviour	 and	 adsorption	 kinetics.	 This	 configuration	 is	 only	
economically	 feasible	 if	 the	adsorption	of	 the	 target	component	to	the	 ligand	 is	very	
strong.	The	particles	have	to	be	recovered	from	the	vessel	(e.g.,	by	microfiltration)	and	
washed	before	the	component	can	be	desorbed.	Desorption	in	batch	configuration	is	
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not	 favourable,	 because	 the	 target	 component	 will	 be	 hardly	 concentrated	 or	 may	
even	be	diluted.	
a)	
	
b)
	
c)
	
Figure	1.3.	Schematic	 representations	of	batch	adsorption	 (a),	 axial	packed	bed	adsorption	or	 axial	 flow	
chromatography	(b),	and	radial	packed	bed	adsorption	or	radial	flow	chromatography	(c).	
Besides	the	packed	bed	configurations,	particles	can	also	be	suspended	in	a	fluidized	
or	 expanded	 bed	 allowing	 particulate	 matter	 to	 pass	 through	 the	 column.	 In	 most	
cases,	desorption	of	the	target	component	is	performed	in	a	packed	bed	configuration,	
due	 to	 the	 high	 resolution	 and	 smaller	 volumes	 of	 desorption	 buffer	 required	 to	
release	 the	 target	 component.	 Also	 magnetic	 particles	 may	 be	 used	 which	 are	
captured	with	a	magnetic	field.	
It	 is	 also	 possible	 to	 use	 a	 stack	 of	membranes	 or	 a	monolith	 instead	 of	 adsorbent	
particles.	A	monolith	is	a	solid	material,	which	is	highly	porous,	and	in	which	pores	are	
highly	interconnected.	Porous	membranes	and	monoliths	are	similar	to	packed	beds,	
except	 for	 the	 lack	of	 intraparticle	 diffusion	 as	 in	 porous	particles.	Because	of	 large	
through‐pores,	the	pressure	drop	is	generally	lower	than	for	packed	beds.	A	drawback	
of	membranes	and	monoliths	is	that	the	adsorption	capacity	is	usually	lower	than	for	
a	packed	bed	of	porous	particles.	
1.4 Research	aim	
Preparative	 affinity	 chromatography	 is	 a	 very	 selective	 method	 of	 separation.	
However,	it	is	not	a	continuous	process,	it	is	labour	intensive	and	requires	significant	
amounts	 of	 solvents.	 On	 top	 of	 that,	 the	 affinity	 ligands	 are	 often	 costly.	 As	 a	
consequence,	affinity	chromatography	is	mainly	used	in	the	pharmaceutical	industry.	
The	 aim	 of	 the	 research	 described	 in	 this	 thesis	was	 to	 investigate	 the	 potential	 of	
affinity	 chromatography	 for	 isolating	 low‐concentrated	 (minor)	proteins	 in	 the	 food	
industry.	The	streams	in	the	food	industry	are	usually	much	larger	and	less	pure	than	
in	 the	 pharmaceutical	 industry	 and	 many	 target	 components	 are	 present	 in	 low	
concentrations.	Besides,	food	products	offer	an	economical	challenge	as	compared	to	
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pharmaceuticals,	 since	 the	 prices	 of	 the	 products	 are	 usually	 much	 lower	 than	 for	
pharmaceuticals.	 In	 this	 research	we	 identified	 the	opportunities	 and	 challenges	 for	
successful	application	of	VHH	 ligand	affinity	 chromatography	on	a	 large	scale	 in	 the	
food	 industry.	 In	 addition,	 we	 set	 up	 a	 window	 of	 operation	 regarding	 different	
aspects	 of	 affinity	 chromatography,	 such	 as	 the	 choice	 of	 resin,	 process	 yields	 and	
process	design.	
1.5 Thesis	outline	
Bovine	serum	albumin	(BSA)	was	chosen	as	a	model	minor	protein	in	dairy	streams.	A	
BSA‐binding	VHH	ligand	was	used.	Bovine	whey	was	chosen	as	a	model	feed	stream	
for	 the	 food	 industry.	 The	 purification	 of	 BSA	 from	 bovine	 whey	 is	 described	 in	
Chapter	 2.	 The	 adsorption	 isotherm	 of	 BSA	 binding	 to	 the	 affinity	 resin	 was	
measured,	 and	 a	 complete	 purification	 process	 with	 adsorption,	 washing	 and	
desorption	 steps	was	 set	 up	 and	 demonstrated	 on	 lab‐scale	 for	 pure	 BSA	 solutions	
with	high	and	low	BSA	concentration	and	for	bovine	whey.	
To	 design	 an	 affinity	 chromatography	 process,	 characterization	 of	 the	 ligand	 is	
essential.	 In	 Chapter	 3,	 the	 binding	 reaction	 between	 the	 VHH	 ligand	 and	 BSA	 is	
investigated	using	isothermal	titration	calorimetry.	With	this	method	it	is	possible	to	
accurately	 determine	 the	 thermodynamics	 of	 binding	 over	 a	 range	 of	 pH	 and	
temperature	values.	This	 information	can	be	used	 to	 find	 the	optimal	 conditions	 for	
adsorption	and	desorption.	
A	ligand	has	to	be	immobilized	onto	a	stationary	phase	before	it	can	be	used	in	affinity	
chromatography,	and	the	immobilization	itself	can	strongly	influence	the	performance	
of	the	system.	Many	adsorbents	with	different	backbone	materials	and	immobilization	
chemistries	 are	 commercially	 available.	 In	Chapter	4,	we	 compare	 several	 different	
resins	 for	 packed	 bed	 chromatography	 and	 propose	 a	 method	 to	 determine	 which	
adsorbent	is	best	based	on	process	requirements.	
Compared	 to	 for	 example	 adsorbents	 for	 ion	 exchange	 chromatography,	 the	
adsorption	 capacity	 of	 affinity	 chromatography	 adsorbents	 is	 relatively	 low.	 The	
feasibility	 of	 a	 cost‐efficient	 chromatography	 process	 relies	 on	 efficient	 use	 of	 the	
adsorbent.	In	Chapter	5	we	describe	the	challenges	to	be	overcome	in	immobilization	
of	ligands	such	as	the	VHH	used	in	this	research.	
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Most	research	on	affinity	chromatography	is	based	on	the	use	of	axial	 flow	columns.	
However,	 a	 radial	 flow	 column	 may	 be	 an	 option	 for	 scale‐up.	 In	 Chapter	 6	 the	
similarities	 and	 differences	 between	 the	 two	 configurations	 are	 described	 using	
experiments	and	mathematical	modelling.		
Chapter	7	concludes	this	research	with	a	general	discussion	on	the	opportunities	and	
challenges	 for	 affinity	 chromatography	 in	 the	 food	 industry.	 A	 few	 other	 popular	
configurations	 for	affinity	 chromatography,	 such	as	membrane	 chromatography,	 are	
described	and	the	research	discussed	in	the	preceding	chapters	is	put	into	a	broader	
perspective.	
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Chapter	2	
Isolation	of	bovine	serum	albumin	from	whey	using	
affinity	chromatography	
	
Abstract	
The	 adsorption	 of	 bovine	 serum	 albumin	 (BSA)	 to	 a	 chromatography	 resin	 with	
immobilized	llama	antibody	fragments	as	affinity	ligands	was	investigated	using	batch	
adsorption	and	packed	bed	chromatography.	The	maximum	adsorption	capacity	of	the	
affinity	 resin	was	21.6	mg/ml	with	 a	Langmuir	 equilibrium	 constant	 of	 20.4	ml/mg	
(1.37×106	 M‐1).	 Using	 packed	 bed	 chromatography,	 BSA	 was	 adsorbed	 from	 pure	
solutions	with	1	mg/ml	BSA	and	0.1	mg/ml	BSA.	Full	recovery	of	BSA	was	achieved	by	
desorption	at	pH	3.	BSA	could	be	concentrated	to	6.9	and	7.7	mg/ml	for	the	1	mg/ml	
and	0.1	mg/ml	experiment	respectively,	when	pooling	the	desorption	fractions	with	a	
concentration	 higher	 than	 1	 mg/ml.	 These	 pools	 comprised	 over	 95%	 of	 the	 total	
desorption	peak	 for	both	concentrations.	BSA	was	also	 isolated	 from	 filtered	bovine	
cheese	whey	containing	less	than	0.1	mg/ml	BSA.	Together	with	BSA,	β‐lactoglobulin	
and	α‐lactalbumin	 concentrations	were	 analysed.	 The	 purified	BSA	was	 in	 this	 case	
concentrated	 to	 7.4	 mg/ml	 BSA	 for	 the	 desorption	 fractions	 with	 a	 concentration	
higher	 than	1	mg/ml.	This	pool	comprised	over	90%	of	the	total	BSA	desorbed.	The	
presence	of	other	components	in	the	feedstock	did	not	alter	the	adsorption	capacity	of	
the	 affinity	 resin.	 Trace	 amounts	 of	 β‐lactoglobulin	 and	 an	 unidentified	 component	
were	found	in	the	desorption	peak;	no	α‐lactalbumin	was	found.	The	results	show	that	
high	 recovery	 combined	 with	 high	 purity	 can	 be	 obtained	 using	 affinity	
chromatography;	 the	 affinity	 process	 presented	 in	 this	 chapter	 can	 be	 easily	
translated	to	the	isolation	of	other	minor	proteins	in	the	food	industry.	
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2.1 Introduction	
Whey	is	a	by‐product	in	the	dairy	industry	that	has	become	an	increasingly	interesting	
source	 of	 proteins	 with	 high	 nutritional	 or	 pharmaceutical	 value.	 Whey	 is	 a	 dilute	
solution,	containing	less	than	7%	(w/w)	dry	matter.	Only	1%	(w/w)	protein	is	present	
in	whey;	other	components	are	lactose,	fat,	minerals	and	vitamins.	The	two	proteins	β‐
lactoglobulin	 (β‐LG)	 and	 α‐lactalbumin	 (α‐LA)	 are	 the	 most	 abundant	 proteins	 [1].	
Besides	 these	 two	proteins,	 other	minor	proteins	are	present	 such	as	bovine	 serum	
albumin	(BSA),	immunoglobulins	and	enzymes.	
The	main	 challenge	 in	 the	 isolation	and	purification	of	 specific	whey	proteins	 is	 the	
low	concentration	of	these	proteins	and	the	complexity	of	whey.	Several	methods	for	
whey	protein	purification	and	fractionation	are	described	in	literature.	An	overview	of	
these	methods	 is	 for	 example	given	by	Zydney	 [2],	 and	El‐Sayed	and	Chase	 [1].	The	
most	important	methods	are	ion	exchange	chromatography	and	membrane	filtration;	
however,	 these	 processes	 are	 usually	 not	 suitable	 for	 isolation	 of	 individual	 minor	
proteins	because	of	their	limited	selectivity.	
Affinity	 chromatography	 is	 a	 more	 promising	 method	 for	 the	 isolation	 of	 specific	
components.	In	affinity	chromatography	a	ligand	attached	to	a	stationary	phase	(e.g.,	a	
bead	made	of	silica	or	agarose)	interacts	strongly	with	the	component	of	interest.	To	
recover	the	component,	it	is	desorbed	using	a	desorption	buffer,	usually	with	a	low	pH	
or	 high	 salt	 concentration.	 Many	 examples	 of	 affinity	 chromatography	 exist	 with	
various	 types	of	 ligands	and	stationary	phases.	We	 found	several	 reports	on	affinity	
chromatography	 for	 protein	 purification	 from	 whey	 (for	 example,	 [3‐6]).	 Heparin	
affinity	 chromatography	 can	 for	 example	 be	 used	 to	 isolate	 protein	 fractions	 or	
lactoferrin.	With	immobilized	antibodies	a	specific	component	can	be	isolated,	but	at	
high	costs	that	limits	the	use	to	analytical	purposes.	
In	this	research	we	focus	on	the	use	of	antibody‐derived	ligands	for	selective	protein	
isolation.	These	ligands	are	made	from	the	binding	domain	fragment	from	antibodies	
from	 Camelidae	 species.	 These	 antibodies	 lack	 so‐called	 light	 chains	 [7].	 The	 small	
binding	domain	 fragment	called	 the	VHH	(variable	heavy‐chain	 region	of	 the	heavy‐
chain	 antibody)	 can	 be	 isolated	 from	 these	 antibodies.	 These	 VHH	 ligands,	 with	 a	
molecular	weight	 of	 12‐15	 kDa,	 have	 high	 thermal	 and	 physical	 stability,	which	 are	
important	 qualities	 for	 ligands	 in	 bioprocessing.	 The	 VHH	 can	 be	 expressed	 in	
microorganisms,	 such	 as	 Saccharomyces	 cerevisiae	 [8,	 9],	 for	 industrial‐scale	
processes.	 Like	 the	 conventional	 monoclonal	 antibodies,	 the	 VHH	 can	 be	 raised	
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against	one	specific	antigen.	Therefore,	the	VHH	ligands	can	be	an	efficient	and	cost‐
effective	 alternative	 for	 conventional	 immunoaffinity	 chromatography.	 Recently,	 a	
commercialized	resin	with	immobilized	VHH	ligands	has	been	investigated	by	Zandian	
and	Jungbauer	[10].	
In	 this	 study	 the	 use	 of	 VHH	 for	 purification	 of	 bovine	 serum	 albumin	 (BSA)	 from	
cheese	 whey	 is	 investigated.	 The	 VHH	 ligand	 was	 developed	 for	 multi‐species	
albumins	 by	 BAC	 (Naarden,	 The	 Netherlands)	 and	 was	 provided	 immobilized	 onto	
NHS	Sepharose	4	Fast	Flow	resin	(GE	Healthcare,	Uppsala,	Sweden).	The	adsorption	
capacity	and	equilibrium	constant	were	determined	with	equilibrium	measurements	
using	pure	BSA	solution.	The	recovery,	final	concentration	and	purity	of	BSA	purified	
from	filtered	cheese	whey	were	measured	to	determine	whether	the	chromatography	
process	 is	 suitable	 for	minor	 protein	 purification.	 Furthermore,	we	 investigated	 the	
productivity	of	the	purification	process.	
2.2 Materials	and	methods	
2.2.1 Materials	
Bovine	 serum	 albumin	 (BSA)	 type	 A3059	 (≥98%	 pure)	 was	 purchased	 at	 Sigma‐
Aldrich	(Zwijndrecht,	The	Netherlands).	NHS‐Sepharose	4	Fast	Flow	with	immobilized	
multi‐species	 albumin	 ligand	was	 supplied	 by	 BAC	 BV	 (Naarden,	 The	 Netherlands).	
Bovine	 cheese	 whey	 was	 supplied	 by	 FrieslandCampina	 (Amersfoort,	 The	
Netherlands).	All	other	reagents	used	were	of	analytical	grade	and	purchased	at	Merck	
(Darmstadt,	 Germany).	 Pure	 water	 was	 obtained	 from	 a	 Milli‐Q	 system	 (Millipore,	
Billerica,	USA).	
2.2.2 Buffer	preparation	
A	phosphate	buffer	was	prepared	by	mixing	10	mM	solutions	of	Na2HPO4	and	KH2PO4	
containing	50	mM	NaCl	 until	 pH	6.5	was	 reached.	 The	pH	 and	 ionic	 strength	 of	 the	
phosphate	buffer	were	similar	to	the	values	for	whey.	This	phosphate	buffer	was	used	
as	the	adsorption	buffer	for	the	experiments	with	pure	BSA	solutions	and	as	the	wash	
buffer	for	all	experiments.	The	desorption	buffer	was	prepared	by	acidifying	a	0.1	M	
glycine	 solution	 with	 1	 M	 HCl	 until	 a	 pH	 of	 3	 was	 reached.	 Prior	 to	 the	
chromatography	 experiments	 the	 buffers	 were	 filtered	 over	 a	 0.22	 μm	 nylon	 filter	
under	vacuum.	
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2.2.3 Batch	uptake	experiments	
A	resin	slurry	was	prepared	by	repetitive	washing	and	draining	the	affinity	resin	over	
a	0.45	μm	filter.	Most	of	the	liquid	was	removed	by	applying	a	vacuum	over	the	filter.	
The	remaining	 resin	 is	 called	 the	drained	resin.	The	resin	was	washed	3	 times	with	
Milli‐Q	water	 and	 3	 times	with	 10	mM	phosphate	 buffer	with	 50	mM	NaCl,	 pH	 6.5.	
Then	 buffer	 was	 added	 to	 the	 desired	 dilution	 (25‐50%	 resin).	 One	 millilitre	 of	
drained	resin	corresponds	to	approximately	1.1	ml	of	packed	resin.	The	resin	slurry	
was	then	transferred	to	tubes	and	BSA	solutions	of	0	to	5	mg/g	were	added.	The	tubes	
were	then	gently	rotated	for	24	hours	at	room	temperature.	Afterwards,	the	resin	was	
allowed	to	settle	and	the	protein	content	of	the	supernatant	was	measured	using	a	UV	
spectrophotometer	at	280	nm.	
A	 non‐linear	 fit	 between	 the	 equilibrium	 BSA	 concentration	 and	 the	 amount	 of	
adsorbed	BSA	was	performed	using	the	Langmuir	equation:	
ݍ ൌ ௤೘௄ೌ஼ଵା௄ೌ஼	 (2.1)	
In	Equation	2.1,	q	represents	the	amount	of	BSA	bound	to	the	resin,	qm	the	maximum	
adsorption	 capacity	 of	 the	 resin,	 c	 the	 concentration	 of	 unbound	 BSA	 in	 the	
surrounding	 fluid,	 and	 Ka	 the	 equilibrium	 constant	 defined	 as	 the	 adsorption	 rate	
constant	divided	by	the	desorption	rate	constant.	
The	 amount	 of	 BSA	 adsorbed	 to	 the	 resin	 seemed	 to	 increase	 further	 than	 the	
predicted	 isotherm	 describes,	 which	may	 suggest	multilayer	 adsorption.	 Therefore,	
also	a	BET	adsorption	isotherm	was	used	to	fit	the	batch	uptake	data:	
ݍ ൌ ௤೘௄ೌ஼
ቀଵା௄ೌ஼ି ಴಴ೞቁ൬ଵି
಴
಴ೄ൰
	 (2.2)	
In	Equation	2.2,	q	represents	the	amount	of	BSA	bound	to	the	resin,	qm	the	maximum	
monolayer	adsorption	capacity	of	 the	 resin,	c	 the	 concentration	of	unbound	BSA,	Ka	
the	equilibrium	constant	and	cS	the	saturation	concentration	of	BSA.	
2.2.4 Packed	bed	adsorption	experiments	
Packed	bed	experiments	were	performed	using	a	Tricorn	5/50	column	attached	to	an	
Äkta	 purifier	 100	 system	 from	GE	Healthcare	 (Uppsala,	 Sweden).	 The	 height	 of	 the	
resin	bed	was	4.75	cm.	Proper	packing	of	 the	column	was	evaluated	by	determining	
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the	 asymmetry	 of	 the	 retention	 peak	 of	 1‐2	 v/v%	 acetone	 in	 ultrapure	 water	 at	 a	
superficial	 liquid	velocity	of	30	cm/h.	According	to	the	manufacturer’s	specifications	
the	asymmetry	should	be	above	0.8	and	below	1.5.	When	the	asymmetry	was	outside	
of	this	range,	the	column	was	disassembled	and	re‐packed.	Between	experiments,	the	
column	was	stored	at	4°C	in	20%	ethanol	in	Milli‐Q	water.	
BSA	 solutions	 of	 1	mg/ml	 and	0.1	mg/ml	were	used	 as	 a	 feed	 solution	 as	well	 as	 a	
sample	of	bovine	cheese	whey.	The	BSA	solutions	were	filtered	under	vacuum	over	a	
0.45	 μm	PVDF	 filter	 (Steritop,	Millipore,	 Billerica,	 USA).	 The	 cheese	whey	 had	 been	
frozen	at	 ‐18°C	prior	to	use.	Before	use,	 the	whey	was	thawed	and	centrifuged	for	3	
minutes	at	5000	rpm	and	filtered	under	vacuum	over	a	0.45	μm	PVDF	filter	(Steritop,	
Millipore,	 Billerica,	 USA)	 with	 a	 glass	 pre‐filter.	 The	 pre‐filter	 had	 to	 be	 replaced	
several	times	during	filtration.	
For	 the	 experiments	 with	 a	 BSA	 concentration	 of	 0.1	 mg/ml	 and	 for	 the	 whey	
experiments,	the	BSA	solution	or	whey	was	cooled	in	a	water	bath	to	a	temperature	of	
approximately	9°C.	The	column	was	cooled	by	wrapping	a	tube	connected	to	the	water	
bath	 around	 the	 column	 and	 insulating	 the	 assembly	 with	 aluminium	 foil.	 The	
temperature	 inside	a	similar	column	filled	with	water	was	approximately	10°C.	This	
cooling	prevented	potential	microbial	growth	which	could	otherwise	have	occurred	at	
the	relatively	long	loading	time	of	up	to	800	minutes.	
Before	each	experiment,	the	column	was	rinsed	with	at	least	3	column	volumes	(CV)	
of	Milli‐Q	water	 and	 subsequently	with	phosphate	 buffer	 until	 a	 stable	 conductivity	
signal	was	 reached.	 The	 feed	 solution	was	pumped	 over	 the	 column	 via	 the	 system	
pump.	To	avoid	protein	loss,	the	in‐line	filter	was	removed	from	the	Äkta	system.	The	
flow	rate	was	0.5	ml/min	throughout	the	experiment.	
Protein	 permeating	 through	 the	 column	 was	 detected	 using	 the	 Äkta’s	 in‐line	 UV	
detector	 at	 280	 nm.	 After	 adsorption,	 the	 column	 was	 rinsed	 with	 several	 column	
volumes	of	phosphate	buffer	(4	CV	for	1	mg/ml	BSA,	6	CV	for	0.1	mg/ml	BSA	and	10	
CV	for	whey).		
The	UV	absorbance	data	from	the	Äkta	were	converted	to	BSA	concentrations	using	a	
calibration	curve	 for	 the	pure	BSA	solutions.	This	curve	was	obtained	by	measuring	
the	stable	absorbance	signal	of	BSA	samples	at	concentrations	ranging	 from	0	 to	20	
mg/ml	without	 attaching	 a	 column.	 However,	 using	 this	 curve	 the	maximum	 outlet	
concentration	in	the	adsorption	phase	of	the	experiment	with	1	mg/ml	BSA	was	found	
to	 be	 overestimated	 by	 approximately	 0.05	 mg/ml.	 For	 the	 experiment	 with	 0.1	
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mg/ml	BSA	this	value	was	overestimated	by	approximately	0.02	mg/ml.	We	corrected	
the	calibration	curve	accordingly	to	be	able	to	calculate	the	BSA	recovery.	
For	the	cheese	whey	experiments	fractions	were	taken	and	frozen	at	‐18°C	until	they	
were	analysed	using	HPLC.	The	average	eluate	volume	of	each	sample	was	used	to	plot	
the	concentration	profile.	
2.2.5 HPLC	analysis	
The	 levels	 of	 BSA	 and	 the	 major	 whey	 proteins	 α‐lactalbumin	 and	 β‐lactoglobulin	
were	 determined	 using	 RP‐HPLC.	 A	 Surveyor	 HPLC	 system	 by	 Thermo	 Scientific	
(Waltham,	USA)	was	used	with	a	Polymer	Labs	PLRP‐S	column	(300	Å,	8	μm,	150	×	4.6	
mm).	 The	 method	 used	 was	 slightly	 adapted	 from	 the	 method	 supplied	 by	 the	
manufacturer.	Solvent	A	was	a	solution	of	0.1%	trifluoroacetic	acid	in	ultrapure	water,	
solvent	B	was	a	solution	of	0.1%	trifluoroacetic	acid	in	acetonitrile.	Elution	took	place	
using	the	following	gradients	of	A:	65‐62%,	0‐8	minutes;	62‐68%,	8‐16	minutes;	58‐
54%,	 16‐22	 minutes;	 54‐0%,	 22‐22.5	 minutes;	 0‐0%,	 22.5‐23.5	 minutes;	 65‐65%,	
23.5‐29.5	minutes.	A	UV	detector	at	220	nm	was	used	for	protein	quantification.	
2.3 Results	and	discussion	
2.3.1 Batch	uptake	experiments	
With	 equilibrium	 batch	 uptake	 experiments	 the	 characteristics	 of	 the	 adsorption	 of	
BSA	 to	 the	 immobilized	 ligand	can	be	determined.	We	 incubated	the	resin	with	BSA	
for	approximately	24	hours,	which	was	 long	enough	 for	diffusion	and	adsorption	of	
BSA	as	was	found	in	prior	(unpublished)	experiments.	The	characteristics	that	can	be	
determined	are	the	maximum	adsorption	capacity	of	the	resin,	qm,	and	the	equilibrium	
constant,	Ka.	The	equilibrium	constant	is	equal	to	the	adsorption	rate	constant	divided	
by	the	desorption	rate	constant.	A	high	Ka	value	therefore	indicates	strong	binding.	
The	 maximum	 adsorption	 capacity	 qm	 was	 23.8	 mg	 BSA/g	 of	 drained	 resin,	 which	
corresponds	 to	 21.6	mg	 BSA/ml	 of	 packed	 resin	 (see	 Equation	 2.1	 and	 Figure	 2.1).	
This	value	is	similar	to	the	adsorption	capacity	of	Cibacron	Blue	Sepharose	from	the	
same	manufacturer	 (GE	Healthcare,	 Uppsala,	 Sweden),	 a	 resin	with	 an	 immobilized	
synthetic	dye.	
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Figure	2.1.	BSA	adsorbed	to	the	affinity	resin	as	a	function	of	equilibrium	BSA	concentration	with	10	mM	
phosphate	buffer,	50	mM	NaCl	pH	6.5	(●)	and	0.1	M	glycine	buffer	pH	3	(○)	at	room	temperature	after	24	
hours	of	adsorption.	The	solid	line	represents	the	Langmuir	fit	with	qm	=	21.6	mg/ml	and	Ka	=	20.4	ml/mg;	
the	dashed	line	represents	the	BET	fit	with		qm	=	22.5	mg/ml,	Ka	=	23.7	ml/mg,	cs	=	24.4	mg/ml.	
The	 isotherm	 depicted	 in	 Figure	 2.1	 indicates	 an	 equilibrium	 constant	 (Ka,	 see	
Equation	 2.1)	 value	 of	 20.4	 ml/mg	 or	 approximately	 1.37×106	 M‐1	 (the	 molecular	
weight	 of	BSA	 is	 approximately	 67	 kDa).	 The	 adsorption	kinetics	 of	 the	VHH	 ligand	
were	also	characterized	by	the	manufacturer	BAC	(Naarden,	The	Netherlands)	using	
Surface	Plasmon	Resonance	(SPR).	According	to	their	measurements	the	ligand	has	a	
Ka	 value	 of	 3.84×107	 M‐1	 or	 approximately	 573	 ml/mg,	 which	 indicates	 a	 higher	
binding	 strength	 than	 measured	 with	 our	 uptake	 experiments.	 There	 are	 several	
possibilities	 to	 explain	 the	 difference	 between	 the	 two	 values.	 First,	 the	 adsorption	
buffers	and	 immobilization	method	used	 for	SPR	were	different	 from	those	used	 for	
the	 batch	 experiments.	 Second,	 in	 the	 pores	 of	 a	 chromatography	 resin,	 steric	
hindrance	may	occur,	by	blocking	of	pores	by	adsorbed	protein,	and	by	ligands	being	
immobilised	too	close	to	each	other	to	allow	a	protein	molecule	to	be	bound	on	each	
ligand.	 The	 ligand	 density	 is	 very	 low	 in	 SPR	 so	 steric	 hindrance	 is	 in	 that	 case	
unlikely.	 Third,	 the	 immobilization	 method	 and	 material	 are	 different	 and	 these	
aspects	influence	the	binding	kinetics.	
Zandian	 and	 Jungbauer	 also	 found	 a	 lower	 value	 for	 the	 binding	 strength	 in	 batch	
uptake	 experiments	 compared	 to	 SPR	 [10].	 They	 ascribed	 this	 mainly	 to	 the	 slow	
diffusion	 in	 the	 resin,	which	 is	not	present	 in	 the	SPR	measurement.	However,	 they	
have	 measured	 the	 adsorption	 in	 time,	 while	 in	 our	 study	 we	 only	 measured	
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equilibrium	data	after	allowing	a	considerable	time	for	diffusion.	Therefore,	diffusion	
limitation	is	probably	not	the	cause	of	the	differences	we	found	here.	
The	adsorption	data	have	also	been	fitted	to	the	BET	model,	because	the	curve	seems	
to	show	some	form	of	multilayer	sorption.	In	the	case	of	BSA	the	assumption	that	only	
monolayer	adsorption	takes	place	may	not	be	valid	since	BSA	is	known	to	form	dimers	
[11].	It	is	therefore	possible	that	BSA	does	not	only	adsorb	to	the	ligand,	but	also	binds	
to	other	BSA	molecules	 in	 the	 resin	particle,	which	 results	 in	multilayer	adsorption.	
The	 BET	 model	 takes	 the	 possibility	 of	 protein	 association	 or	 aggregation	 into	
account.	The	values	found	for	the	BET	fit	are	maximum	adsorption	capacity	qm	=	22.5	
mg/ml	packed	resin,	Ka	=	23.7	ml/mg,	and	cs	=	24.4	mg/ml	packed	resin	(see	Equation	
2.2	and	Figure	2.1).	The	deviation	between	the	two	adsorption	models,	Langmuir	and	
BET,	 becomes	 most	 apparent	 at	 BSA	 concentrations	 above	 1.5	 mg/ml.	 For	 minor	
component	separation,	the	Langmuir	isotherm	would	therefore	suffice.	
The	 adsorption	 of	 BSA	 to	 the	 affinity	 resin	was	 also	measured	with	 the	 desorption	
buffer	 (Figure	2.1).	The	amount	of	BSA	adsorbed	was	very	 low	 in	 this	buffer,	 so	 the	
desorption	buffer	is	effective.	
2.3.2 Packed	bed	experiments	with	pure	BSA	solution	
The	adsorption	of	BSA	to	the	 immobilized	 ligand	was	also	studied	using	packed	bed	
chromatography.	In	Figure	2.2the	outlet	BSA	concentration	as	a	function	of	the	outlet	
volume	is	shown.	At	the	start	of	the	experiment	a	BSA	solution	is	applied	and	BSA	is	
adsorbed	to	the	column.	Somewhat	 later	BSA	starts	to	break	through	and	finally	the	
outlet	concentration	is	equal	to	the	inlet	concentration.	The	little	‘hump’	at	the	start	of	
the	curve	may	be	due	to	mass	transfer	limitation:	some	of	the	BSA	molecules	entering	
the	column	may	not	have	had	enough	time	to	diffuse	into	the	beads	and	adsorb.	After	
full	breakthrough,	the	inlet	solution	is	switched	to	the	washing	buffer	and	so	the	non‐
adsorbed	BSA	is	flushed	from	the	column	until	the	outlet	concentration	reaches	zero.	
The	inlet	solution	is	changed	to	desorption	buffer	and	the	adsorbed	BSA	is	released	in	
a	tall	and	narrow	peak.	
The	 total	 area	 underneath	 the	 chromatogram	 should	 represent	 the	 total	 amount	 of	
BSA	 applied	 to	 the	 column	 if	 all	 BSA	 is	 desorbed	 from	 the	 column.	 The	 area	
underneath	 the	 adsorption	 and	 washing	 stage	 is	 due	 to	 column	 overloading	 and	
represents	 BSA	 that	 was	 not	 adsorbed	 by	 the	 column.	 The	 area	 underneath	 the	
desorption	peak	was	adsorbed	and	later	released.	
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Figure	2.2.	BSA	 outlet	 concentration	 as	 a	 function	 of	 outlet	 volume.	 The	BSA	 concentrations	 of	 the	 feed	
solution	 were	 1	 mg/ml	 (a	 and	 b,	 room	 temperature)	 and	 0.1	 mg/ml	 (c	 and	 d,	 ~10°C).	 Adsorption	 and	
washing	with	10	mM	phosphate	buffer,	50	mM	NaCl,	pH	6.5,	desorption	with	0.1	M	glycine	pH	3	at	a	flow	
rate	of	0.5	ml/min.	
For	 the	 experiment	with	 approximately	 1	mg/ml	BSA	we	 applied	 approximately	 57	
mg	in	total,	and	the	area	underneath	the	chromatogram	represents	approximately	53	
mg.	For	the	0.1	mg/ml	experiment	we	applied	59	mg	of	BSA	and	calculated	a	recovery	
of	60	mg.	In	both	cases	we	may	assume	total	recovery	because	the	difference	between	
BSA	applied	and	calculated	is	less	than	10%.	
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From	Figure	2.2	we	may	conclude	that	the	BSA	sample	in	the	desorption	peak	is	more	
concentrated	than	the	initial	sample.	For	the	high	concentration	experiment	a	total	of	
18.2	mg	of	BSA	is	desorbed	from	the	column.	Since	the	column	volume	is	0.93	ml,	the	
adsorption	capacity	equals	19.5	mg/ml	packed	 resin.	This	 is	 in	 accordance	with	 the	
equilibrium	adsorption	capacity	found	in	the	adsorption	isotherm	in	Figure	2.1.	If	we	
would	pool	the	entire	desorption	peak,	the	concentration	would	be	approximately	3.7	
mg/ml.	If	we	would	only	pool	the	fractions	with	a	concentration	higher	than	the	feed	
concentration	of	1	mg/ml,	the	concentration	would	be	approximately	6.9	mg/ml.	This	
part	of	the	desorption	peak	comprises	96.7%	of	the	total	peak.	
For	the	low	concentration	experiment	17.2	mg	of	BSA	is	desorbed,	which	equals	18.5	
mg/ml	packed	 resin,	which	 is	 slightly	higher	 than	expected	 from	the	 isotherm.	Also	
here	the	BSA	is	more	concentrated	in	the	desorption	peak:	approximately	2.69	mg/ml	
for	the	entire	peak	and	7.7	mg/ml	for	the	part	of	the	peak	higher	than	1	mg/ml	(95.6%	
of	 the	 entire	 peak).	 This	 indicates	 a	 concentration	 factor	 of	 up	 to	 77.	 For	 minor	
component	 separation,	 it	 is	 crucial	 that	 the	 component	 can	 be	 retrieved	 in	 a	much	
more	concentrated	form.	
2.3.3 BSA	adsorption	from	filtered	whey	
BSA	was	also	purified	from	400	ml	bovine	cheese	whey	that	had	been	frozen	prior	to	
use.	We	 filtered	 the	whey	prior	 to	 the	purification	because	of	 the	particulate	matter	
and	HPLC	 analysis	 of	 the	 samples.	 Filtration	 after	 the	 packed	 bed	 adsorption	 could	
lower	 the	 amount	 of	 proteins	 present	 in	 the	 sample	 and	 would	 thus	 introduce	 a	
source	of	 experimental	 error	 in	 the	HPLC	 analysis.	 The	 concentrations	of	 the	major	
whey	proteins	β‐LG	and	α‐LA	were	measured	as	well	as	 the	BSA	concentration.	The	
initial	concentrations	in	the	filtered	whey	sample	were	2.3	mg/ml	for	β‐LG,	0.5	mg/ml	
for	α‐LA	and	0.1	mg/ml	 for	BSA.	Normally,	 the	 concentrations	of	 these	proteins	are	
higher	 in	whey.	 Some	 of	 the	 protein	 probably	 precipitated	 due	 to	 freezing	 and	was	
removed	in	the	following	filtration.	
In	 Figure	 2.3a	 the	 chromatograms	 for	 BSA,	 β‐LG	 and	 α‐LA	 are	 shown.	 In	 the	
adsorption	 phase	 up	 to	 400	ml	 outlet	 volume	 breakthrough	 of	 all	 three	 proteins	 is	
observed.	Then	the	concentrations	drop	to	zero	due	to	washing.	At	approximately	410	
ml	desorption	starts	and	it	is	clearly	visible	that	BSA	elutes	from	the	column	in	a	sharp	
peak.	
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Figure	2.3.	α‐LA	(○),	and	β‐LG	(●;	both	left	Y‐axis)	and	BSA	concentration	(▲,	right	Y‐axis)	as	a	function	of	
outlet	 volume	 (a);	 BSA	 concentration	 as	 a	 function	 of	 outlet	 volume	 (b).	 Adsorption	with	 filtered	 whey,	
washing	with	10	mM	phosphate	buffer,	50	mM	NaCl	pH	6.5	and	desorption	with	0.1	M	glycine	pH	3	at	a	flow	
rate	of	0.5	ml/min	at	approximately	10°C.		
2.3.3.1 Adsorption	and	washing	
In	the	adsorption	phase	(see	Figure	2.3a)	we	can	clearly	see	that	BSA	is	adsorbed	to	
the	 column,	 and	 this	 is	 proven	 in	 the	 desorption	 peak	 in	 the	 final	 stage	 of	 the	
chromatography	process.	Both	α‐LA	and	β‐LG	break	through	sooner	than	BSA.	There	
are	 some	 fluctuations	 in	 the	 β‐LG	 concentration,	 the	 reason	 for	 this	 fluctuation	 is	
unknown.	
At	the	washing	stage,	the	protein	concentrations	drop	significantly.	At	the	end	of	the	
10	 CV	 washing	 stage,	 the	 protein	 concentrations	 were	 0.008	 mg/ml	 for	 β‐LG	 and	
0.014	mg/ml	for	BSA,	α‐LA	was	not	present.	The	higher	concentration	for	BSA	in	the	
washing	stage	is	an	indication	that	BSA	is	more	strongly	retained	by	the	column	than	
the	 other	 proteins.	 The	 washing	 stage	 could	 have	 been	 prolonged	 to	 remove	 all	
proteins	from	the	column.	However,	10	CV	volumes	of	washing	buffer	is	already	more	
than	 for	 the	experiments	with	pure	BSA	solutions	 (4	and	6	CV	 for	1	mg/ml	and	0.1	
mg/ml	BSA).	Washing	 is	 clearly	 slower	 for	 the	whey	experiment	 than	 for	pure	BSA,	
indicating	that	all	proteins	are	somehow	more	strongly	retained	by	the	column.	 It	 is	
possible	 that	 unbound	 proteins	 inhibit	 the	 diffusion	 of	 proteins	 from	 within	 the	
particle,	but	the	exact	reason	for	the	longer	washing	stage	is	unknown.	It	is	however	
important	 to	 note	 the	 large	 wash	 volume,	 because	 in	 industrial‐scale	 applications,	
washing	and	equilibration	may	thus	require	 larger	amounts	of	buffer	than	expected.	
This	 does	not	 only	 reduce	 the	productivity	 of	 the	 column,	 but	 it	 also	 requires	 large	
Chapter	2	
20	
buffer	 storage	 tanks	and	 results	 in	 significant	waste	 streams.	 In	 this	 experiment	we	
applied	 approximately	 400	CV	of	whey	 and	10	CV	of	washing	does	 not	 seem	much.	
However,	at	200	ml	(approximately	200	CV),	the	outlet	BSA	concentration	has	reached	
the	 inlet	 concentration	 and	 the	 adsorption	 stage	 could	 have	 been	 terminated.	 It	 is	
even	 more	 common	 to	 terminate	 adsorption	 and	 switch	 to	 washing	 at	 10%	
breakthrough	of	the	target	component,	which	in	this	case	would	be	at	40	CV.	In	that	
case,	 the	volume	required	 for	washing	would	equal	25%	of	 the	sample	volume.	The	
washing	stage	is	therefore	very	important.	We	will	 further	elaborate	on	this	 issue	in	
Section	2.3.4.	
2.3.3.2 Desorption,	purity	and	recovery	
The	 desorption	 peak	 shows	 a	 maximum	 BSA	 concentration	 of	 approximately	 8.6	
mg/ml	(see	Figure	2.3b).	The	amount	of	BSA	in	the	desorption	peak	equals	14.7	mg,	
which	 would	 correspond	 to	 15.8	 mg/ml	 packed	 resin.	 According	 to	 the	 Langmuir	
isotherm	 shown	 in	 Figure	 2.1,	 we	 would	 expect	 a	 capacity	 of	 approximately	 14.5	
mg/ml.	The	deviation	is	most	likely	due	to	experimental	error,	for	example	because	of	
the	different	protein	quantification	methods	 (direct	UV	measurement	versus	HPLC).	
We	may	therefore	conclude	that	the	presence	of	other	components	in	whey	does	not	
significantly	alter	the	adsorption	capacity	of	the	resin.	
The	BSA	concentration	in	the	total	desorption	peak	was	2.5	mg/ml,	and	7.4	mg/ml	for	
the	 part	 of	 the	 peak	 higher	 than	 1	mg/ml	 (91.9%	 of	 the	 total	 peak).	 This	 result	 is	
similar	to	the	6.9	mg/ml	and	7.7	mg/ml	obtained	in	the	pure	BSA	experiments.	
A	little	peak	of	β‐LG	was	present	in	the	desorption	peak	of	BSA.	The	total	amount	was	
less	 than	 0.02	 mg	 with	 the	 highest	 concentration	 measured	 being	 0.007	 mg/ml.	
Unfortunately	 this	 minor	 amount	 of	 β‐LG	 was	 eluted	 together	 with	 BSA.	 The	 β‐LG	
must	 have	 been	 retained	 to	 the	 column,	 but	 the	 adsorption	 is	 expected	 to	 be	 non‐
specific.	 A	 possible	 reason	 could	 be	 that	 β‐LG	 diffused	 into	 a	 particle	 and	 then	 got	
‘trapped’	when	BSA	molecules	were	adsorbed.	The	β‐LG	could	not	diffuse	out	of	 the	
particle	until	 some	BSA	molecules	were	desorbed,	which	only	happened	 in	 the	 final	
stages	 of	 the	 process.	 This	 could	 also	 explain	 the	 larger	 wash	 volume	 required	 for	
whey	compared	to	pure	BSA	solutions.	 In	former	experiments	(not	presented	in	this	
chapter)	 also	 minor	 quantities	 of	 β‐LG	 were	 present	 in	 the	 desorption	 peak.	 The	
reason	that	α‐LA	was	not	observed	is	probably	because	of	the	almost	five‐fold	lower	
concentration	of	α‐LA	compared	to	β‐LG.	
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Other	 than	 a	 trace	 of	 β‐LG,	 an	 unidentified	 component	 was	 seen	 in	 the	 HPLC	
chromatograms	of	the	desorption	fractions.	The	retention	time	for	BSA	for	the	HPLC	
method	used	was	approximately	15	minutes	and	 the	unknown	component	eluted	at	
around	 18	 minutes.	 The	 component	 was	 not	 seen	 on	 the	 HPLC	 chromatograms	 of	
whey,	 probably	 because	 of	 its	 low	 concentration.	 In	 terms	 of	 HPLC	 peak	 area,	 the	
unknown	 component	 comprised	 less	 than	 5%	 of	 the	 BSA	 peak	 area.	 We	 tested	
whether	the	peak	originated	from	the	buffer,	but	this	was	not	the	case.	Because	we	do	
not	know	what	 the	 component	 is,	we	 cannot	 calculate	 the	 exact	purity	of	BSA.	 It	 is,	
however,	likely	that	the	purity	well	exceeds	90%	based	on	the	proteins	we	measured.	
By	 dividing	 the	 amount	 of	 each	 protein	 in	 the	 column	 eluate	 by	 the	 amount	 of	 the	
protein	present	 in	 the	whey	sample	applied	we	could	calculate	 the	recovery	of	each	
protein.	 For	 β‐LG	 the	 recovery	 was	 97%,	 for	 α‐LA	 and	 BSA	 both	 104%,	 which	
represents	full	recovery	taking	into	account	experimental	error.	
2.3.4 Optimization	of	column	productivity	
In	 this	 chapter	 we	 measured	 full	 breakthrough	 curves,	 which	 is	 not	 common	 for	
industrial‐scale	 processes.	 As	 mentioned	 in	 Section	 2.3.3.1,	 the	 adsorption	 stage	 in	
these	processes	is	often	terminated	at	10%	breakthrough,	which	is	a	probably	a	good	
choice	 for	 high‐value	 products	 that	 have	 been	 produced	 specifically.	 Examples	 are	
antibodies,	 drugs,	 and	 fermentation	 products.	 However,	 in	 the	 case	 of	 minor	
component	 separation	 from	 large	 streams,	 the	10%	breakthrough	value	may	not	be	
the	most	ideal	in	terms	of	productivity.	
In	Figure	2.4	the	productivity	and	the	yield	of	the	adsorption	processes	for	0.1	mg/ml	
and	1	mg/ml	BSA	solutions,	as	discussed	in	Section	2.3.2,	are	shown	as	a	function	of	
BSA	breakthrough.	We	define	the	productivity	here	as	the	amount	of	BSA	that	can	be	
purified	 with	 the	 given	 column	 divided	 by	 the	 process	 time.	 The	 figures	 were	
generated	 with	 the	 same	 data;	 no	 model	 was	 applied.	 The	 little	 ‘hump’	 from	 the	
breakthrough	 curves	 (see	 Figure	 2.2)	 is	 somewhat	 magnified	 in	 the	 productivity	
curve.	In	Section	2.3.3.1	we	state	that	the	washing	stage	takes	at	least	10	CV	for	BSA	
purification	from	whey.	Desorption	takes	another	10	CV	and	then	the	column	needs	to	
be	regenerated	for	the	next	batch,	which	takes	at	least	4	CV.	Apart	from	the	adsorption	
phase,	 a	 total	 of	 24	 CV	 of	 buffers	 is	 required	 for	 the	 process,	 which	 is	 part	 of	 the	
process	 time.	 The	 adsorption	 time	 naturally	 varies	 with	 the	 degree	 of	 BSA	
breakthrough	and	is	directly	calculated	from	the	chromatograms	shown	in	Figure	2.2.	
We	assume	no	influence	of	the	degree	of	breakthrough	on	the	length	of	the	washing,	
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desorption	and	regeneration	steps.	The	yield	is	calculated	from	the	chromatograms	as	
the	amount	of	BSA	adsorbed	divided	by	the	amount	of	BSA	applied,	since	we	assume	
full	 recovery	 of	 the	BSA	 adsorbed.	 The	 flow	 rate	 equals	 0.5	ml/min	 throughout	 the	
process.	
	
Figure	 2.4.	 Productivity	 (solid	 lines,	 left	 axis)	 and	 yield	 (dashed	 lines,	 right	 axis)	 as	 a	 function	 of	 BSA	
breakthrough	for	1	mg/ml	BSA	solution	(a),	and	0.1	mg/ml	BSA	solution	(b).	Data	were	calculated	using	the	
chromatograms	of	Figure	2.2.	
From	 Figure	 2.4	 it	 is	 clear	 that	 the	 productivity	 of	 the	 process	 is	 about	 five	 times	
higher	 with	 the	 higher	 BSA	 concentration,	 even	 though	 the	 equilibrium	 adsorption	
capacities	are	not	that	far	apart	(18.5	mg/ml	resin	for	0.1	mg/ml	BSA	and	19.5	mg/ml	
resin	 for	 1	 mg/ml	 BSA).	 The	 reason	 for	 the	 higher	 productivity	 for	 higher	 feed	
concentration	is	that	less	feed	solution	is	required	to	saturate	the	column,	resulting	in	
a	lower	adsorption	time	than	for	a	low	feed	concentration.	When	the	‘traditional’	10%	
breakthrough	point	would	be	used,	the	productivities	would	have	been	7.9	mg/h	for	
the	 high	 concentration	 and	0.5	mg/h	 for	 the	 low	 concentration,	with	 95%	yield	 for	
both	 cases.	 The	 optimal	 productivity	 would	 be	 62%	 breakthrough	 resulting	 in	 12	
mg/h	for	the	high	concentration	with	78%	yield,	and	33%	breakthrough	resulting	in	
2.4	mg/h	with	81%	yield	for	the	low	concentration.	The	productivities	are	very	low,	
because	 of	 the	 small‐scale	 column	 used.	 However,	 the	 productivity	 and	 yield	
calculations	show	that	it	is	worthwhile	to	determine	the	breakthrough	point	at	which	
the	adsorption	process	should	be	terminated	to	obtain	maximum	productivity.	
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2.4 Conclusions	
In	 this	chapter	we	have	shown	that	 the	affinity	resin	with	 immobilized	VHH	 ligands	
provides	 a	 highly	 selective	 tool	 for	 purification	 of	 BSA,	 leading	 to	 concentration	
factors	of	more	than	an	order	of	magnitude.	Full	recovery	of	BSA	can	be	obtained	with	
an	acidic	desorption	buffer.	When	a	real	feedstock	such	as	bovine	cheese	whey	is	used,	
BSA	can	also	be	retrieved	in	a	much	more	concentrated	and	purified	form.	
The	degree	of	protein	breakthrough	at	which	the	adsorption	process	is	terminated	has	
a	 significant	 influence	 on	 the	 productivity	 of	 the	 process.	 Instead	 of	 applying	 the	
commonly	 used	 10%	 breakthrough,	 an	 optimum	 can	 be	 found	 by	 calculating	 the	
productivity	of	the	process	as	a	function	of	protein	breakthrough,	which	can	result	in	
more	 efficient	 use	 of	 the	 chromatography	 column.	 This	 is	 of	 particular	 interest	 for	
purification	 processes	 where	 the	 feed	 is	 not	 specifically	 produced	 for	 the	 target	
protein,	for	example	for	otherwise	invaluable	waste	streams.	
Since	 the	 VHH	 ligands	 can	 be	 produced	 for	 many	 different	 target	 components,	 the	
purification	of	other	components	 from	whey	or	other	 feedstock	 in	 the	 food	 industry	
can	be	envisaged.	Because	of	the	high	selectivity,	this	method	is	particularly	useful	for	
minor	component	isolation.	
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Chapter	3	
The	influence	of	pH	and	temperature	on	bovine	serum	
albumin	–	VHH	ligand	binding	
	
Abstract	
The	 thermodynamics	 of	 the	 binding	 reaction	 between	 bovine	 serum	 albumin	 and	 a	
multi‐species	 albumin	 VHH	 (llama	 antibody	 fragment)	 were	 measured	 using	
isothermal	titration	calorimetry	(ITC).	The	pH	was	varied	between	pH	5	and	pH	8.5,	
and	the	temperature	between	20	°C	and	50	°C.	The	equilibrium	constant	(Ka)	showed	
a	maximum	at	pH	6.5	at	40	°C:	4.86×107	M‐1.	The	lowest	value	for	Ka	was	measured	at	
pH	8.5	at	50	°C:	1.83×106	M‐1,	which	is	not	enough	for	efficient	desorption.	The	Gibbs	
free	 energy	 of	 binding	 (ΔG)	 was	 on	 average	 ‐10	 kcal/mol,	 ranging	 between	 ‐9.1	
kcal/mol	(pH	8.5,	20	°C)	and	‐11.0	kcal/mol	(pH	5,	50	°C	and	pH	6.5,	40	°C).	Entropy‐
enthalpy	 compensation	 seems	 to	 occur,	 where	 the	 enthalpy	 ΔH	 becomes	 more	
negative	 with	 increasing	 temperature,	 and	 the	 entropy	 (as	 –TΔS)	 becomes	 more	
positive.	 At	 higher	 pH	 values,	 the	 values	 for	 ΔH	 are	 also	 more	 negative,	 and	
consequently	–TΔS	more	positive.	The	compensation	between	entropy	and	enthalpy	
seems	logical,	since	the	binding	of	 the	two	proteins	results	 in	a	more	negative	value	
for	ΔH,	but	at	 the	expense	of	conformational	 freedom,	hence	the	positive	value	for	–
TΔS.		
	
	
	
	
	
	
This	chapter	is	a	manuscript	in	preparation:	Besselink,	Tamara;	Strubel,	Maurice;	Janssen,	Anja	
E.M.;	 and	Boom,	Remko	M.	The	 influence	of	pH	and	 temperature	on	bovine	 serum	albumin	–	
VHH	ligand	binding.		 	
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3.1 Introduction	
The	 current	 demand	 for	 pure	 specialty	 compounds	 requires	 highly	 specific	
purification	steps,	such	as	affinity	chromatography.	A	promising	ligand	for	this	type	of	
chromatography	is	a	fragment	from	a	llama	antibody,	called	the	VHH	(variable	heavy‐
chain	 region	 of	 the	 heavy‐chain	 antibody)	 [1‐6].	 This	 small‐sized	 protein	 of	
approximately	12	to	15	kDa	is	heat	and	acid	stable	and	can	bind	antigens	with	similar	
binding	strength	as	the	often	used	monoclonal	antibodies.	Furthermore,	it	is	possible	
to	produce	these	VHH	ligands	on	a	large	scale	in	a	Saccharomyces	cerevisiae	strain	[2,	
5]	after	 immunisation	and	 isolation.	The	combination	of	 these	properties	makes	 the	
VHH	ligand	a	promising	ligand	for	industrial‐scale	affinity	chromatography.	
In	this	study	we	investigated	the	binding	between	bovine	serum	albumin	(BSA)	and	a	
multi‐species	 albumin	 VHH.	 According	 to	 the	 VHH	 ligand’s	 manufacturer	 (BAC	 BV,	
Naarden,	 The	 Netherlands),	 the	 adsorption	 equilibrium	 constant,	 Ka,	 between	 the	
ligand	and	BSA	is	3.84×107	M‐1	at	neutral	pH.	This	value	was	measured	using	surface	
plasmon	resonance,	which	requires	ligand	immobilisation	to	a	gold	surface.	This	value		
may	 be	 different	 from	 the	 situation	 in	 which	 the	 ligand	 is	 free	 in	 solution	 or	
immobilised	to	a	different	surface,	such	as	an	activated	resin,	and	is	likely	to	depend	
on	 pH.	 Zandian	 and	 co‐workers	 determined	 the	 equilibrium	 constants	 for	 a	
commercially	 available	 resin	 with	 immobilized	 VHH	 for	 IgG	 purification.	 The	
equilibrium	 constants	 were	 2.38×108	 M‐1	 and	 2.5	 ×107	 M‐1	 using	 surface	 plasmon	
resonance	 and	 batch	 uptake	 experiments	 respectively	 [7]:	 almost	 a	 factor	 10	
difference.	For	both	the	albumin	ligand	as	the	IgG	ligand	the	binding	between	the	VHH	
and	the	target	protein	 is	clearly	strong.	This	 is	beneficial	 for	protein	adsorption,	but	
usually	 requires	 harsh	 desorption	 conditions:	 in	 both	 cases	 a	 buffer	 of	 pH	 3.	 Even	
though	 the	 ligand	 may	 be	 stable	 at	 these	 conditions,	 the	 target	 protein	 may	 well	
denature	at	such	harsh	conditions.	
Even	 though	 it	 is	 possible	 to	 select	 VHH	 ligands	 that	 allow	 a	 relatively	 high	 pH	 for	
desorption	 (around	 pH	 4),	 this	 still	 requires	 large	 volumes	 of	 buffer	 and	 therefore	
large	 quantities	 of	 chemicals.	 To	 neutralise	 the	 pH	 for	 further	 processing,	 a	 base	 is	
required,	eventually	leading	to	saline	solutions	which	need	to	be	desalted.	If	it	would	
be	possible	to	use	a	different	method	for	desorption	which	does	not	require	chemicals,	
a	significant	cost	reduction	could	be	achieved.	
In	 2001,	 Pérez	 and	 co‐workers	 [8]	 found	 that	 the	 VHH	 ligand	 they	 investigated	
unfolded	reversibly	in	two	stages.	The	first	stage	was	local	unfolding	up	to	313	K	and	
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global	unfolding	above	333	K.	If	the	unfolding	would	result	in	antigen	release,	it	could	
be	possible	to	use	a	relatively	mild	temperature	increase	for	desorption.	In	that	case,	
the	quantity	of	chemicals	could	be	reduced	and	further	processing	could	be	simplified,	
but	this	obviously	depends	on	the	heat	stability	of	the	protein	that	is	adsorbed	to	the	
VHH	 ligand.	 Dolk	 et	 al.	 [9]	 found	 that	 a	 VHH	 that	 binds	 to	 a	 synthetic	 dye	 shows	
induced	 refolding	 by	 the	 dye	 at	 elevated	 temperatures,	 which	 may	 limit	 the	
possibilities	of	using	increased	temperature	for	desorption.	However,	a	slight	shift	in	
both	temperature	and	pH	may	still	be	effective.	
To	our	knowledge,	the	binding	between	a	VHH	ligand	and	its	target	protein	has	not	yet	
been	studied	as	a	function	of	pH	and	temperature.	We	studied	the	adsorption	reaction	
between	 a	 multi‐species	 albumin	 VHH	 ligand	 and	 BSA	 in	 detail	 using	 isothermal	
titration	calorimetry	(ITC).	With	ITC	it	is	possible	to	determine	the	Gibbs	free	energy	
ΔG,	enthalpy	ΔH,	entropy	ΔS	and	equilibrium	adsorption	constant	Ka	of	the	adsorption	
reaction.	
3.2 Materials	and	methods	
3.2.1 Materials	
BSA	 (type	A3059,	 ≥98%	pure	 lyophilized	 powder,	MW	~67	 kDa)	was	 purchased	 at	
Sigma‐Aldrich	 (Zwijndrecht,	 the	 Netherlands)	 and	 used	 as	 such.	 The	 multi‐species	
albumin	VHH	(MW	12.559	kDa)	was	provided	by	BAC	BV	(Naarden,	The	Netherlands)	
in	 solution	with	 50	mM	 sodium	phosphate,	 0.5	M	 sodium	 chloride	 at	 pH	 7.4.	 Other	
reagents	were	of	at	least	analytical	grade.	All	solutions	were	prepared	with	pure	water	
obtained	using	a	Milli‐Q	system	(Millipore,	Billerica,	USA).	
3.2.2 Buffer	and	sample	preparation	
Phosphate	buffered	saline	(PBS)	was	used	containing	10	mM	phosphate	with	137	mM	
NaCl	and	2.7	mM	KCl	at	a	pH	range	between	4	and	8.5.	For	pH	5	through	8.5,	10	mM	of	
saline	Na2HPO4	solution	was	mixed	with	10	mM	saline	KH2PO4	solution	to	achieve	the	
desired	pH.	For	pH	4,	a	saline	solution	of	10	mM	phosphoric	acid	and	10	mM	Na2HPO4	
were	mixed	to	reach	the	desired	pH	values.	
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3.2.3 ITC	measurements	and	analysis	
The	VHH	solution	was	dialysed	against	the	appropriate	phosphate	buffer	using	Slide‐
A‐Lyzer	Dialysis	cassettes	with	a	molecular	weight	cut‐off	value	of	3.5	kDa	(Thermo	
Fisher	Scientific	Inc.,	Waltham,	USA).	It	was	not	possible	to	dialyse	the	VHH	solution	to	
pH	4;	even	dilution	prior	to	dialysis	could	not	prevent	the	protein	solution	becoming	
turbid.	The	concentrations	of	the	VHH	solutions	at	pH	5,	6	and	8.5	were	determined	
using	HPLC	with	the	original	VHH	solution	as	a	reference	(Tosoh	TSKgel	G2000SWxl	
7.8	mm	×	30	cm	(Tosoh	Bioscience,	Tokyo,	Japan),	eluent	30%	acetonitrile	in	Milli‐Q	
water	(Millipore,	Billerica,	USA)	with	0.1%	trifluoroacetic	acid,	flow	rate	1.5	ml/min	at	
room	 temperature,	 detection	 at	 214	 nm).	 For	 pH	 6.5	 and	 pH	 7.4,	 the	 VHH	
concentration	was	determined	using	UV	spectrometry	at	280	nm.	BSA	was	dissolved	
in	the	same	buffer	as	used	for	VHH	dialysis.	
The	heat	changes	due	to	BSA‐VHH	adsorption	at	pH	5,	6	and	8.5	were	measured	using	
an	 ITC200	 from	 MicroCal	 (GE	 Healthcare,	 Uppsala,	 Sweden).	 The	 reference	 cell	 was	
filled	with	 degassed	Milli‐Q	water.	 The	 sample	 cell	was	 filled	with	 200	 µl	 degassed	
VHH	solution	and	the	syringe	was	filled	with	40	µl	BSA	solution.	For	pH	6.5	and	pH	7.4	
a	VP‐ITC	was	used	 from	MicroCal	 (Northampton,	USA)	with	1.4	ml	 cell	 volume	 and	
274	µl	syringe	volume.	The	measurement	principles	are	the	same	for	both	ITC	devices.	
Time	 intervals	 were	 adjusted	 to	 suit	 each	 measurement.	 The	 VHH	 and	 BSA	
concentration,	 injection	volume	and	number	of	 injections	 for	each	measurement	can	
be	 found	 in	Table	3.1.	For	each	pH,	 the	 ITC	measurements	were	performed	at	20	°C	
(25	°C	for	pH	6.5	and	pH	7.4),	40	°C	and	50	°C	at	least	in	duplicate.	
The	heat	of	dilution	of	BSA	was	measured	by	repeating	the	measurements	with	buffer	
in	 the	 sample	 cell	 instead	of	VHH	solution.	The	dilution	heats	were	 then	 subtracted	
from	the	BSA‐VHH	heats.	For	some	measurements,	direct	subtraction	of	 the	dilution	
heats	resulted	in	a	final	plateau	for	the	integrated	heat	plot	deviating	from	zero,	which	
could	 not	 result	 in	 a	 proper	 fit.	 Therefore,	 the	mean	 value	 of	 the	 final	 plateau	was	
subtracted	from	the	curve.	Shifting	the	integrated	heat	plot	along	the	y‐axis	does	not	
influence	 the	 values	 of	 the	 equilibrium	 constant	 Ka,	 the	 enthalpy	 ΔH	 or	 the	
stoichiometry.	Because	 the	values	of	 the	entropy	and	Gibbs	 free	 energy	 are	derived	
from	these	 three	values,	 these	also	do	not	change.	However,	 this	 is	only	valid	 if	 this	
shift	in	heat	does	not	depend	on	the	molar	ratio.	Furthermore,	using	the	mean	value	of	
the	 last	 few	 points	 requires	 that	 a	 plateau	 is	 reached,	 to	 ensure	 saturation	 of	 the	
ligand	 in	 the	 sample	 cell.	 For	 all	 the	measurements	 at	 pH	 7.4	 a	 shift	 was	 required	
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which	varied	between	‐6.5	and	‐13	kcal/mol.	For	other	measurements	the	correction	
was	smaller	or	zero.	
The	 corrected	 data	were	 fitted	 to	 the	 one‐site	 binding	model	 in	 the	 ITC	module	 of	
Origin	 7	 (OriginLab,	 Northampton,	MA,	 USA)	 provided	 by	MicroCal	 (GE	Healthcare,	
Uppsala,	Sweden)	to	obtain	values	for	the	reaction	enthalpy	(ΔH),	entropy	(ΔS),	Gibbs	
free	energy	(ΔG)	and	equilibrium	constant	(Ka).	
Table	3.1.	Experimental	conditions	for	the	ITC	measurements.	The	measurements	for	pH	5,	6	and	8.5	were	
performed	with	an	ITC200	(MicroCal,	GE	Healthcare,	Uppsala,	Sweden);	for	pH	6.5	and	pH	7.4	a	VP‐ITC	was	
used	(MicroCal,	Northamption,	USA).	
pH	 Temp.	
(°C)	
[VHH]	
(mM)	
[BSA]	
(mM)	
Injection	volume	
(µl)	
Number	of	
injections	
5	 20,	40	 0.0125	 0.129	 1.2	 201	
5	 50	 0.0125	 0.129	 2	 18	
6	 20,	40	 0.0125	 0.129	 1.2	 20	
6	 50	 0.0125	 0.129	 2	 18	
6.5	 25,	40,	50	 0.0084	 0.100	 7	 25	
7.4	 25	 0.0216	 0.259	 7	 25	
7.4	 40	 0.0108	 0.259	 7	 25	
7.4	 50	 0.0109	 0.259	 7	 25	
8.5	 20,	40,	50	 0.0399	 0.278	 2.4	 16	
1	One	out	of	three	measurements	was	done	with	16	injections	for	20°C	and	17	for	40°C.	
3.3 Results	and	discussion	
ITC	 measurements	 provide	 insight	 into	 the	 thermodynamics	 of	 the	 adsorption	
reaction	 by	 directly	 measuring	 the	 heat	 released	 or	 adsorbed	 during	 this	 reaction.	
Small	amounts	of	BSA	are	titrated	into	ligand	solution	and	each	titration	results	 in	a	
small	 temperature	 increase	(for	exothermic	reactions)	or	decrease	(for	endothermic	
reactions)	in	the	sample	cell	containing	the	ligand	solution.	The	ITC	equipment	has	to	
either	add	or	remove	heat	from	the	sample	cell	to	maintain	the	same	temperature	as	
the	reference	cell.	These	heats	are	recorded	for	each	injection	and,	after	correcting	for	
the	 baseline,	 result	 in	 a	 raw	 heat	 plot	 as	 in	 the	 top	 section	 of	 Figure	 3.1.	 The	 first	
negative	 peaks	 in	 this	 plot	 indicate	 that	 the	 first	 part	 of	 the	 reaction	 is	 exothermic,	
later	on	it	becomes	endothermic.	Integration	of	each	peak	results	in	an	integrated	heat	
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plot,	see	Figure	3.1,	bottom	section.	For	more	extensive	information	on	ITC,	we	refer	
to,	for	example,	[10‐13].	
	
Figure	3.1.	Example	of	an	ITC	measurement	(pH	8.5	at	20°C,	see	Table	3.1).	Top	section:	raw	heat	plot	with	
heat	adsorbed	or	released	as	a	function	of	time,	each	peak	represents	an	injection	with	BSA	solution	into	the	
sample	cell	 containing	 the	VHH.	Bottom	section:	 integrated	heat	of	 every	peak	as	a	 function	of	 the	molar	
ratio	between	BSA	and	VHH.	
Other	 than	 the	 heat	 of	 the	 adsorption	 reaction,	 there	 are	 other	 processes	 that	
influence	the	heat	signal.	These	are	heat	of	dilution	(of	both	ligand	and	BSA),	possibly	
the	 heat	 of	 stirring	 and	 the	 heat	 of	 re‐conformation	 (agglomeration,	
folding/unfolding).	The	heat	of	 ligand	dilution	 is	 in	 this	case	not	 taken	 into	account,	
because	 the	 sample	 cell	 is	 much	 larger	 than	 the	 amount	 of	 BSA	 solution	 injected.	
Therefore,	the	heat	of	ligand	dilution	is	often	regarded	as	negligible.	All	the	data	were,	
however,	 corrected	 for	 the	 dilution	 heat	 of	 BSA.	 There	 may	 have	 been	 other	
components,	such	as	lyophilisation	salts,	present	in	the	BSA	sample,	which	also	caused	
some	 minor	 dilution	 effects.	 These	 effects	 are	 accounted	 for	 in	 the	 dilution	 heat	
measurements	because	the	same	BSA	sample	was	used.	
To	 obtain	 values	 for	 the	 reaction	 stoichiometry,	 equilibrium	 constant,	 enthalpy,	
entropy	and	Gibbs	free	energy,	the	integrated	heat	plot	is	fitted	to	the	built‐in	One	Set	
of	Sites	Model	 in	 the	 ITC	module	of	Origin	7	(see	Section	3.2.3).	This	means	that	we	
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have	assumed	that	 there	 is	only	one	site	at	which	the	binding	between	BSA	and	the	
VHH	ligand	occurs.	The	raw	heat	plots	and	integrated	heat	plots	of	all	measurements	
are	included	in	the	Appendix.	
3.3.1 Equilibrium	constant	
In	Figure	3.2	the	values	of	the	equilibrium	constant	Ka	for	each	temperature	(20	°C	or	
25	 °C,	 40	 °C	 and	 50	 °C)	 are	 shown	 as	 a	 function	 of	 pH.	 In	 general,	 the	 equilibrium	
constant	 decreases	 with	 increasing	 pH.	 On	 average,	 the	 equilibrium	 constant	 is	
highest	at	40	°C,	which	seems	logical	since	both	BSA	and	the	VHH	are	of	animal	origin	
where	they	need	to	perform	best	around	body	temperature.	However,	at	around	the	
pH	of	blood,	pH	7.4,	the	bond	is	not	the	strongest,	but	lower	than	at	pH	5,	6	and	6.5.	
Within	 this	 temperature	 and	 pH	 range,	 the	maximum	binding	 strength	 is	 at	 pH	 6.5	
with	a	Ka‐value	of	4.86×107	M‐1	 (on	average)	at	40	 °C.	At	pH	5	and	50	 °C	 there	also	
seems	to	be	a	maximum,	but	the	errors	are	quite	large,	which	may	be	the	result	of,	for	
example,	protein	denaturation.	
A	possible	explanation	for	the	high	equilibrium	constants	at	pH	5	is	the	opposite	net	
charge	 of	 the	 proteins	 at	 this	 pH	 value.	 The	 isoelectric	 points	 are	5.65	 for	 the	VHH	
ligand	(BAC,	Naarden,	The	Netherlands)	and	4.7	for	BSA	[14].	Between	those	two	pH	
values	the	net	charges	of	the	proteins	are	opposite	and	this	could	strengthen	the	bond.	
Below	pH	4.7	and	above	pH	5.65	the	proteins	would	repel	each	other	in	terms	of	net	
charge,	which	would	explain	a	decrease	in	the	value	for	the	equilibrium	constant	from	
pH	6.5	onwards	(see	Figure	3.2).	Still	 lower	pH	values	would	probably	also	result	 in	
less	 favourable	 adsorption,	 but	 unfortunately	 we	 could	 not	 obtain	 a	 VHH	 ligand	
solution	of	appropriate	concentration	to	perform	ITC	measurements	below	pH	5	(see	
Section	3.2.3).	The	 turbid	solution	we	obtained	when	preparing	 the	VHH	solution	at	
pH	4	could	be	a	result	of	a	change	in	conformation	of	the	VHH	protein.	This	may	also	
explain	the	lack	of	binding	at	lower	pH	values	(see	Chapter	2).	
The	 lowest	 equilibrium	 constant	 is	 obtained	 at	 pH	 8.5	 at	 50	 °C:	 1.83×106	M‐1.	 This	
value	 is	 still	 too	 high	 for	 desorption.	 A	 buffer	with	 high	 pH	would	 also	 not	 present	
clear	advantages	over	using	an	acidic	buffer	which	results	in	more	efficient	desorption	
(see	Chapter	2).	
Chapter	3	
32	
	
Figure	3.2.	Equilibrium	constant	Ka	as	a	function	of	pH	for	20°C	(pH	5,	6,	and	8.5,	open	symbols)	and	25°C	
(pH	6.5	and	7.4,	black	symbols)	(a),	40°C	(b),	and	50°C	(c).	Error	bars	are	the	errors	as	calculated	with	the	
One	Set	of	Sites	Model	in	Origin	7,	the	dotted	line	represents	the	average	values	for	Ka.	
The	error	in	the	equilibrium	constant	is	largest	at	the	highest	values,	which	is	due	to	
the	 nature	 of	 the	 measurement.	 The	 Ka	 value	 is	 obtained	 from	 the	 slope	 of	 the	 S‐
shaped	curve	as	shown	in	Figure	3.1,	bottom	section.	When	the	Ka	value	is	high,	there	
are	only	 few	points	available	 to	determine	 the	slope,	which	results	 in	a	 larger	error	
compared	 to	 a	 lower	 Ka	 value.	 Generally,	 good	 estimates	 can	 be	 made	 when	 the	
product	of	the	 ligand	concentration	and	the	Ka	value,	 the	c‐value,	 is	between	10	and	
preferably	100,	but	definitely	lower	than	1000.	When	the	c‐value	is	too	low,	the	slope	
is	too	shallow;	when	it	is	too	high,	the	slope	is	too	steep	to	accurately	determine	the	
value	for	the	equilibrium	constant.	For	our	measurements	the	c‐values	were	between	
approximately	 50	 and	 600,	 with	 the	 majority	 around	 150.	 This	 indicates	 that	 the	
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ligand	 concentrations	 could	 have	 been	 reduced	 in	 some	 cases	 to	 obtain	 better	
estimates	 for	 Ka.	 However,	 the	 heats	 measured	 were	 very	 low,	 the	 largest	 being	
approximately	 ‐1.5	µcal/s.	This	 implies	 that	 the	 concentrations	 could	not	have	been	
significantly	lowered,	since	this	would	reduce	the	signal	even	further.	
The	 equilibrium	 constant	 determined	 by	 the	 manufacturer	 was	 3.84×107	 M‐1	 at	
neutral	pH,	which	 is	higher	 than	 the	values	we	observed	at	pH	7.4	at	25	 °C,	namely	
6.72×106	 M‐1	 on	 average.	 However,	 both	 values	 lie	 within	 the	 same	 order	 of	
magnitude.	The	difference	may	be	caused	by	the	measurement	method,	but	also	 the	
sample	preparation,	BSA	sample	used,	and	many	other	factors.	In	Chapter	2	we	used	
immobilised	VHH	to	obtain	an	adsorption	isotherm	at	pH	6.5	at	ambient	temperature,	
with	 a	 buffer	with	 slightly	 lower	 ionic	 strength.	 The	 equilibrium	 constant	 obtained	
was	approximately	1.4×106	M‐1,	which	is	clearly	lower	than	the	value	measured	with	
ITC:	 2.07×107	M‐1.	 This	may	 be	 due	 to	 the	 immobilisation	 of	 the	 VHH	 ligand	which	
could	limit	the	conformational	changes	necessary	for	binding	BSA.	
3.3.2 Stoichiometry	
For	 the	 adsorption	 reaction,	we	 assumed	 that	 one	 BSA	molecule	 binds	 to	 one	 VHH	
molecule.	 Theoretically,	 the	 ITC	 measurements	 should	 therefore	 indicate	 a	
stoichiometry	 close	 to	 1.	 The	 stoichiometry	 can	 be	 determined	 from	 the	 inflection	
point	 of	 the	 S‐curve	 in	 the	 lower	 section	 of	 Figure	 3.1.	 At	 the	 inflection	 point,	 the	
amount	 of	 BSA	 titrated	 into	 the	 sample	 cell	 is	 equal	 to	 the	 amount	 of	 binding	 sites	
available;	 in	our	case	equal	to	the	amount	of	VHH	ligand	since	we	assume	1	binding	
site	per	ligand	molecule.	At	that	point	less	binding	occurs	resulting	in	smaller	values	of	
ΔH	until	complete	saturation.	In	the	case	of	infinitely	strong	binding,	there	would	not	
be	an	inflection	point,	but	just	a	step	change	in	ΔH,	because	all	binding	sites	would	be	
occupied	instantly.	
As	 indicated	 in	Figure	3.3,	 the	stoichiometry	was	not	equal	 to	1,	but	varied	between	
0.4	and	0.9.	The	stoichiometry	seems	to	 increase	with	 increasing	pH	and,	except	 for	
pH	6.5	and	7.4,	with	increasing	temperature.	A	deviation	in	the	stoichiometry	could	be	
due	 to	 different	 effective	 concentration	 of	 either	 of	 the	 two	 proteins	 involved.	 We	
expect	that	the	error	in	concentration	is	the	highest	for	the	ligand	solution,	because	of	
the	dialysis	and	dilution.	We	did	measure	the	protein	content	after	dialysis,	but	part	of	
the	 ligand	may	have	become	 inactive.	 This	may	also	hold	 for	possibly	 denatured	or	
otherwise	dysfunctional	BSA.	
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Figure	3.3.	Reaction	stoichiometry	as	a	function	of	temperature	for	pH	5	(○),	pH	6	(▲),	pH	6.5	(×),	pH	7.4	
(●)	and	pH	8.5	(□).	Error	bars	were	too	small	to	be	plotted.	
A	difference	in	initial	active	concentrations	could	explain	that	the	stoichiometry	is	not	
equal	to	1,	but	it	does	not	explain	the	temperature	and	pH	dependence	of	this	value.	
Other	processes,	such	as	protein	denaturation	and	agglomeration	may	play	a	role,	but	
the	exact	mechanism	is	unclear.	The	fitted	stoichiometry	value	does	not	influence	the	
heat	of	binding	nor	the	equilibrium	constant.	
3.3.3 Reaction	enthalpy,	entropy	and	Gibbs	free	energy.	
The	most	distinctive	 feature	of	 ITC	measurements	 is	 the	direct	measurement	of	 the	
reaction	enthalpy,	ΔH.	Using	a	model,	the	equilibrium	constant	Ka	can	be	determined	
and	through	that	the	Gibbs	free	energy	ΔG	(via	ΔG	=	‐RTln(Ka))	and	entropy	ΔS	of	the	
reaction	(via	ΔG	=	ΔH	‐	TΔS).	In	Figure	3.4	the	enthalpy	(ΔH),	entropy	(‐TΔS)	and	Gibbs	
free	energy	(ΔG)	are	plotted	for	each	pH	as	a	function	of	temperature.	
To	 begin	 with,	 the	 adsorption	 reaction	 is,	 as	 expected,	 favourable,	 which	 can	 be	
concluded	from	the	negative	value	for	ΔG:	between	‐9.1	kcal/mol	for	pH	8.5	at	20	°C,	
and	‐11.0	kcal/mol	for	pH	5	at	50	°C	and	pH	6.5	at	40	°C.	The	value	drops	slightly	as	
temperature	is	 increased,	except	for	pH	8.5	where	the	ΔG	remains	constant	over	the	
temperature	range.	The	values	for	ΔG	are	slightly	higher	at	pH	7.4	and	8.5	than	at	the	
acidic	pH	values,	which	is	also	visible	from	the	Ka	values	in	Figure	3.2.	
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Figure	3.4.	Reaction	 enthalpy	 (ΔH,	●),	 entropy	 (‐TΔS,	▲)	 and	 Gibbs	 free	 energy	 (ΔG,	 ○)	 as	 a	 function	 of	
temperature	 measured	 using	 ITC	 for	 a)	 pH	 5;	 b)	 pH	 6;	 c)	 pH	 6.5;	 d)	 pH	 7.4;	 and	 e)	 pH	 8.5.	 Standard	
deviations	for	the	enthalpy	ranged	between	0.2	and	1.1	kcal/mol	(not	shown).	 	
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Figure	3.5.	Entropy	(TΔS)	as	a	function	of	ΔH	for	all	ITC	measurements.	
The	binding	between	the	VHH	ligand	and	BSA	is	favourable	from	an	enthalpy	point	of	
view,	 but	 unfavourable	 in	 terms	 of	 entropy.	 It	 seems	 logical	 that	 –TΔS	 increases	 at	
higher	 temperature:	 due	 to	 the	 greater	 thermal	 energy	 the	 proteins	 gain	 more	
freedom	of	motion.	Binding	will	result	in	less	conformational	freedom	when	the	bonds	
between	the	two	proteins	replace	the	bonds	with	water	molecules.	In	short	this	means	
that	 there	 is	 good	 bonding	 between	 the	 two	 molecules	 resulting	 in	 a	 negative	
enthalpy,	but	there	is	an	increase	in	order	because	a	complex	is	formed,	resulting	in	a	
positive	 value	 for	 –TΔS.	 This	 phenomenon	 is	 referred	 to	 as	 enthalpy‐entropy	
compensation	[15],	and	is	more	clearly	illustrated	in	Figure	3.5	where	TΔS	 is	plotted	
against	 ΔH.	 The	 relation	 between	 entropy	 and	 enthalpy	 is	 practically	 unity,	 with	 a	
slope	of	1.008.	
There	is	some	debate	whether	the	enthalpy‐entropy	compensation	is	real	or	an	effect	
of	the	constraints	of	the	measurement	(e.g.,	[16,	17]).	This	discussion	arose	from	the	
deduction	 of	 enthalpy	 and	 entropy	 values	 from	 the	 van	 ‘t	 Hoff	 equation,	where	 the	
natural	 logarithm	 of	 the	 equilibrium	 constant	 is	 plotted	 against	 the	 reciprocal	
temperature.	The	enthalpy	can	then	be	derived	from	the	slope	and	the	entropy	from	
the	intercept	of	the	plot.	However,	an	error	in	the	slope	also	introduces	an	error	in	the	
intercept.	On	top	of	that,	the	errors	tend	to	be	rather	large,	which	seemed	to	explain	
some	cases	of	the	enthalpy‐entropy	compensation	found	in	literature.	
With	ITC,	the	value	for	the	enthalpy	and	the	equilibrium	constant,	and	thus	the	Gibbs	
free	 energy,	 are	 derived	 more	 independently.	 However,	 the	 equilibrium	 constant	
could	not	be	very	accurately	determined	in	some	cases	(see	Figure	3.2).	To	prove	that	
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the	 compensation	 effects	 found	 in	 this	 study	 are	 statistically	 significant	 more	
extensive	statistical	analysis	is	required,	which	is	beyond	the	scope	of	this	study.	
In	any	case,	it	seems	that	the	entropy‐enthalpy	compensation	is	not	entirely	equal	at	
each	temperature.	Between	20	°C	and	40	°C	there	is	a	slight	decrease	in	ΔG	(except	for	
pH	 8.5	where	ΔG	 is	 constant),	 which	 results	 in	 a	 tighter	 bond.	 At	 this	 temperature	
range,	 the	 enthalpic	 contribution	 to	 binding	 increases	 more	 than	 the	 entropic	
contribution.	The	difference	in	ΔG	between	40	°C	and	50	°C	could	not	be	determined	
with	sufficient	accuracy.	
The	enthalpy	and	entropy	do	not	only	vary	with	temperature,	they	also	vary	with	pH.	
Above	pH	6,	the	enthalpy	is	more	negative	and	the	enthalpy	more	positive.	This	may	
be	due	to	conformational	changes	of	either	the	BSA	or	the	VHH	ligand	molecule	or	the	
charge	of	the	molecules.	The	exact	mechanism	is,	however,	unclear.	
3.4 Conclusions	
In	 this	 chapter	 we	 used	 ITC	 measurements	 to	 investigate	 the	 influence	 of	 pH	 and	
temperature	on	the	adsorption	of	BSA	to	a	multi‐species	albumin	VHH	ligand.	The	aim	
was	 to	possibly	 find	another	method	 for	desorption	 than	a	drastic	pH	decrease.	We	
did	 not	 find	 a	 conclusive	 answer,	 but	 a	 slight	 pH	 increase	 with	 an	 increase	 in	
temperature	has	a	negative	effect	on	the	adsorption.	However,	this	is	not	enough	for	
efficient	desorption.	
The	ITC	measurements	revealed	that	the	bond	between	BSA	and	VHH	ligand	is	driven	
by	 enthalpy	 and	 negatively	 influenced	 by	 entropy.	 Enthalpy‐entropy	 compensation	
seems	to	occur,	but	further	statistical	analysis	 is	required	to	determine	whether	this	
effect	is	a	result	of	the	measurement	constraints	or	an	actual	mechanism.	
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Appendix	
On	the	following	pages	the	raw	ITC	heat	plots	(top	sections)	and	integrated	heat	plots	
(lower	sections)	are	shown	for	each	measurement	(see	Section	3.2.1	and	Figure	3.1).	
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Chapter	4	
Comparison	of	activated	chromatography	resins	for	
protein	immobilization	
	
Abstract	
The	 adsorption	 of	 bovine	 serum	 albumin	 (BSA)	 to	 an	 immobilized	 camelid‐derived	
antibody	fragment	against	BSA	was	investigated	using	six	different	activated	resins,	of	
which	 two	 prototypes.	 The	 resins	 differed	 in	 base	 material	 (cellulose,	 agarose	 and	
polymethacrylate),	coupling	chemistry	and	particle	size.	The	adsorption,	washing	and	
desorption	 stage	 of	 the	 affinity	 chromatography	 process	 were	 taken	 into	 account.	
Dynamic	 binding	 capacities	 at	 10%	 breakthrough	 ranged	 between	 0.76	 and	 4.8	mg	
BSA	 per	 ml	 resin.	 The	 number	 of	 column	 volumes	 required	 for	 washing	 ranged	
between	 2.9	 and	 10	 column	 volumes.	 One	 of	 the	 resins	 did	 not	 yield	 a	 higher	 BSA	
concentration	 in	 the	 desorption	 step,	 while	 the	 highest	 concentration	 was	 13‐fold.	
Two	 resins	 were	 unsuitable	 for	 this	 specific	 process	 because	 of	 their	 low	 dynamic	
binding	 capacity,	 high	 wash	 volume	 and	 hardly	 any	 product	 concentration.	 We	
present	a	method	to	rank	and	weigh	the	properties	of	 the	resins	to	 find	the	optimal	
resin	to	meet	specific	requirements.		
For	three	of	 the	activated	resins	 the	effect	of	adsorption	 flow	rate	was	varied,	while	
the	 washing	 and	 desorption	 flow	 rate	 was	 kept	 the	 same.	 The	 dynamic	 binding	
capacity	decreased	with	increasing	flow	rate,	as	expected.	For	one	resin,	the	washing	
volume	remained	constant,	but	for	the	others	it	decreased	with	increasing	adsorption	
flow	rate.	This	could	give	an	indication	of	the	influence	of	intraparticle	diffusion.	The	
number	of	column	volumes	required	to	purify	a	given	amount	of	BSA	increases	with	
increasing	flow	rate,	which	 indicates	that	higher	 flow	rates	do	not	necessarily	speed	
up	the	process.	
	
	
This	 chapter	 is	 submitted	 as:	 Besselink,	 Tamara;	 Liu,	 Meng;	 Ottens,	 Marcel;	 van	 Beckhoven,	
Ruud;	Janssen,	Anja	E.M.;	and	Boom,	Remko	M.	Comparison	of	activated	chromatography	resins	
for	protein	immobilization.	 	
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4.1 Introduction	
Affinity	chromatography	is	a	unique	separation	process	because	of	its	high	selectivity	
for	 the	 desired	 target	 protein	 compared	 to	 other	 separation	 processes,	 such	 as	 ion	
exchange	chromatography,	salt	precipitation	and	extraction.	Affinity	chromatography	
can	often	replace	several	unit	operations	in	downstream	processing	with	only	one.	
Affinity	 chromatography	 can	 be	 used	 to	 purify	 a	 large	 variety	 of	 compounds.	Well‐
known	 non‐protein	 ligands	 are	 dyes	 such	 as	 Cibacron	 Blue	 which	 is	 used	 to	 bind	
albumins	and	several	enzymes	[1,	2].	Protein‐based	ligands	can	be	naturally	occurring	
ligands	 such	 as	 lectins	 for	 oligosaccharide	 purification	 [3]	 or	 Protein	 A	 and	 G	 for	
immunoglobulin	purification.	 It	 is	also	possible	 to	design	an	affinity	 ligand,	which	 is	
done	 in	 for	 example	 immunoaffinity	 chromatography.	 Specific	 antibodies	 are	 here	
produced	against	the	compound	of	interest	[4,	5].	Immunoaffinity	chromatography	is	
however	mainly	used	 for	 analytical	 and	 small‐scale	purposes	because	production	of	
the	antibodies	is	a	costly	process	yielding	only	small	amounts	of	antibody.	Antibodies	
are	also	relatively	 large	(MW	>	150	kDa)	which	 inherently	 limits	 the	capacity	of	 the	
system,	 while	 these	 large	 proteins	 are	 rather	 sensitive	 to	 denaturation.	 Therefore,	
efforts	have	been	made	to	design	specific	ligands	that	are	more	stable	and	economical.	
One	promising	type	of	ligand	is	derived	from	llama	antibodies.	In	1993	a	unique	type	
of	antibodies	lacking	light	chains	was	discovered	in	serum	from	Camelidae	species	[6].	
From	these	heavy‐chain	antibodies	the	even	smaller	binding	domain	fragment	called	
the	 VHH	 (variable	 heavy‐chain	 region	 of	 the	 heavy‐chain	 antibody)	 can	 be	 isolated.	
These	 VHH	 antibody	 fragments	 have	 high	 thermal	 and	 physical	 stability,	which	 are	
important	 qualities	 for	 ligands	 in	 bioprocessing.	 The	 VHH	 can	 be	 expressed	 in	
microorganisms,	 such	 as	 Saccharomyces	 cerevisiae	 [7,	 8],	 which	 is	 important	 for	
industrial‐scale	processes.	More	details	about	these	affinity	ligands	can	be	found	in	a	
review	by	Muyldermans	 [9].	An	affinity	 resin	with	VHH	 ligand	against	 IgG	has	been	
commercialized	by	GE	Healthcare	 (Uppsala,	 Sweden)	and	was	 recently	evaluated	by	
Zandian	and	Jungbauer	[10].	
Once	the	ligand	is	chosen,	it	is	important	to	immobilize	the	ligand	onto	a	solid	support	
material,	 in	 this	 case	a	chromatography	resin.	Resins	can	be	made	 from	a	variety	of	
materials,	such	as	agarose,	cellulose,	silica,	polyacrylamide	and	polymethacrylate	[11,	
12].	The	 ligand	should	be	covalently	attached	 to	minimize	 leaching	 into	 the	product	
and	loss	of	efficiency.	It	should	further	retain	its	functionality	after	being	attached	to	
the	 resin.	Harsh	desorption,	 regeneration	 and	 cleaning‐in‐place	methods	 should	not	
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harm	 the	 resin	nor	 the	 ligand	 and	 its	 immobilization	 to	 the	 resin.	Manufacturers	 of	
chromatography	resins	often	provide	activated	resins	that	are	already	functionalized	
to	 use	 a	 specific	 coupling	 chemistry	 [13].	 Common	 coupling	 chemistries	 in	
commercially	available	 resins	are	N‐hydroxysuccinimide	 (NHS),	 epoxy	and	aldehyde	
coupling.	
To	our	knowledge,	a	comparison	between	activated	resins	of	different	materials	and	
immobilization	 chemistries	 has	 not	 yet	 been	 performed.	 A	 comparison	 between	
commercially	available	Protein	A	resins	has	been	made	by	for	example	Hahn	et	al.	[14]	
and	Fahrner	 et	 al.	 [15].	Many	 ion	 exchange	materials	 have	been	 investigated	by	 for	
example	Levison	et	al.	[16]	and	Staby	and	co‐workers	[17‐22].	Three	immobilization	
methods	for	agarose	resins	have	been	compared	by	Van	Sommeren	et	al.	[23].		
In	 this	 chapter	 we	 report	 on	 a	 method	 to	 choose	 an	 optimal	 resin	 in	 the	 example	
purification	of	bovine	serum	albumin	(BSA)	using	immobilized	VHH	against	BSA.	Six	
different	resins	were	evaluated.	Four	resins	are	commercially	available,	the	other	two	
are	 prototypes	 provided	 by	 the	manufacturer.	We	 immobilized	 a	 VHH	 against	 BSA	
onto	 these	 resins	 and	 investigated	 the	 differences	 in	 dynamic	 binding	 capacity,	
process	volume	and	physical	properties	between	the	resins.	
4.2 Materials	and	methods	
4.2.1 Materials	
Bovine	 Serum	Albumin	 (minimum	98%,	A7096)	was	purchased	 from	Sigma‐Aldrich	
(Zwijndrecht,	 The	 Netherlands).	 All	 other	 reagents	 were	 purchased	 from	 Merck	
(Darmstadt,	Germany)	and	were	of	analytical	grade.	Multi‐species	albumin	ligand	was	
kindly	provided	by	BAC	BV	(Naarden,	The	Netherlands).	
A	10	times	concentrated	phosphate	buffered	saline	(PBS)	buffer	pH	7.4	was	prepared	
by	dissolving	80	g	NaCl,	2	g	KCl,	17.8	g	of	Na2HPO4.2H2O	and	2.5	g	KH2PO4	in	1	litre	of	
Milli‐Q	water	 (Millipore,	Billerica,	USA).	The	diluted	buffer	was	used	as	PBS	pH	7.4.	
PBS	pH	2	was	made	by	acidifying	this	buffer	with	3.5	M	phosphoric	acid.	
	
Chapter	4	
52	
4.2.2 Ligand	immobilization	
The	 properties	 of	 each	 resin	 are	 presented	 in	 Table	 4.1.	 For	 each	 immobilization	
approximately	 20	mg	 of	 ligand	was	 added	 to	 1	 g	 of	 resin.	 The	 concentration	 of	 the	
ligand	solution	was	approximately	10	mg/ml.	After	blocking	the	resins	were	washed	
alternating	 with	 3	 times	 PBS	 pH	 2	 and	 3	 times	 PBS	 pH	 7.4.	 When	 the	 resin	 with	
immobilized	ligand	was	not	in	use,	it	was	stored	in	20%	ethanol	at	4°C.	
Table	4.1.	Properties	of	activated	resins	used	in	this	study.	
	 NHS	
Sepharose	FF	
Big	Beads1	 Sepabeads	
FP‐EP400	
Glyoxal	
Agarose	
Cellufine	
Formyl	
Pall1	
Manufacturer	 GE	
Healthcare	
GE	
Healthcare	
Resindion	 ABT	 Chisso	 Pall	
Backbone	 4%	agarose	 6%	agarose	 poly‐
methacrylate	
6%	agarose	 cellulose	 cellulose	
Particle	size	
(µm)	
45‐165	 100‐300	 50‐100	 35	 125‐210	 80‐100	
Coupling	
chemistry	
NHS	 NHS	 epoxy	 aldehyde	 aldehyde	 aldehyde	
Spacer	arm		
(#	‐C‐)	
14	 10	 3	 12	 8	 0	
Bed	height	
(mm)	
48	 105	 59	 48	 104	 104	
1	 The	 Big	 Beads	 and	 Pall	 resins	 were	 in	 a	 development	 stage	 at	 the	 time	 of	 the	 experiments	 and	 are	
therefore	not	representative	for	existing	or	new	commercial	products.	
4.2.2.1 NHS	coupling	
With	NHS	coupling	the	ligand	is	covalently	attached	to	the	resin	via	an	amine	group,	
creating	a	stable	amide	bond	[24].	The	NHS	coupling	protocol	was	followed	for	NHS	
Sepharose	4	Fast	Flow	and	the	prototype	Big	Beads,	both	obtained	from	GE	Healthcare	
(Uppsala,	Sweden).	The	ligand	was	first	dialysed	against	a	10	times	larger	volume	of	
coupling	buffer	(0.1	M	HEPES,	0.5	M	NaCl,	pH	8).	The	resin	was	washed	with	3	times	
10	column	volumes	(CV)	of	cold	1	mM	HCl	over	a	sintered	glass	filter.	After	the	ligand	
was	 added	 the	mixture	was	 incubated	overnight	 at	 4°C	while	 rotating.	 The	 coupled	
resin	was	then	filtered	on	a	sintered	glass	filter.	The	non‐reacted	groups	of	the	resin	
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were	 blocked	 by	 incubating	 with	 0.1	 M	 Tris,	 0.5	 M	 NaCl,	 pH	 8	 for	 one	 hour	 while	
rotating.	
4.2.2.2 Epoxy	coupling	
An	epoxy‐activated	resin	can	form	a	stable	bond	with	amine,	sulfhydryl	and	hydroxyl	
groups	[25].	The	Sepabeads	FP‐EP	400	(Resindion	S.R.L.,	Binasco,	Italy)	were	supplied	
as	a	powder	which	had	to	be	swollen	in	a	PBS	buffer	at	pH	7.4.	The	Sepabeads	were	
filtered	on	a	sintered	glass	filter,	rinsed	with	PBS	and	a	few	times	with	at	least	10	CV	
of	coupling	buffer	(0.1	M	NaHCO3,	0.5	M	Na2HSO4,	pH	9).	The	ligand	was	dialysed	while	
stirring	 against	 a	 20	 times	 larger	 volume	 of	 coupling	 buffer	 for	 at	 least	 4	 hours	 at	
room	temperature.	
The	resin	and	 ligand	solution	were	mixed	and	 incubated	 for	64	hours	at	37°C	while	
rotating.	The	resin	was	filtered	over	a	sintered	glass	filter	and	incubated	with	5	CV	of	
blocking	buffer	(0.1	M	Tris,	0.5	M	NaCl,	pH	8)	while	rotating	for	at	 least	one	hour	at	
room	temperature.	
4.2.2.3 Aldehyde	coupling	
Amine	 groups	 of	 the	 ligand	 can	 also	 be	 coupled	 to	 an	 aldehyde	 group	 on	 the	 resin	
through	 reductive	 amination	 [13].	 Aldehyde	 coupling	 was	 done	 for	 the	 Glyoxal	
Agarose	beads	from	ABT	Beads	(Madrid,	Spain),	Cellufine	Formyl	from	Chisso	(Tokyo,	
Japan)	and	an	early	stage	prototype	aldehyde	resin	(referred	to	in	this	chapter	as	Pall)	
provided	by	Pall	(Portsmouth,	United	Kingdom).	The	resin	was	filtered	over	a	sintered	
glass	 filter	 and	 rinsed	with	 coupling	buffer,	PBS	pH	7.4	with	0.5	M	NaCl.	The	 ligand	
solution	 and	 30	 µl	 of	 5M	 cyanoborohydride	 per	 ml	 of	 resin	 were	 added	 and	 the	
mixture	was	 incubated	 overnight	 at	 room	 temperature	while	 rotating.	 The	 coupled	
resin	was	then	filtered	over	a	sintered	glass	filter	and	blocked	with	0.1	M	Tris,	0.5M	
NaCl,	pH	8	for	1	hour	at	room	temperature.	
4.2.3 BSA	breakthrough	experiments	
Breakthrough	 experiments	 were	 performed	 by	 packing	 the	 beads	 in	 Tricorn	 5	
columns	with	an	inner	diameter	of	5	mm	(GE	Healthcare,	Uppsala,	Sweden)	of	varying	
bed	height.	The	bed	height	was	measured	using	a	ruler.	The	bed	heights	of	 the	NHS	
Sepharose,	Sepabeads	and	Glyoxal	Agarose	columns	were	approximately	5	cm.	For	the	
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BigBeads,	Cellufine	Formyl	and	Pall	 resins	 the	bed	height	was	approximately	10	 cm	
(exact	 values	 given	 in	 Table	 4.1).	 An	 Äkta	 Explorer	 100	 (GE	 Healthcare,	 Uppsala,	
Sweden)	was	used	to	pump	buffer	and	BSA	solutions	over	the	resin	and	monitor	the	
UV	absorbance	 at	280	nm.	The	 system	volume	was	determined	by	 injecting	 a	 small	
amount	of	3%	v/v	acetone	solution	without	attaching	a	column	and	was	found	to	be	
1.14	ml.	
BSA	solutions	with	a	concentration	of	1	mg/ml	were	prepared	in	equilibration	buffer	
(PBS	pH	7.4).	A	 flow	rate	of	0.5	ml/min	 (~150	cm/h)	was	used	 for	equilibration	 (5	
CV),	sample	application	and	washing.	For	desorption	PBS	pH	2	was	used	at	a	flow	rate	
of	2	ml/min	(~600	cm/h).	The	Big	Beads,	Cellufine	Formyl	and	the	Pall	aldehyde	resin	
were	also	evaluated	at	adsorption	flow	rates	ranging	between	0.17	(~50	cm/h)	and	2	
ml/min	 (~600	cm/h).	Washing	and	desorption	 flow	rates	were	kept	constant	at	0.5	
ml/min	and	2	ml/min	respectively.	
4.2.4 Calculation	of	process	properties	
To	 compare	 the	 resins	we	derived	 several	properties	 from	 the	 experimental	 results	
obtained	with	 the	packed	beds.	To	 further	 clarify	 the	measured	properties	a	 typical	
chromatogram	 is	 shown	 in	 Figure	 4.1.	 Three	 stages	 of	 the	 purification	 process	 are	
visible,	 the	 equilibration	 and	 regeneration	 stage	 are	 left	 out.	 The	 first	 stage	 is	 the	
adsorption	stage,	which	runs	from	the	start	until	the	first	maximum	in	the	graph.	This	
stage	 is	 also	 often	 referred	 to	 as	 the	 breakthrough	 curve.	 The	 second	 stage	 is	 the	
washing	 stage	 in	which	 the	 outlet	 concentration	 drops	 to	 zero	 or	 almost	 zero.	 The	
peak	at	the	end	of	the	curve	indicates	the	third	stage,	the	elution	or	desorption.	The	
shape	 of	 the	 curve	 in	 each	 stage	 is	 determined	 by	 the	 resin	 properties	 and	
experimental	conditions.	
The	maximum	breakthrough	was	calculated	as	the	maximum	BSA	concentration	at	the	
column	outlet	during	adsorption	divided	by	the	BSA	concentration	at	the	inlet	(in	this	
case	1	mg/ml).	This	value	shows	to	which	extent	the	column	was	saturated	with	BSA.	
The	dynamic	binding	 capacity	 at	10%	 (DBC10%)	breakthrough	was	 calculated	as	 the	
amount	of	BSA	bound	 to	 the	 column	when	 the	outlet	 concentration	 reaches	10%	of	
the	 inlet	 concentration,	divided	by	 the	column	volume.	 In	Figure	4.1	 the	area	 in	 the	
chromatogram	that	represents	DBC10%	is	indicated.	It	should	be	noted	that	the	DBC10%	
is	dependent	on	feed	concentration,	a	higher	feed	concentration	will	lead	to	a	higher	
DBC10%	(up	to	a	certain	maximum).	The	wash	volume	was	determined	as	the	number	
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of	column	volumes	(CV)	of	buffer	required	to	wash	the	column	after	adsorption	until	
the	BSA	concentration	at	the	outlet	dropped	to	10%	of	the	inlet	concentration.	
	
Figure	4.1.	Typical	chromatogram	(thick	solid	line)	as	measured	in	this	study	(data	from	Cellufine	Formyl,	
flow	rate	0.17	ml/min).	The	horizontal	lines	indicate	the	5%	(dash‐dotted),	10%	(dashed)	and	100%	(solid)	
of	the	inlet	concentration.	
In	a	purification	process	collecting	the	entire	desorption	peak	will	result	in	a	relatively	
dilute	sample,	which	may	then	require	 further	concentration.	Therefore,	we	decided	
to	 specify	 a	 collected	 fraction,	which	 is	 the	 fraction	 that	 has	 a	 higher	 concentration	
than	the	inlet	concentration.	This	means	that	the	left	and	right	parts	of	the	desorption	
peak	were	 ‘discarded’.	 The	 volume	 of	 the	 collected	 fraction	 is	 expressed	 in	 column	
volumes	 (CV;	 see	 Figure	 4.1).	 The	 yield	 was	 calculated	 as	 the	 percentage	 of	 the	
desorbed	BSA	in	the	collected	fraction	compared	to	the	total	amount	of	BSA	desorbed.	
A	 high	 yield	 indicates	 a	 sharp	 and	 therefore	 more	 desirable	 desorption	 peak.	 We	
defined	the	concentration	factor	as	the	average	concentration	in	the	collected	fraction	
divided	 by	 the	 inlet	 (feed)	 concentration.	 The	 process	 volume	 is	 determined	 as	 the	
number	 of	 column	 volumes	 (CV)	 required	 to	 purify	 1	mg	 of	 BSA	 per	ml	 resin.	 It	 is	
calculated	by	 first	determining	 the	 sum	of	 the	 volume	of	BSA	 solution	 applied	until	
10%	breakthrough,	the	wash	volume	and	the	volume	of	the	total	desorption	peak	(see	
Figure	4.1).	This	volume	is	then	divided	by	DBC10%	to	obtain	the	process	volume.	The	
right‐hand	tail	of	the	desorption	peak	lower	than	5%	of	the	inlet	concentration	is	not	
taken	into	account	in	this	calculation.	
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4.3 Results	and	discussion	
4.3.1 BSA	breakthrough	experiments	
All	resins	could	be	successfully	used	to	immobilize	the	VHH	ligand,	and	bind	BSA	in	a	
packed	bed	configuration.	The	chromatograms	of	the	resins	are	shown	in	Figure	4.2,	
in	which	the	outlet	concentration	is	divided	by	the	inlet	concentration	for	adsorption.	
The	 steeper	 the	 breakthrough	 curve,	 the	 better	 the	 adsorption	 kinetics	 and	 mass	
transfer.	Good	mass	transfer	is	also	indicated	by	a	short	washing	stage	and	a	tall	and	
narrow	 desorption	 peak.	 For	 all	 resins,	 the	 breakthrough	 curves	 are	 quite	 shallow.	
The	 prototype	 Big	 Beads	 and	 Glyoxal	 Agarose	 resins	 show	 the	 shallowest	
breakthrough	curves.	This	could	be	due	to	the	adsorption	kinetics,	but	since	the	same	
type	of	ligand	is	used	for	every	bead,	a	large	difference	in	adsorption	kinetics	between	
the	beads	is	not	expected.	Therefore,	the	shallow	shape	of	the	breakthrough	curve	is	
most	likely	due	to	slow	diffusion	into	the	beads.	The	volume	required	for	washing	is	
also	 longer	 for	 the	 Big	 Beads	 and	 Glyoxal	 Agarose	 resins,	 which	 supports	 the	
observation	of	slow	diffusion.	
The	data	extracted	from	the	chromatograms	are	summarized	in	Table	4.2.	Except	for	
the	 Big	 Beads	 and	 Sepabeads,	 BSA	 was	 applied	 to	 the	 columns	 until	 at	 least	 90%	
breakthrough.	 The	 Big	 Beads	 were	 saturated	 until	 73%	 breakthrough,	 and	 the	
Sepabeads	were	saturated	until	88%	breakthrough.	The	maximum	binding	capacity	of	
the	 different	 resins	 cannot	 be	 determined	 accurately	 from	 the	 measured	
breakthrough	 curves.	 In	 a	 large‐scale	 process,	 adsorption	 is	 usually	 terminated	 at	 a	
specific	level	of	breakthrough.	This	level	of	breakthrough	depends	on	the	commercial	
value	of	the	target	in	case	of	preparative	chromatography,	or	on	the	maximal	allowed	
concentration	 in	 a	 scavenging	 process.	 Therefore,	 the	 dynamic	 binding	 capacity	 is	
more	relevant	to	practice,	and	more	often	used	than	the	maximum	binding	capacity.	In	
case	the	chromatography	process	is	aimed	at	purifying	a	target	present	in	a	low‐value	
feed	 stream,	 it	 might	 be	 economically	 interesting	 to	 saturate	 the	 chromatography	
column,	 but	 even	 then	 a	 resin	 with	 good	 mass	 transfer	 properties	 might	 be	 more	
economical	 to	 use	 than	 a	 resin	with	 a	 high	 binding	 capacity,	 as	 it	 will	 allow	 larger	
throughput.	 	
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Figure	4.2.	Normalized	outlet	concentration	(outlet	BSA	concentration	divided	by	the	concentration	of	the	
sample)	against	outlet	volume	for	the	resins	NHS	Sepharose	(a,	bed	height	48	mm),	Big	Beads	(b,	105	mm),	
Sepabeads	(c,	59	mm),	Glyoxal	Agarose	(d,	48	mm),	Cellufine	Formyl	(e,	104	mm)	and	Pall	(f,	104	mm).	The	
adsorption	and	wash	flow	rates	were	0.5	ml/min	and	desorption	flow	rate	was	2	ml/min.	
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The	DBC10%	of	the	resins	investigated	ranged	between	0.76	and	4.8	mg	BSA	/	ml	resin	
(Table	4.2),	with	the	Sepabeads	having	the	lowest	and	Big	Beads	the	highest	DBC10%.	A	
low	DBC10%	can	have	several	reasons.	First,	the	amount	of	 ligand	immobilized	to	the	
resin	 can	 be	 low.	 The	 immobilized	 ligand	 may	 also	 be	 partly	 dysfunctional,	 which	
depends	 on	 the	 immobilization	method	 and	 active	 group	 density.	 According	 to	 the	
manufacturer	 of	 the	 Sepabeads,	 the	 pore	 size	 is	 in	 the	 range	 of	 30	 to	 40	 nm.	 It	 is	
therefore	 likely	 that	 the	 BSA	 molecule,	 having	 a	 hydrodynamic	 diameter	 of	
approximately	 8	 nm,	 but	 usually	 at	 partly	 present	 in	 the	 form	 of	 dimers	 or	 even	
multimers,	 is	not	able	to	enter	the	bead	efficiently,	especially	after	immobilization	of	
the	 VHH.	 Even	 though	 a	 difference	 in	 bed	 height	 exists	 between	 the	 beads,	 the	
influence	 on	 DBC10%,	 should	 not	 be	 that	 large	 because	 the	 liquid	 velocity	 in	 the	
columns	was	the	same.	Besides,	the	DBC10%	was	calculated	per	volume	resin,	not	per	
column.	DBC10%	 is	however	not	necessarily	 the	best	 indicator	 for	 resin	performance	
because	it	is	solely	based	on	the	adsorption	phase	of	the	purification	process.	
Table	4.2.	Measured	properties	of	activated	resins	used	in	this	study.	An	explanation	of	the	properties	can	
be	found	in	Section	4.2.4.	
	 NHS	
Sepharose	FF	
Big	
Beads1	
Sepabeads
FP‐EP400	
Glyoxal	
Agarose	
Cellufine	
Formyl	
Pall1	
Max	breakthrough	 0.94	 0.73	 0.88	 0.92	 0.98	 0.97	
DBC10%(mg	BSA	/ml	resin)	 4.0	 4.8	 0.76	 2.4	 3.8	 2.1	
Wash	volume	(CV)	 3.7	 6.3	 10	 9.12	 2.9	 6.1	
Max	desorption	
concentration	/	inlet	
concentration	
13	 7.6	 1.1	 6.3	 4.7	 12.5	
Volume	collected	fraction	
(CV)	
2.1	 3.0	 0.81	 3.6	 2.3	 2.2	
Yield	 0.96	 0.91	 0.29	 0.88	 0.88	 0.93	
Concentration	factor	 7.9	 4.4	 0.90	 3.9	 3.0	 5.7	
Process	volume	
(CV/mg	BSA/ml	resin)	
3.20	 3.93	 22.97	 9.13	 3.21	 6.62	
1	 The	 Big	 Beads	 and	 Pall	 resins	 were	 in	 a	 development	 stage	 at	 the	 time	 of	 the	 experiments	 and	 are	
therefore	not	representative	for	existing	or	new	commercial	products.	
2	The	wash	step	was	too	short	to	reach	10%	of	the	inlet	BSA	concentration.	
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An	often	overlooked,	but	 essential	part	of	 the	purification	process	 is	 the	desorption	
step.	The	best	desorption	peaks	are	clearly	those	of	NHS	Sepharose	and	the	prototype	
Pall	resins,	because	they	are	very	narrow	and	tall	(see	Figure	4.2).	For	each	of	the	six	
resins	the	maximum	desorption	concentration	compared	to	the	inlet	concentration	is	
given	in	Table	4.2.	In	this	particular	case	the	Sepabeads	do	not	perform	well,	because	
the	BSA	solution	obtained	after	desorption	is	of	an	almost	equal	concentration	as	the	
feed	solution.	This	is	due	to	the	low	binding	capacity,	the	DBC10%	is	only	0.76	mg	BSA	/	
ml	resin,	and	mass	 transfer	 limitation,	which	results	 in	 the	high	wash	volume	and	a	
wide	desorption	peak.	The	residence	time	was	short	for	the	Sepabeads	and	the	results	
may	be	improved	by	increasing	the	residence	time.	However,	the	NHS	Sepharose	also	
had	an	equal	residence	time	but	showed	a	much	shorter	wash	volume.	This	indicates	
that	mass	transfer	limitation	for	the	Sepabeads	is	not	only	due	to	the	short	residence	
time.	
The	 NHS	 Sepharose	 and	 prototype	 Pall	 resins	 yield	 the	 highest	 desorption	
concentration;	 the	 highest	 concentration	 in	 the	 desorption	 peak	 is	 13	 times	 higher	
than	the	initial	BSA	concentration	(see	Table	4.2).	The	prototype	Pall	resin	has	a	wider	
desorption	 peak	 than	 NHS	 Sepharose,	 so	 the	 concentration	 factor	 of	 the	 collected	
fraction	is	highest	for	NHS	Sepharose	(see	Figure	4.2).	The	prototype	Big	Beads	would	
probably	 have	 reached	 a	 higher	 concentration	 factor	 if	 the	 column	 was	 further	
saturated,	but	this	would	require	longer	residence	times,	for	example	by	a	lower	flow	
rate	of	the	mobile	phase.	
The	 concentration	 factor	 alone	 also	 does	 not	 completely	 cover	 resin	 performance.	
Therefore	 the	number	of	 column	volumes	 required	 to	purify	1	mg	of	BSA	per	ml	of	
resin,	the	process	volume,	is	calculated.	Table	4.2	shows	that	NHS	Sepharose	has	the	
lowest	process	volume,	closely	followed	by	Cellufine	and	Big	Beads.	
4.3.2 Resin	selection	
Selection	of	resin	depends	on	multiple	criteria.	Therefore	it	is	interesting	to	rank	the	
resins	for	important	properties.	In	Table	4.3	an	example	is	given	for	the	DBC10%,	wash	
volume,	concentration	factor	and	process	volume.	Each	resin	is	ranked	such	that	the	
resin	with	 the	best	value	 for	 that	property	ranks	as	1,	 the	second	best	as	number	2,	
etc.	In	case	of	DBC10%,	the	value	should	be	as	high	as	possible;	therefore	the	resin	with	
the	 highest	 DBC10%,	 in	 this	 case	 the	 Big	 Beads,	 is	 ranked	 number	 1.	 For	 the	 wash	
volume	the	value	should	be	as	low	as	possible	to	be	the	best,	and	this	is	true	for	the	
Cellufine	Formyl	resin.	Depending	on	the	process,	each	property	can	be	given	a	certain	
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weight	 according	 to	 its	 importance.	 An	 example	may	 be	 that	 DBC10%	 is	 considered	
more	important	than	the	wash	volume,	so	the	rank	for	DBC10%	could	be	given	a	weight	
of	3	compared	to	the	wash	volume.	When	all	the	properties	of	interest	are	ranked,	the	
ranks	are	added	up	to	a	score.	The	lowest	score	should	then	indicate	the	most	suitable	
resin.	In	Table	4.3	no	weights	have	been	assigned	to	the	properties,	so	all	properties	
are	 deemed	 equally	 important.	 From	 this	 table	 it	 is	 evident	 that	 NHS	 Sepharose	
followed	by	Big	Beads,	Cellufine	Formyl	and	the	prototype	Pall	 resin	perform	better	
than	 the	Sepabeads	and	Glyoxal	Agarose.	The	 results	 for	 the	Sepabeads	and	Glyoxal	
Agarose	resins	may	be	improved	by	increasing	the	residence	time,	but	the	residence	
time	for	NHS	Sepharose	was	equal.	The	Big	Beads	and	Pall	resins	were	examined	at	a	
development	 stage	 and	 therefore	 the	 final	 commercial	 products	 may	 have	 other	
properties	than	found	in	this	study.	
Table	4.3.	Ranking	and	scoring	of	resin	properties.	
	 NHS	
Sepharose	
Big	
Beads1	
Sepabeads	 Glyoxal	
Agarose	
Cellufine	
Formyl	
Pall1	
DBC10%	 2	 1	 6	 4	 3	 5	
Wash	volume	 2	 4	 6	 5	 1	 3	
Concentration	
factor	
1	 3	 6	 4	 5	 2	
Process	volume	 1	 3	 6	 5	 2	 4	
Total	score	 6	 11	 24	 18	 11	 14	
1	 The	 Big	 Beads	 and	 Pall	 resins	 were	 in	 a	 development	 stage	 at	 the	 time	 of	 the	 experiments	 and	 are	
therefore	not	representative	for	existing	or	new	commercial	products.	
4.4 Influence	of	adsorption	flow	rate	on	process	performance	
The	 influence	 of	 flow	 rate	 on	 the	 adsorption	 process	 was	 investigated	 for	 the	
prototype	Big	Beads,	Cellufine	Formyl	and	prototype	Pall	resins	(see	Appendix,	Table	
A1	and	Figure	4.3).	For	all	resins	the	highest	DBC10%	was	obtained	at	the	lowest	flow	
rate	(see	Figure	4.3a),	which	is	according	to	expectations,	and	supports	the	conclusion	
that	 slow	 diffusion	 is	 the	 reason	 of	 their	 non‐optimal	 performance	 in	 the	 earlier	
experiments.	 A	 low	 flow	 rate	 implies	 a	 high	 residence	 time,	 which	 is	 beneficial	 for	
mass	transfer	and	adsorption	kinetics.	In	this	case	we	expect	intraparticle	diffusion	to	
be	limiting.	At	a	longer	residence	time,	more	time	is	available	for	BSA	to	diffuse	into	
the	bead.	The	DBC10%	of	Big	Beads	and	Pall	are	almost	twice	as	high	as	the	DBC10%	of	
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the	 Cellufine	 Formyl	 beads	 at	 50	 cm/h	 (0.17	 ml/min),	 but	 both	 drop	 rapidly	 with	
increasing	flow	rate.	At	300	cm/h	and	600	cm/h	there	is	no	clear	difference	between	
the	three	beads	in	terms	of	DBC10%.	
	
Figure	4.3.	a)	Dynamic	binding	capacity	at	10%	breakthrough;	b)	wash	volume;	and	c)	process	volume	as	a	
function	of	superficial	velocity	during	adsorption	for	Big	Beads	(●),	Cellufine	Formyl	(▲)	and	Pall	(○)	resins.	
The	wash	volume	shown	in	Figure	4.3b	gives	insight	into	diffusion	limitation.	Only	the	
adsorption	 flow	 rate	 was	 altered,	 the	 flow	 rate	 for	 washing	 was	 constant	 at	 0.5	
ml/min	(150	cm/h).	At	a	low	flow	rate	during	adsorption,	the	required	wash	volume	
is	 high,	 because	 BSA	 has	 diffused	 into	 the	 bead	 completely	 or	 almost	 completely.	
Therefore	it	requires	more	time	for	all	the	unbound	BSA	to	leave	the	bead	and	enter	
the	bulk	liquid.	In	short,	the	wash	volume	should	decrease	with	increasing	adsorption	
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flow	rate	when	 intraparticle	diffusion	 is	 limiting.	Big	Beads	are	 larger	 than	Pall	 and	
Cellufine	 Formyl	 beads	 (see	 Table	 4.1)	 and	 therefore	 the	 diffusion	 path	 inside	 the	
bead	is	the	longest	of	the	three	beads.	At	short	residence	times	in	the	column,	the	BSA	
cannot	 fully	 saturate	 the	 Big	 Beads	 because	 of	 diffusion	 limitation.	 This	 effect	 also	
holds	for	the	Pall	and	Cellufine	Formyl	beads,	but	to	a	lesser	extent	due	to	the	shorter	
diffusion	path.	The	Cellufine	Formyl	shows	a	constant	wash	volume	for	all	flow	rates,	
which	indicates	limited	intraparticle	diffusion	limitation.	This	bead	may	well	contain	
larger	pores	which	help	in	quick	transfer	of	BSA	into	and	out	of	the	beads.	
The	 process	 volume	 increases	 more	 than	 linearly	 with	 increasing	 adsorption	 flow	
rate,	which	is	shown	in	Figure	4.3c.	At	a	low	flow	rate	the	process	volume	is	more	or	
less	independent	of	the	type	of	bead;	all	beads	show	a	process	volume	between	2	and	
3	CV	per	mg	of	BSA.	As	the	flow	rate	for	adsorption	increases,	differences	between	the	
beads	become	larger.	The	Big	Beads	show	the	highest	dependence	of	process	volume	
on	flow	rate.	The	Pall	and	Cellufine	Formyl	resins	require	half	the	process	volume	of	
Big	Beads	at	an	adsorption	flow	rate	of	2	ml/min	(600	cm/h).	This	large	difference	is	
mainly	due	 to	 the	much	smaller	amount	of	washing	buffer	required	 for	 the	Pall	and	
Cellufine	Formyl	resins	compared	to	the	Big	Beads.	All	other	properties	measured	at	
different	 adsorption	 flow	 rates	 for	 Big	 Beads,	 Cellufine	 Formyl	 and	 Pall	 resins	 are	
summarized	in	Table	A1	in	the	Appendix.	
The	pressure	drop	of	 the	 resins	has	not	been	 investigated,	but	 can	be	an	 important	
issue	for	process	design.	Especially	the	smaller	beads	will	exhibit	high	pressure	drop.	
The	 Big	 Beads	 were	 specifically	 designed	 for	 high	 flow	 rates	 (the	 hydrodynamic	
resistance	typically	depends	on	the	square	of	the	bead	size)	and	would	thus	be	a	good	
choice	 for	 large‐scale	 processing.	 It	 is	 however	 important	 to	 realize	 that	 increasing	
adsorption	 flow	 rates	 will	 cause	 decreasing	 dynamic	 binding	 capacities	 and	 larger	
process	volumes.	
4.5 Conclusions	
The	activated	resins	 investigated	 in	 this	chapter	could	all	be	used	 to	 immobilize	 the	
VHH	 ligand	 and	were	 able	 to	 bind	 BSA.	 However,	 large	 differences	 in	 performance	
could	be	observed.	
Each	chromatographic	process	has	different	requirements.	Comparing	resins	based	on	
only	 one	 property	 (often	 the	 DBC10%)	 will	 not	 result	 in	 finding	 the	 optimal	 resin	
available.	A	ranking	and	weighing	of	each	property	important	for	a	particular	process	
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enables	a	good	decision	based	on	experimentally	determined	breakthrough	curves	for	
very	 different	 resins.	 From	 the	 six	 resins	 investigated,	 the	 Sepabeads	 and	 Glyoxal	
Agarose	were	found	to	be	unsuitable	 for	the	separation	of	BSA	with	the	VHH	ligand.	
The	 further	 choice	 of	 resin	 depends	 on	 the	 importance	 given	 to	 each	 of	 the	 resin	
properties,	which	may	include	other	properties	than	evaluated	here,	such	as	cleaning‐
in‐place	(CIP)	properties,	resin	life	time	and	price.		
The	method	of	comparing	resins	described	in	this	chapter	is	well	suitable	to	compare	
resins	of	very	different	nature.	It	is	further	possible	to	compare	results	from	literature	
by	using	the	simple	and	intuitive	method	of	ranking	and	weighing	to	find	a	selection	of	
resins	that	can	be	used	in	the	chromatography	process	of	interest.	
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Chapter	5	
Efficiency	of	protein‐based	ligand	immobilization	for	
affinity	chromatography	
	
Abstract	
Affinity	 chromatography	often	relies	on	specific	 ligands	 that	are	 immobilized	onto	a	
resin.	The	adsorption	capacities	of	 such	resins	are	much	 lower	 than	 those	observed	
for,	 for	 example,	 ion	 exchange	 resins.	 We	 here	 report	 on	 the	 efficiency	 of	 ligand	
immobilization	and	subsequent	protein	adsorption.	A	llama	antibody	fragment	against	
bovine	 serum	 albumin	 (BSA)	 was	 immobilized	 on	 three	 commercially	 available	
activated	resins	(Epoxy‐activated	Sepharose	6B	and	NHS	Sepharose	4	Fast	Flow	from	
GE	 Healthcare	 (Uppsala,	 Sweden)	 and	 aldehyde‐activated	 Cellufine	 Formyl	 from	
Chisso	(Tokyo,	Japan)).	The	adsorption	capacity	of	the	affinity	resins	was	determined	
using	 packed	 bed	 chromatography.	 Between	 41	 and	 71%	 of	 the	 ligand	 could	 be	
immobilized	 using	 the	 manufacturer’s	 protocol	 (including	 coupling,	 blocking	 and	
washing);	however,	only	10	to	24%	of	the	immobilized	ligand	was	able	to	bind	BSA.	
We	 also	 immobilized	 BSA	 directly	 to	 the	 activated	 resins	 by	 adding	 different	
concentrations	of	BSA	per	ml	resin	instead	of	the	ligand.	The	amount	of	BSA	that	could	
be	 immobilized	 increased	 with	 the	 amount	 of	 BSA	 added.	 The	 efficiency	 of	
immobilization	ranged	between	 less	 than	50%	for	 the	highest	concentration	 to	over	
70%	for	the	lowest	BSA	concentration.	Thus,	the	concentration	of	the	protein	during	
immobilization	is	an	important	parameter	for	the	final	density	of	immobilized	protein	
(BSA	or	ligand)	to	the	resin	and	thus	for	the	final	adsorption	capacity.	
	
	
	
	
This	 chapter	will	 be	 submitted	 as:	 Besselink,	 Tamara;	 Strubel,	 Maurice;	 van	 der	 Padt,	 Albert;	
Janssen,	Anja	E.M.;	and	Boom,	Remko	M.	Efficiency	of	protein‐based	ligand	immobilization	for	
affinity	chromatography.	 	
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5.1 Introduction	
Affinity	chromatography	 is	an	efficient	method	to	specifically	 isolate	one	component	
from	a	complex	mixture	with	high	purity.	In	case	there	is	a	specific	ligand	available	for	
the	 compound	 to	 be	 purified	 or	 removed,	 this	 ligand	 has	 to	 be	 immobilized	 onto	 a	
stationary	phase.	This	procedure	is	often	applied	for	immunoaffinity	chromatography,	
which	for	example	utilises	a	monoclonal	antibody	 immobilized	onto	a	resin	(see,	 for	
example,	 [1]).	 To	 immobilize	 proteins	 onto	 chromatography	 resins,	 several	
procedures	are	possible,	of	which	covalent	attachment	is	the	most	common	one.	Many	
activated	 resins	 are	 available	 on	 the	market,	with	 different	 types	 of	 immobilization	
chemistry.	It	is	crucial	that	the	ligand	is	immobilized	in	such	a	way	that	it	can	bind	the	
target	 compound	 after	 immobilization	 (see	 Figure	 5.1).	 The	 active	 adsorption	 site	
should	therefore	not	be	blocked.	The	ligand	has	to	be	covalently	attached	to	the	resin	
to	 minimize	 leaching	 [2],	 but	 should	 still	 have	 enough	 flexibility	 for	 adsorption.	 A	
spacer	arm	is	often	applied	to	ensure	this.	An	overview	of	immobilization	chemistries	
can	be	found	in	a	book	chapter	by	Kim	and	Hage	[3].	
Because	 ligands	 are	 often	 expensive,	 the	 ligand	 should	 be	 used	 as	 efficiently	 as	
possible.	Besides,	the	resin	costs	are	usually	a	very	important	aspect	of	the	economic	
feasibility	 of	 an	 affinity	 chromatography	 process.	 The	 amount	 of	 resin	 required	
depends	 largely	 on	 the	 adsorption	 capacity	 of	 the	 resin.	 Ion	 exchangers	 may	 have	
static	 adsorption	 capacities	 as	high	 as	 240	mg/ml	bovine	 serum	albumin	 (BSA)	 [4],	
although	100	to	150	mg/ml	is	more	common.	In	molar	concentrations,	the	capacities	
vary	 between	 1.5	 and	 3.5	 µmol/ml	 resin	 BSA	 (MW	 ~67	 kDa).	 The	 adsorption	
capacities	 are	much	 lower	 for	 affinity	 chromatography	 resins,	which	may	be	due	 to	
inefficient	use	of	the	affinity	ligands;	for	example,	immobilization	at	the	wrong	side	of	
the	ligand	may	inhibit	binding	of	the	target	component.	
We	 distinguish	 two	 types	 of	 efficiency	 for	 affinity	 ligand	 immobilization.	 First,	 the	
efficiency	 of	 immobilization	 itself:	 the	 amount	 of	 ligand	 immobilized	 relative	 to	 the	
amount	of	 ligand	available	 for	 immobilization.	Second,	 the	efficiency	of	 the	 ligand	to	
bind	 the	 target:	 the	 amount	 of	 target	 adsorbed	 relative	 to	 the	 amount	 of	 ligand	
immobilized	(see	Figure	5.1).	
Some	 research	 has	 been	 done	 on	 the	 efficiency	 of	 immobilization	 and	 subsequent	
adsorption,	 mainly	 in	 the	 field	 of	 antibody	 immobilization.	 Part	 of	 that	 research	 is	
aimed	 at	 immobilization	 to	 biosensors	 (e.g.,	 [5,	 6]).	We	 found	 only	 few	 papers	 that	
quantitatively	 determine	 either	 the	 immobilization	 efficiency	 or	 the	 adsorption	
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efficiency	 [7,	 8],	 but	 these	papers	 are	not	 very	 recent	and	 the	 authors	 activated	 the	
resins	 themselves,	 which	 makes	 comparison	 with	 commercially	 available	 activated	
resins	difficult.	
	
Figure	5.1.	Schematic	representation	of	immobilization	and	adsorption.	
For	commercially	available	affinity	resins,	 the	 immobilization	efficiency	 is	unknown,	
but	 for	some	resins	 it	 is	possible	 to	evaluate	 the	adsorption	efficiency.	As	examples,	
one	 may	 take	 commercially	 available	 Cibacron	 Blue	 resins	 and	 their	 capacities	 as	
reported	by	the	manufacturer.	Blue	Sepharose	from	GE	Healthcare	(Uppsala,	Sweden)	
has	a	static	adsorption	capacity	of	more	than	18	mg/ml	or	0.27	µmol/ml	 for	human	
serum	 albumin	 (HSA;	 MW	 ~67	 kDa)	 according	 to	 the	 manufacturer.	 A	 total	 of	 7	
µmol/ml	Cibacron	Blue	is	attached	to	the	resin,	as	reported	by	GE	Healthcare,	so	there	
are	26	dye	 ligands	 available	 for	 each	HSA	molecule	 that	 can	maximally	 adsorb.	The	
adsorption	 efficiency	with	 a	 reaction	 stoichiometry	 of	 1	would	 then	 be	 3.8%.	 Even	
though	the	stoichiometry	may	not	be	exactly	1,	the	dye	ligands	are	obviously	present	
in	large	excess.	The	Blue	Trisacryl®	M	resin	from	Pall	(Portsmouth,	United	Kingdom)	
has	a	reported	adsorption	capacity	of	up	to	15	mg/ml	or	0.22	µmol/ml	for	HSA	and	up	
to	 7	 mg/ml	 or	 0.10	 µmol/ml	 for	 BSA.	 The	 manufacturer	 states	 that	 4	 µmol/ml	
Cibacron	Blue	 is	 immobilized	onto	 the	 resin,	which	 indicates	at	 least	18	dye	 ligands	
per	 HSA	 molecule,	 implying	 an	 adsorption	 efficiency	 of	 5.6%.	 For	 relatively	 cost‐
effective	 ligands,	 the	 adsorption	 efficiency	 may	 not	 be	 an	 issue	 per	 se,	 but	 the	
adsorption	capacity	obviously	is	an	issue,	especially	for	larger‐scale	applications.	
For	 more	 expensive	 ligands	 such	 as	 Protein	 A	 or	 monoclonal	 antibodies,	 the	
adsorption	efficiency	 is	even	more	 important	 than	a	relatively	 inexpensive	 ligand	as	
Cibacron	Blue.	A	 study	by	Hahn	and	co‐workers	 from	2005	shows	an	average	static	
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adsorption	capacity	of	around	60	mg/ml	or	0.38	µmol/ml	for	several	Protein	A	resins	
that	bind	IgG	(MW	~160	kDa)	[9].	Unfortunately,	the	amount	of	Protein	A	immobilized	
is	unknown,	so	the	adsorption	efficiency	is	unclear.	However,	the	adsorption	capacity	
is	 relatively	 low,	 as	 is	 also	mentioned	by	Low	and	co‐workers	 [10],	who	stated	 that	
there	 is	 a	 need	 for	 higher	 capacity	 Protein	 A	 resins	 to	 keep	 up	 with	 antibody	
production.	
Application	 of	 affinity	 chromatography	 in,	 for	 example,	 the	 food	 industry,	 makes	
improvement	of	adsorption	capacity	even	more	urgent,	as	large	amounts	of	feedstock	
have	 to	 be	 processed,	 requiring	 high	 capacity	 purification.	 Even	 when	 the	 target	
concentration	 is	 low,	 a	 high	 capacity	 is	 important	 because	 of	 the	 high	 resin	 and	
equipment	 costs.	 It	 is	 therefore	 important	 to	 further	 investigate	 the	 efficiency	 of	
ligand	immobilization	on	an	activated	resin.	
We	 here	 report	 on	 the	 efficiency	 of	 immobilization	 of	 a	 protein‐based	 ligand	 onto	
three	 commercially	 available	 activated	 resins.	 We	 focused	 on	 the	 application	 of	
fragments	 of	 antibodies	 produced	 by	Camelidae,	 the	 so‐called	VHH	 (variable	 heavy‐
chain	region	of	the	heavy‐chain	antibody)	[11,	12].	The	VHH	used	was	developed	for	
adsorption	 of	 albumins,	 in	 this	 case	 bovine	 serum	 albumin	 (BSA).	 The	 three	 resins	
were	 Epoxy‐activated	 Sepharose	 6B	 and	 N‐hydroxy‐succinimide	 (NHS)‐activated	
Sepharose	 4	 Fast	 Flow	 from	 GE	 Healthcare	 (Uppsala,	 Sweden),	 and	 the	 aldehyde‐
activated	Cellufine	Formyl	from	Chisso	(Tokyo,	Japan).	We	also	immobilized	BSA	itself	
directly	 to	 these	 resins	 to	 compare	 the	 amount	 of	 immobilized	 BSA	 with	 the	
adsorption	 capacity	 of	 the	 resins	 for	 immobilized	 VHH	 ligand.	 We	 determined	 the	
influence	 of	 BSA	 concentration	 on	 the	 amount	 of	 BSA	 immobilized.	 This	 provides	
information	 on	 how	 to	 improve	 the	 immobilization	 of	 proteins	 for	 affinity	
chromatography.	
5.2 Materials	and	methods	
5.2.1 Materials	
The	VHH	multi‐species	albumin	ligand	(MW	12.669	kDa)	was	kindly	provided	by	BAC	
BV	(Naarden,	The	Netherlands).	BSA	(A3059	(essentially	globulin	and	protease	 free,	
≥98%	pure),	for	the	immobilization	and	A6003	(essentially	fatty	acid	free,	≥96%	pure)	
for	 adsorption)	 was	 obtained	 from	 Sigma‐Aldrich	 (Zwijndrecht,	 The	 Netherlands).	
Other	reagents	were	purchased	at	Sigma‐Aldrich	or	Merck	(Darmstadt,	Germany)	and	
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were	of	analytical	purity.	Demineralized	water	was	obtained	using	a	Millipore	Milli‐Q	
system	(Billerica,	USA).	
Epoxy‐activated	 Sepharose	 6B	 and	 NHS‐activated	 Sepharose	 4	 Fast	 Flow	 were	
purchased	at	GE	Healthcare	(Uppsala,	Sweden).	Cellufine	Formyl	was	kindly	provided	
by	Chisso	(Tokyo,	Japan).	An	overview	of	the	activated	resins	is	provided	in	Table	5.1.		
Table	5.1.	Overview	of	resins	investigated	
Resin	 Material	 Particle	size	
(µm)	
Spacer	length	
(#	‐C‐)	
Active	group	 Active	group	
density	(µmol/ml)	
Epoxy	
Sepharose	6B	
Agarose	 45‐165	 12	 Epoxy	 19‐40	
NHS		
Sepharose	4FF	
Agarose	 45‐165	 14	 N‐hydroxy‐
succinimide	
16‐23	
Cellufine	Formyl	 Cellulose	 125‐210	 8	 Aldehyde	 15‐20	
5.2.2 Immobilization	
For	 the	 immobilization,	 the	 procedure	 provided	 by	 the	manufacturer	was	 followed.	
The	 coupling	 buffers	 used	 were	 0.1	 M	 NaHCO3	 +	 0.5	 M	 Na2SO4,	 pH	 9	 for	 Epoxy	
Sepharose	6B;	0.1	M	HEPES	+	0.5	M	NaCl,	pH	8	for	NHS	Sepharose	4	FF;	and	10	mM	
PBS	(phosphate	buffer	with	137	mM	NaCl	and	2.7	mM	KCl)	pH	7.4	+	0.5	M	NaCl	with	
30	µl	5	M	cyanoborohydride	per	ml	resin	for	Cellufine	Formyl.	
For	each	resin	0.1	M	Tris	+	0.5	M	NaCl,	pH	8	was	used	as	a	blocking	buffer.	For	Epoxy	
Sepharose	 6B	 and	 NHS	 Sepharose	 4	 Fast	 Flow	 blocking	 took	 place	 at	 room	
temperature	for	1	hour,	for	Cellufine	Formyl	for	2	hours.	
The	resins	were	washed	with	10	mM	PBS	pH	7.4	and	pH	2,	alternating	the	pH	between	
steps.	
Prior	 to	 VHH	 ligand	 immobilization,	 the	 ligand	 was	 dialyzed	 against	 the	 coupling	
buffer.	 Approximately	 10	 ml	 (exact	 amount	 measured	 per	 experiment)	 of	 ligand	
solution	 with	 a	 concentration	 of	 about	 1	 mM	 was	 added	 to	 4.5	 ml	 of	 each	 resin.	
Coupling	took	place	overnight	at	room	temperature.	The	resin	was	then	filtered	over	a	
sintered	glass	filter	prior	to	blocking	and	washing.	The	filtrate	after	coupling	was	kept	
for	analysis.	
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For	 the	 BSA	 immobilization,	 BSA	 was	 dissolved	 into	 the	 coupling	 buffer	 at	
concentrations	of	approximately	15,	40	and	70	mg/ml.	For	each	concentration	4	ml	
BSA	solution	was	added	to	2	ml	settled	resin.	The	coupling	procedure	was	the	same	as	
for	the	VHH	ligand.	The	same	blocking	procedure	was	used	as	described	above,	with	
10	 ml	 blocking	 buffer	 per	 2	 ml	 resin.	 The	 NHS	 and	 Epoxy	 Sepharose	 resins	 were	
washed	once	with	10	ml	10	mM	PBS	pH	2	and	once	with	the	same	amount	of	10	mM	
PBS	pH	7.4.	The	Cellufine	Formyl	resin	was	washed	once	with	10	ml	10	mM	PBS	pH	
7.4.	 The	 BSA	 concentrations	 in	 the	 blocking	 and	 wash	 buffers	 were	 measured	 in	
addition	to	the	concentration	in	the	remaining	coupling	buffer.	
5.2.3 Protein	quantification	
The	 ligand	 and	 BSA	 concentrations	 were	 determined	 using	 HPLC	 with	 a	 TSKgel	
G2000SWxl	 column	 (7.8	mm	 ×	 30	 cm,	 Tosoh	 BioScience,	 Tokyo,	 Japan).	 Solution	 A	
consisted	 of	 Milli‐Q	 water	 with	 0.1%	 trifluoroacetic	 acid	 (TFA),	 solution	 B	 of	
acetonitrile	with	0.1%	TFA.	Elution	was	performed	isocratically	with	70%	A	and	30%	
B	at	room	temperature	and	a	flow	rate	of	1.5	ml/min.	The	proteins	were	detected	with	
UV	spectrometry	at	214	nm.	
5.2.4 Determination	BSA	adsorption	capacity	
The	resins	were	poured	in	Tricorn	5/100	columns	(GE	Healthcare,	Uppsala,	Sweden)	
with	 a	 diameter	 of	 5	mm,	 and	 a	 height	 of	 approximately	 10	 cm.	 The	 columns	were	
connected	to	an	Äkta	Purifier	100	system	(GE	Healthcare,	Uppsala,	Sweden)	with	UV	
detection	at	280	nm.	A	5	mg/ml	BSA	solution	in	10	mM	PBS	pH	7.4	was	led	over	the	
columns	at	a	flow	rate	of	0.25	ml/min	until	a	plateau	was	reached.	The	columns	were	
then	washed	with	10	mM	PBS	pH	7.4	until	the	BSA	concentration	dropped	to	zero.	The	
BSA	 adsorbed	 was	 desorbed	 using	 0.1	 M	 glycine	 acidified	 with	 HCl	 to	 pH	 3.	 The	
amount	of	BSA	corresponding	to	the	desorption	peak	was	defined	as	 the	adsorption	
capacity	of	the	column.	
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5.3 Results	and	discussion	
5.3.1 Efficiency	of	VHH	ligand	immobilization	
The	three	resins	used	all	have	different	properties,	as	summarized	in	Table	5.1.	For	all	
the	 resins	 a	 spacer	 arm	 was	 available,	 which	 may	 improve	 immobilization	 and	
adsorption	properties	for	small	ligands.	The	three	immobilization	methods	used	result	
in	random	orientation	because	of	the	various	positions	of	reactive	amino	acids	in	the	
ligand.	The	NHS	and	aldehyde	active	groups	are	known	to	react	mainly	with	terminal	
amine	groups	or	lysine	residues,	of	which	this	ligand	has	three	according	to	the	ligand	
manufacturer	 (BAC	 BV,	 Naarden,	 The	 Netherlands).	 The	 epoxy	 chemistry	 is	 also	
capable	of	immobilization	through	hydroxyl	or	thiol	groups.	The	ligand	contains	only	
two	 cysteine	 residues,	 which	 may	 be	 used	 for	 immobilization	 depending	 on	 their	
position	in	the	protein.	
The	ligand	concentrations	and	results	of	the	experiments	are	shown	in	Table	5.2.	The	
number	of	 active	groups	available	was	 in	all	 cases	much	higher	 than	 the	number	of	
ligand	molecules	available.		
The	reaction	between	the	active	group	and	the	ligand	eventually	can	be	summarized	
as	follows:	
ܽܿݐ݅ݒ݁	݃ݎ݋ݑ݌ ൅ ݈݅݃ܽ݊݀	 → ݅݉݉݋ܾ݈݅݅ݖ݁݀	݈݅݃ܽ݊݀	 (5.1)	
Since	 the	active	groups	are	 in	excess,	 the	amount	of	 ligand	available	 in	 the	coupling	
buffer	 determines	 the	 amount	 of	 ligand	 that	 can	 be	 immobilized.	 The	 efficiency	 of	
ligand	immobilization	(ηimm)	is	calculated	as	follows:	
ߟ௜௠௠ ൌ ஼ೇಹಹ,బ௏೎ି஼ೇಹಹ,భ௏೎஼ೇಹಹ,బ௏೎ ൌ
஼ೇಹಹ,బି஼ೇಹಹ,భ
஼ೇಹಹ,బ 	 (5.2)	
In	this	equation,	CVHH,0	is	the	initial	ligand	concentration	in	the	coupling	buffer,	Vc	the	
volume	of	coupling	buffer	and	CVHH,1	the	ligand	concentration	after	coupling.	
As	 shown	 in	Table	5.2,	 the	 immobilization	efficiency	 is	between	41	and	71%.	There	
are	some	other	reports	in	which	the	immobilization	efficiency,	also	referred	to	as	the	
coupling	efficiency,	was	measured	(e.g.,	[2,	7,	8]).	Van	Sommeren	and	co‐workers	used	
a	 prototype	 of	 the	 NHS	 Sepharose	 we	 used	 in	 this	 research	 and	 found	 an	
immobilization	efficiency	of	100%	 for	 IgG	 [2].	They	used	 several	 amounts	of	 IgG:	0,	
2.9,	5.4	and	11.1	mg	per	ml	resin.	Assuming	a	molecular	weight	of	the	IgG	of	160	kDa,	
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the	largest	amount	added	per	ml	resin	was	0.07	µmol	which	is	much	lower	than	the	
amount	 of	 VHH	 added	 in	 our	 experiments.	 This	 probably	 explains	 the	 100%	
immobilization	efficiency	Van	Sommeren	et	al.	found	for	the	IgG	immobilization.	If	we	
would	have	applied	a	similar	amount	of	VHH	as	they	applied	IgG	in	their	experiments,	
the	immobilization	efficiency	would	have	been	higher	than	found	here.	However,	the	
overall	 adsorption	 capacity	 would	 have	 been	 much	 lower	 because	 much	 less	 VHH	
would	 have	 been	 immobilized.	 The	 influence	 of	 ligand	 concentration	 on	 the	
immobilization	efficiency	is	further	investigated	using	BSA	as	a	model	ligand,	which	is	
discussed	in	Section	5.3.3.	
Table	5.2.	Overview	of	experimental	conditions	and	results	for	the	immobilization	of	VHH	ligand.	
	 Epoxy	
Sepharose	
NHS	Sepharose	 Cellufine	
Formyl	
Ligand	concentration	(µmol/ml)	 0.92	 1.10	 0.92	
Ligand	added	(µmol/ml	resin)	 1.84	 2.68	 2.05	
Ligand	added	(mol/mol	active	group)	 0.05	‐	0.10	 0.12	‐	0.17	 0.10	‐	0.14	
Ligand	immobilized	(µmol/ml	resin)1	 0.98	 1.91	 0.84	
Ligand	immobilized	(mol/mol	active	group)	 0.025	–	0.052	 0.083	–	0.120	 0.042	–	0.056	
Immobilization	efficiency	ηimm	(%)	 53	 71	 41	
Theoretical	adsorption	capacity	(mg	BSA/ml	resin)	 66	 128	 57	
Actual	adsorption	capacity	(mg	BSA/ml	resin)	 6.6	 20.6	 13.8	
Adsorption	efficiency	ηads	(%)	 10	 16	 24	
1Based	on	the	ligand	concentration	in	the	coupling	buffer	after	immobilization	
5.3.2 Adsorption	efficiency	
The	adsorption	efficiency	of	the	immobilized	ligand	(ηads)	is	defined	as	follows:	
ߟ௔ௗ௦ ൌ ொಳೄಲ௡∙஼ೇಹಹ೔ ൌ
ொಳೄಲ
ொಳೄಲ∗
	 (5.3)	
In	this	equation	QBSA	is	the	amount	of	BSA	adsorbed	per	volume	resin,	n	is	the	number	
of	 BSA	 molecules	 that	 can	 be	 adsorbed	 by	 one	 VHH	 molecule	 and	 ܥ௏ுு௜ 	 is	 the	
immobilized	 ligand	 concentration	 in	 mass	 per	 volume	 resin.	 The	 theoretical	
adsorption	 capacity	 ܳ஻ௌ஺∗ 	 is	 equal	 to	 n	 times	 ܥ௏ுு௜ .	 In	 this	 case	 n	 equals	 1,	 and	
therefore	 theoretically	 just	 as	 many	 BSA	 molecules	 can	 be	 adsorbed	 as	 there	 are	
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immobilized	 ligands.	 The	 theoretical	 adsorption	 capacity	 of	 128	 mg/ml	 for	 NHS	
Sepharose	lies	very	close	to	the	capacity	of	an	ion	exchange	resin	(approximately	150	
mg/ml),	in	contrast	to	the	capacity	that	is	realised	in	practice	(see	Table	5.2).	
The	adsorption	efficiency	is	a	measure	of	availability	of	the	ligand.	As	summarized	in	
Table	5.2,	the	values	vary	between	10	and	24%.	There	can	be	several	reasons	why	the	
adsorption	efficiency	is	low.	
 The	amount	of	ligand	immobilized	may	be	lower	than	calculated	based	on	the	
ligand	 concentration	 after	 immobilization:	 some	 ligand	 may	 have	 been	
released	after	blocking	and	washing.	Therefore,	we	 further	 investigated	this	
by	using	BSA	as	a	model	for	the	ligands,	see	Section	5.3.3.	
 Not	all	ligands	are	necessarily	functional.	For	example,	part	of	the	ligand	may	
be	 denatured	 prior	 to	 the	 immobilization	 reaction.	 It	 is	 expected	 that	 this	
does	 not	 vary	 considerably	 between	 the	 resins,	 although	 there	 might	 be	
differences	in	ligand	stability	in	different	coupling	buffers.	
 For	 some	 immobilized	 ligands	 the	 adsorption	 site	 may	 be	 inaccessible	
because	 of	 the	 orientation	 of	 the	 ligand.	 The	 ligand	 can	 be	 upside‐down	or	
stretched	 over	 several	 active	 groups	 rendering	 it	 dysfunctional.	 The	 ligand	
orientation	may	be	dependent	on	the	immobilization	method	used	and	on	the	
concentration	of	active	groups.	Too	many	active	groups	on	the	resin	surface	
may	 result	 into	 many	 multipoint	 attachments	 which	 may	 decrease	 the	
functionality	of	the	ligand.	
 Some	 of	 the	 immobilized	 ligands	may	 be	 inaccessible	 to	 BSA,	 because	 BSA	
cannot	 diffuse	 far	 enough	 into	 the	 pores	 to	 reach	 all	 the	 ligands.	 The	 VHH	
ligand	molecule	is	about	5	times	smaller	than	the	BSA	molecule,	and	the	pores	
may	have	become	even	narrower	due	to	the	ligand	immobilization.	The	pore	
sizes	of	the	different	base	materials	are	expected	to	be	similar.		
 Finally,	the	adsorption	efficiency	depends	on	the	BSA	concentration.	Based	on	
experience	 (see	 Chapter	 2),	 the	 BSA	 concentration	 used	 should	 result	 in	
saturation	of	the	affinity	resin.	It	is	worth	noting	that	in	an	actual	process	the	
product	 concentration	 is	 often	 lower	 than	 the	 concentration	 at	 which	
maximum	saturation	occurs.		
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The	 low	 adsorption	 efficiency	 is	 a	 clear	 indicator	 that	more	 research	 is	 required	 to	
improve	 the	 activated	 resins	 further.	 The	 results	 show	 that	 in	 terms	 of	 adsorption	
efficiency,	 the	 immobilization	 of	 the	 VHH	 is	 best	 performed	 using	 the	 aldehyde	
chemistry,	 followed	 by	NHS	 and	 epoxy.	However,	 this	may	 be	 different	 for	 another	
ligand,	 since	 the	position	of	 certain	amino	acids	determines	which	 chemistry	works	
best.	
5.3.3 BSA	immobilization	
The	low	adsorption	capacities	of	affinity	resins	with	immobilized	ligands	may	be	due	
to	 both	 the	 immobilization	 and	 the	 adsorption	 efficiency.	 The	 immobilization	
efficiency	 may	 be	 improved	 by	 changing	 the	 conditions	 for	 the	 immobilization	
reaction,	such	as	the	ligand	concentration.	Therefore,	we	studied	the	influence	of	the	
ligand	 concentration	 on	 the	 immobilization	 efficiency	using	BSA	 instead	of	VHH	 for	
the	immobilization,	with	the	same	coupling	procedures.	 Immobilized	BSA	is	denoted	
as	 BSAi	 to	 distinguish	 it	 from	 BSA	 adsorbed	 to	 immobilized	 VHH	 ligand.	 The	
immobilization	 capacity	 of	 BSAi	 should	 be	 similar	 to	 the	 theoretical	 adsorption	
capacity	 as	presented	 in	Table	 5.2	 if	 both	 capacities	 are	 only	 limited	by	 the	 surface	
area	available	for	BSA.	BSA	concentrations	in	the	solutions	before	and	after	each	step	
were	measured	to	accurately	determine	the	amount	of	BSAi	immobilized.	The	results	
are	summarized	in	Figure	5.2	and	Figure	5.3.	
In	Figure	5.2a	the	amount	of	BSAi	immobilized	per	volume	resin	is	plotted	against	the	
amount	 of	 BSA	 available	 for	 immobilization	 per	 volume	 resin.	 The	 amount	 of	 BSAi	
immobilized	 increases	 upon	 increasing	 the	 amount	 of	 BSA	 added.	 At	 low	
concentrations	 (lower	 than	 20	 mg/ml	 resin	 or	 0.02	 mol/mol	 active	 groups),	 all	
protein	is	immobilised	and	the	immobilization	efficiency	is	100%.	This	agrees	with	the	
results	by	van	Sommeren	and	co‐workers	[2].	At	higher	concentrations	however,	the	
immobilisation	efficiency	is	clearly	much	lower,	and	continues	to	decrease	with	higher	
concentrations	of	 ligand	offered.	The	 line	may	well	 reach	a	maximum	value	at	some	
point,	but	his	value	will	be	much	higher	than	the	values	considered	here.		
Figure	 5.2b	 shows	 that	 only	 a	 small	 number	 of	 BSAi	 molecules	 is	 immobilized	
compared	 to	 the	 number	 of	 active	 groups	 available	 initially,	 which	means	 that	 the	
number	 of	 active	 groups	 as	 such	 is	 not	 limiting.	 It	 is,	 however,	 possible	 that	 side	
reactions	 occur	with	 the	 active	 groups,	which	 do	 not	 result	 in	 BSAi	 immobilization.	
NHS	 groups	 are	 known	 to	 rapidly	 hydrolyse	 in	 aqueous	 solutions,	 which	 competes	
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with	the	immobilization	reaction	[3].	This	does,	however,	not	hold	for	the	epoxy	and	
aldehyde	groups.	
	
Figure	5.2.	a)	Amount	 of	 BSAi	 immobilized	 per	 volume	 resin	 as	 a	 function	 of	 amount	 of	 BSA	 added	 per	
volume	resin;	b)	amount	of	BSAi	 immobilized	per	active	group	as	a	 function	of	amount	of	BSA	added	per	
active	group	for	Epoxy	Sepharose	(●),	NHS	Sepharose	(▲),	Cellufine	Formyl	(□).	The	dashed	line	indicates	
the	theoretical	maximum	amount	of	BSA	immobilized.	
In	Figure	5.3	the	mass	balance	for	BSA	is	shown	for	each	immobilization	experiment.	
Each	 section	of	 the	bar	 represents	 the	 amount	 of	BSA	 recovered	 in	 that	 step	of	 the	
immobilization	process,	divided	by	the	total	amount	of	BSA	added	initially.	The	lowest	
(black)	 section	 represents	 the	 immobilization	 efficiency:	 the	 amount	 of	 BSAi	
immobilized	 divided	 by	 the	 amount	 of	 BSA	 added,	 similar	 to	 Equation	 5.2	 for	 VHH	
immobilization.	
For	Epoxy	Sepharose,	the	immobilization	efficiency	is	more	or	less	constant	over	the	
range	of	BSA	concentrations	applied.	The	epoxy	reaction	is	known	to	be	rather	slow	
and	may	therefore	be	approximated	with	0th	order	kinetics,	which	may	be	the	reason	
for	 the	 constant	 immobilization	 efficiency.	 For	 the	 NHS	 Sepharose	 and	 Cellufine	
Formyl,	 however,	 the	 efficiency	 decreases	 with	 increasing	 amount	 of	 BSA	 added.	
Increasing	the	amount	of	BSA	results	in	more	BSA	in	the	residual	coupling	buffer	and	
blocking	and	washing	steps.	Even	though	the	efficiency	decreases	with	increasing	BSA	
concentration,	 the	 absolute	 number	 of	 molecules	 immobilized	 per	 ml	 resin,	 the	
immobilization	 capacity,	 increases.	For	affinity	 chromatography,	 the	 capacity	 should	
be	 as	 high	 as	 possible,	 partly	 at	 the	 expense	 of	 immobilization	 efficiency,	 especially	
when	the	non‐immobilized	ligands	could	be	re‐used	in	some	way.	
Chapter	5	
78	
	
Figure	 5.3.	 The	 percentage	 of	 BSA	 recovered	 in	 each	 step	 of	 the	 immobilization	 process	 for	 each	 BSA	
concentration	using	a)	Epoxy	Sepharose,	b)	NHS	Sepharose	and	c)	Cellufine	Formyl.	From	bottom	to	top,	the	
bar	sections	represent	the	percentage	of	BSAi	 immobilized	(the	immobilization	efficiency),	the	percentage	
of	BSA	in	the	residual	coupling	buffer,	in	the	blocking	buffer	and	in	the	washing	steps.	
After	 blocking	 of	 the	 active	 groups	 of	 the	 resins	 a	 considerable	 amount	 of	 BSA	 is	
retrieved	in	the	blocking	buffer.	The	percentage	of	BSA	found	in	the	blocking	buffer	is	
15	to	20%	of	the	amount	of	BSA	added,	and	this	is	more	than	would	be	expected	on	
the	basis	of	the	amount	of	liquid	present	in	the	pores	and	surrounding	liquid.	Some	of	
the	 immobilized	BSAi	may	have	been	released	 from	the	resin	during	blocking,	but	 it	
could	also	have	been	BSA	that	was	non‐specifically	bound	to	the	resin.	The	washing	
Efficiency	of	protein‐based	ligand	immobilization	for	affinity	chromatography	
79	
steps	account	for	only	a	small	amount	of	BSA,	probably	still	present	in	the	liquid	in	the	
pores	after	blocking.	
The	 results	 from	 the	BSA	 immobilization	 experiments	 show	 that	 a	 lower	 amount	of	
BSAi	can	be	immobilized,	in	our	case	approximately	70	mg/ml	resin,	compared	to	the	
amount	of	BSA	that	can	be	adsorbed	by	an	ion	exchanger	of	the	same	base	material,	at	
around	150	mg/ml.	Steric	hindrance	 for	 the	activated	resin	 is	unlikely,	because	 that	
would	 also	 occur	 during	 adsorption	 to	 an	 ion	 exchange	 resin,	 although	 the	 pore	
geometry	in	an	ion	exchange	resin	could	be	quite	different	compared	to	an	activated	
resin.	The	extent	of	steric	hindrance	in	an	ion	exchange	resin	may	be	less	because	the	
adsorption	is	reversible,	but	it	would	still	be	significant.	
The	immobilization	capacity	of	BSAi	is	higher	than	the	actual	BSA	adsorption	capacity	
of	the	affinity	resin	with	immobilized	VHH.	BSA	is	a	much	larger	protein	than	the	VHH	
ligand	 and	 there	 are	 therefore	more	 residues	 available	 for	 immobilization,	 possibly	
resulting	in	more	stable	bonds.	Besides,	for	the	BSAi	immobilization,	the	orientation	of	
the	protein	is	not	an	issue,	because	we	do	not	require	an	adsorption	site	to	be	exposed	
such	as	 for	 the	VHH.	The	 theoretical	BSA	adsorption	capacities	of	 the	affinity	 resins	
are	 similar	 to	 the	BSAi	 immobilization	 capacities	 for	 the	 Epoxy‐activated	 Sepharose	
and	Cellufine	Formyl,	and	higher	for	the	NHS‐activated	Sepharose.	It	is,	therefore,	not	
unreasonable	 to	 assume	 that	 the	 same	 trends	 are	 valid	 for	 both	 the	 VHH	
immobilization	and	the	BSAi	immobilization.	
For	 the	 VHH	 immobilization	 we	 did	 not	 check	 the	 VHH	 concentrations	 for	 the	
subsequent	steps	of	blocking	and	washing.	Some	of	the	VHH	ligand	probably	remained	
in	 the	 blocking	 buffer,	 similar	 to	 the	 BSA	 experiments.	 If	 the	 values	 for	 VHH	
immobilization	 are	 similar	 to	 those	 of	 the	 BSAi	 immobilization,	 the	 VHH	
immobilization	 efficiency	 may	 be	 overestimated	 and	 the	 adsorption	 efficiency	
underestimated.	Even	though	that	could	indicate	a	deviation	from	the	data	presented	
in	Table	5.2,	 the	most	 important	 issue	remains	 that	 the	majority	of	 the	 immobilized	
ligand	is	not	able	to	bind	BSA.	Improving	ligand	functionality	is	therefore	a	potential	
route	to	optimize	affinity	chromatography	processes.	
A	 possibility	 to	 improve	 the	 adsorption	 efficiency	 is	 to	 selectively	 immobilize	 the	
ligand	 to	 expose	 the	 adsorption	 site	 to	 which	 the	 BSA	 can	 adsorb:	 site‐directed	
immobilization.	For	antibodies,	it	is	for	example	possible	to	use	specific	carbohydrate	
groups	 on	 the	 antibody	 to	 react	 with	 the	 solid	 support	 or	 to	 covalently	 link	 the	
antibody	 to	an	antibody‐binding	protein	 like	Protein	A	or	Protein	G	 [6,	13,	14].	The	
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first	method	seems	more	suitable	for	larger	scale	processes	than	the	last,	because	in	
the	 last	 case	 an	 extra	protein	 is	 required	which	 also	needs	 to	 be	 immobilized	 in	 an	
efficient	manner.	It	is	also	possible	to	tailor	the	protein	to	expose	specific	groups	away	
from	 the	 adsorption	 site	 that	 can	 be	 used	 for	 immobilization.	 This	 can	 be	 done	 by	
chemical	modifications	or	using	genetic	engineering	[6,	13,	14].	Whether	tailor‐made	
affinity	 ligands	will	 have	 an	 improved	 immobilization	 efficiency	 is	 uncertain,	 but	 it	
could	improve	the	adsorption	efficiency.	
5.4 Conclusions	
Based	on	the	immobilization	of	VHH	on	three	different	activated	resins	we	conclude	
that	 in	 most	 practical	 cases	 the	 initial	 active	 group	 density	 on	 the	 resins	 is	 much	
higher	than	the	final	density	of	immobilized	ligand.	As	observed	with	immobilization	
of	 BSA,	 the	 amount	 of	 protein	 immobilized	 increases	 by	 increasing	 the	 amount	 of	
protein	 initially	 applied.	 However,	 the	 efficiency	 of	 immobilization	 is	 lower	 for	 the	
NHS‐	 and	 aldehyde‐activated	 resins,	which	means	 that	 an	 increasing	 portion	 of	 the	
ligand	remains	unused.	The	trends	for	VHH	immobilization	are	assumed	to	be	similar.	
A	significant	amount	of	protein	applied	for	the	immobilization	ends	up	in	the	blocking	
buffer.	This	may	be	because	of	non‐specific	adsorption,	or	because	the	immobilization	
bond	between	the	protein	and	the	resin	was	broken.	
To	make	 affinity	 chromatography	with	 immobilized	 ligands	 cost‐effective	 for	 large‐
scale	 processes,	 the	 adsorption	 capacity	 has	 to	 be	 dramatically	 improved.	 The	
immobilization	 efficiency	 may	 be	 tuned	 by	 changing	 the	 ligand	 concentration	 and	
densities	of	the	active	groups.	However,	with	less	than	half	of	the	immobilized	ligand	
functional,	it	should	be	possible	to	bring	down	the	resin	volumes	at	least	two‐fold	by	
further	 improving	 the	 adsorption	 efficiency.	This	would	 already	 significantly	 reduce	
costs	and	improve	the	applicability	of	affinity	chromatography	on	larger	scales.	
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Chapter	6	
Are	axial	and	radial	flow	chromatography	different?	
	
Abstract	
Radial	 flow	 chromatography	 can	 be	 a	 solution	 for	 scaling	 up	 a	 packed	 bed	
chromatographic	 process	 to	 larger	 processing	 volumes.	 In	 this	 study	we	 compared	
axial	 and	 radial	 flow	affinity	 chromatography	both	experimentally	and	 theoretically.	
We	used	an	axial	 flow	column	and	a	miniaturized	radial	 flow	column	with	a	ratio	of	
1.8	between	outer	and	inner	surface	area,	both	with	a	bed	height	of	5	cm.	The	columns	
were	packed	with	 affinity	 resin	 to	 adsorb	BSA.	The	 average	velocity	 in	 the	 columns	
was	 set	 equal.	 No	 difference	 in	 performance	 between	 the	 two	 columns	 could	 be	
observed.	
To	gain	more	insight	into	the	design	of	a	radial	flow	column,	the	velocity	profile	and	
resin	 distribution	 in	 the	 radial	 flow	 column	 were	 calculated.	 Using	 mathematical	
models	we	found	that	the	breakthrough	performance	of	radial	flow	chromatography	is	
very	similar	to	axial	flow	when	the	ratio	between	outer	and	inner	radius	of	the	radial	
flow	 column	 is	 around	 2.	 When	 this	 ratio	 is	 increased,	 differences	 become	 more	
apparent,	but	remain	small.	Therefore,	the	choice	between	axial	and	radial	flow	will	be	
based	on	cost	price,	foot	print	and	packing	characteristics.	For	small	scale	processes,	
axial	 flow	chromatography	 is	probably	 the	best	 choice,	 for	 resin	volumes	of	 at	 least	
several	tens	of	litres,	radial	flow	chromatography	may	be	preferable.	
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6.1 Introduction	
Liquid	chromatography	is	a	well‐known	separation	procedure	for	both	analytical	and	
preparative	 purposes.	 The	 demand	 for	 highly	 pure,	 specialty	 compounds	 increases,	
hence	 the	 necessity	 for	 a	 selective	 purification	 step	 such	 as	 preparative	 affinity	
chromatography.	With	affinity	chromatography,	it	is	possible	to	isolate	one	compound	
from	a	complex	mixture	in	a	single	operation.	
The	benchmark	in	liquid	chromatography	is	axial	flow	chromatography,	consisting	of	
a	packed	bed	column	of	particles.	Axial	flow	chromatography	is	thoroughly	described,	
both	 theoretically	 and	 experimentally.	 An	 overview	 of	 preparative	 axial	 flow	
chromatography	 is	given	by	Guiochon	and	co‐workers	[1].	A	recent	book	on	protein	
chromatography	 process	 development	 and	 scale‐up	 has	 been	 written	 by	 Carta	 and	
Jungbauer	[2],	which	is	also	mainly	focused	on	axial	flow	chromatography.	
Nowadays,	 soft	 beads	 made	 of	 agarose	 are	 commonly	 used	 for	 affinity	
chromatography.	 In	scaling	up	axial	 flow	columns	from	laboratory	 to	 industrial	size,	
several	problems	may	arise	due	to	the	low	pressure	resistance	of	the	resin.	Therefore,	
an	 industrial‐size	 axial	 flow	 column	 is	 often	 a	 wide,	 and	 very	 short	 cylinder.	 This	
design	makes	the	column	expensive	and	difficult	to	handle.	The	equipment	costs	rise	
exponentially	with	the	width	of	the	column.	
Radial	 flow	chromatography	 is	 an	 interesting	alternative	 to	 the	 scale‐up	problem	of	
axial	 flow	 chromatography	 [3].	 A	 radial	 flow	 column	 consists	 of	 two	 concentric	
cylinders	between	which	the	resin	bed	is	packed.	The	liquid	is	directed	from	outside	
inwards	 or	 vice‐versa,	 resulting	 in	 horizontal,	 radial	 flow.	 Small‐scale	 radial	 flow	
columns	for	test	purposes	are	usually	wedge‐shaped	to	mimic	the	velocity	profile	that	
exists	in	a	full‐scale	radial	flow	column.	
Radial	 flow	 chromatography	 has	 been	 investigated	 both	 experimentally	 and	
theoretically	 [3‐21].	Some	research	has	been	done	to	compare	axial	 flow	with	radial	
flow.	 Gu	 and	 co‐workers	 [6]	 studied	 multicomponent	 radial	 flow	 chromatography	
using	a	theoretical	approach.	They	showed	that	axial	and	radial	flow	chromatography	
are	 similar	 in	 terms	 of	 modelling	 and	 that	 differences	 between	 the	 configurations	
arise	from	a	difference	in	mass	transfer	and	dispersion	parameters.	
Tsaur	 and	 Shallcross	 [15]	 also	 used	 a	 theoretical	 approach	 to	 assess	 differences	
between	axial	and	radial	flow	ion	exchange.	They	simulated	breakthrough	curves	of	a	
wedge‐shaped	radial	flow	column	of	254	ml	with	25.6	cm	bed	thickness	and	an	axial	
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flow	 column	 of	 245	 ml	 with	 50	 cm	 bed	 thickness	 at	 several	 flow	 rates	 and	 salt	
concentrations.	 The	 direction	 of	 flow	 for	 the	 radial	 flow	 column	 in	 their	 work	was	
outward.	 They	 found	 that	 the	 radial	 bed	 was	 slightly	 more	 efficient,	 which	 they	
claimed	to	be	due	to	the	variation	in	liquid	velocity	in	the	bed	and	to	a	smaller	effect	of	
dispersion	for	the	radial	configuration.	
Tharakan	 and	Belizaire	 [12]	 found	no	 significant	 difference	 in	 the	 antibody	 capture	
efficiency	 between	 axial	 and	 radial	 flow	 chromatography	 for	 their	 immunoaffinity	
chromatography	 process	 with	 similar	 bed	 thickness.	 They	 suggested	 that	 radial	
dispersion,	mass	transfer	and	intraparticle	diffusion	are	probably	not	limiting	in	their	
case.	
Kim	and	Lee	[13]	found	that	the	flow	rate	in	a	radial	flow	column	is	2	to	3	times	higher	
than	 in	 an	 axial	 flow	 column	 at	 equal	 pressure	 drop	 and	 bed	 volume.	 In	 their	
comparison	 the	bed	 thickness	of	 the	 radial	 flow	column	was	almost	3	 times	shorter	
than	the	axial	flow	column,	which	may	explain	the	difference	in	flow	rate.	They	did	not	
find	significant	differences	in	protein	purification	for	the	two	configurations.		
In	2007,	Cabanne	and	co‐workers	[19]	compared	an	axial	and	a	wedge‐shaped	radial	
flow	column	of	equal	bed	thickness	and	volume.	They	separated	a	mixture	of	bovine	
serum	 albumin	 (BSA)	 and	 ovalbumin	 with	 radial	 and	 axial	 flow	 ion	 exchange	
chromatography.	Their	conclusion	was	that	the	radial	flow	column	performed	better	
than	 the	 axial	 flow	 column	 in	 terms	 of	 resolution,	 number	 of	 theoretical	 plates	 per	
meter,	 equilibration	 volume	 and	peak	width.	However,	 the	 columns	might	 not	 have	
been	 equally	 well‐packed:	 the	 asymmetry	 factor	 of	 the	 axial	 flow	 column	 for	 an	
acetone	pulse	was	1.83,	 and	 the	value	 for	 the	 radial	 flow	column	was	1.1.	The	axial	
flow	column	would	usually	be	repacked	when	such	an	asymmetry	value	is	measured,	
which	then	might	have	resulted	in	better	performance	of	the	axial	flow	column.	
Even	 though	 there	 is	 literature	 available	 in	 which	 axial	 and	 radial	 flow	
chromatography	 are	 compared,	 we	 think	 it	 is	 necessary	 to	 perform	 a	 systematic	
comparison	that	combines	practice	and	theory.	In	the	available	literature,	the	effect	of	
the	ratio	between	outer	and	inner	radius	of	the	radial	flow	column,	i.e.,	the	curvature	
of	the	radial	column,	is	not	investigated.	This	ratio	is	an	important	design	parameter.	
In	 this	 paper	we	 compare	 an	 axial	 flow	 chromatography	 column	with	 a	 radial	 flow	
chromatography	column	to	find	out	whether	the	two	configurations	are	truly	different	
in	the	case	of	single	component	affinity	chromatography.	We	use	small‐scale	columns	
packed	with	a	resin	with	llama	antibody	fragment	(see	[22,	23]	and	Chapter	2)	against	
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BSA	used	to	purify	BSA	from	a	pure	BSA	solution.	We	also	determined	whether	there	
is	 a	 difference	 between	 inward	 and	 outward	 flow	 for	 the	 radial	 flow	 column.	 The	
comparison	 is	broadened	by	using	 the	mathematical	 general	 rate	model	 to	 simulate	
the	 concentration	 profiles	 inside	 the	 axial	 and	 radial	 flow	 columns	 with	 different	
ratios.	To	our	knowledge,	 the	 concentration	profiles	 along	 the	 column	bed	have	not	
yet	 been	 investigated	 for	 radial	 flow	 chromatography,	 although	 these	 profiles	 give	
more	 understanding	 in	 the	 process.	 Finally,	 we	 include	 pressure	 drop	 and	 column	
dimensions	in	the	comparison	to	determine	which	configuration	suits	best	for	a	given	
chromatography	process.	
6.2 Definitions	
In	 Figure	 6.1	 a	 schematic	 representation	 of	 both	 an	 axial	 and	 radial	 flow	 column	 is	
shown.	For	an	axial	 flow	column	the	two	design	parameters	are	ra,	 the	radius	of	 the	
column,	and	L,	the	bed	height	or	thickness.	The	variable	z	defines	the	position	in	the	
bed.	For	a	radial	 flow	column	z	 also	varies	between	0	and	bed	 thickness	L,	which	 is	
now	defined	as	the	difference	between	r2,	the	radius	of	the	outer	cylinder,	and	r1,	the	
radius	 of	 the	 inner	 cylinder.	 Finally,	Hr	 is	 the	 height	 of	 the	 radial	 flow	 column.	 In	 a	
radial	flow	column,	the	fluid	flow	is	horizontal	and	therefore	scale‐up	can	take	place	
by	increasing	Hr.	The	ratio	between	r2	and	r1	is	defined	as	α.	
	
Figure	6.1.	Schematic	representation	of	an	axial	(left)	and	radial	flow	column	(right).	Variable	z	is	indicated	
for	downward	axial	flow	and	inward	radial	flow.	
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6.3 Materials	and	methods	
6.3.1 Materials	
Bovine	 serum	 albumin	 (BSA)	 type	 A3059	 ≥98%	 pure	 lyophilized	 powder)	 was	
purchased	at	Sigma‐Aldrich	 (Zwijndrecht,	The	Netherlands).	All	other	 reagents	used	
were	 of	 analytical	 grade	 and	 purchased	 at	 Sigma‐Aldrich	 or	 Merck	 (Darmstadt,	
Germany).	 Demineralized	 water	 was	 obtained	 using	 a	 Millipore	 Milli‐Q	 system	
(Billerica,	USA).	
Phosphate	 buffer	 (PBS)	 was	 prepared	 by	mixing	 10	 mM	 solutions	 of	 Na2HPO4	 and	
KH2PO4	 containing	 137	 mM	 NaCl	 and	 2.7	 mM	 KCl	 until	 pH	 7.4	 was	 reached.	 The	
glycine	buffer	used	for	desorption	was	prepared	by	acidifying	a	0.1	M	glycine	solution	
with	1	M	HCl	until	a	pH	of	3	was	reached.	
6.3.2 Affinity	chromatography	
For	 the	 affinity	 chromatography	 experiments	 the	 columns	 were	 packed	 with	 NHS	
Sepharose	 4	 Fast	 Flow	 resin	 (GE	 Healthcare,	 Uppsala,	 Sweden)	 with	 immobilized	
multi‐species	 albumin	 ligand	 derived	 from	 llama	 antibodies	 which	 was	 kindly	
supplied	by	BAC	BV	(Naarden,	The	Netherlands).	An	Äkta	Purifier	100	(GE	Healthcare,	
Uppsala,	Sweden)	was	used	for	the	column	experiments	with	 in‐line	UV	detection	at	
280	 nm.	 For	 both	 the	 axial	 and	 radial	 flow	 column,	 the	 packing	 was	 checked	 by	
determining	 the	 asymmetry	 of	 a	 1	 v/v%	 acetone	 solution	 as	 indicated	 by	 the	
manufacturer.		
A	1	mg/ml	BSA	solution	in	10	mM	phosphate	buffer	pH	7.4	was	used	as	a	sample	in	
adsorption.	 After	 adsorption,	 the	 unbound	 BSA	 was	 washed	 from	 the	 resin	 with	
adsorption	buffer.	Desorption	took	place	with	0.1	M	glycine/HCl	pH	3	until	no	more	
BSA	was	detected	from	the	column.	
6.3.2.1 Radial	flow	chromatography	
Radial	 flow	affinity	chromatography	was	performed	using	a	micro‐RFC	column	from	
Proxcys	(Nieuw‐Amsterdam,	The	Netherlands;	see	Figure	6.2).	This	column	is	similar	
to	an	axial	flow	column,	but	mimics	a	radial	flow	column	by	its	conical	shape.	The	bed	
thickness	was	5	cm,	bed	volume	4.412	ml,	inlet	area	110	mm2,	outlet	area	60	mm2	(for	
inward	flow,	vice	versa	for	outward	flow).	Adsorption	and	desorption	were	performed	
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with	both	 inward	(large	outside	surface	to	small	 inside	surface,	standard	downflow)	
and	 outward	 flow	 (upflow)	 at	 a	 flow	 rate	 of	 1.5	ml/min	 (which	 corresponds	 to	 an	
average	velocity	of	~111	cm/h).	
	
Figure	 6.2.	 Schematic	 representation	 of	 the	 micro‐RFC	 column	 from	 Proxcys	 (Nieuw‐Amsterdam,	 The	
Netherlands).	 Inward	 flow	 is	 mimicked	 by	 liquid	 flow	 from	 left	 to	 right,	 outward	 flow	 vice	 versa.	 This	
picture	was	reproduced	with	permission	from	Proxcys.	
6.3.2.2 Axial	flow	chromatography	
The	radial	flow	column	performance	was	also	compared	to	an	axial	flow	column.	For	
the	comparison	a	Tricorn	5/50	axial	flow	column	(GE	Healthcare,	Uppsala,	Sweden)	of	
0.5	cm	diameter	and	5	cm	bed	thickness	was	used.	The	bed	thickness	was	equal	to	the	
bed	 thickness	 of	 the	 radial	 flow	 column.	 The	 superficial	 flow	 rate	 in	 the	 axial	 flow	
column	was	set	equal	to	the	average	superficial	flow	rate	in	the	radial	flow	column	of	
111	cm/h.	
6.3.3 Modelling	
6.3.3.1 General	rate	model	
A	mathematical	model	can	be	used	 to	predict	 the	outlet	concentration	of	a	 radial	or	
axial	 flow	 column	 at	 different	 process	 conditions.	Many	 examples	 of	 the	 calculation	
and	application	of	these	models	are	available	in	literature	(e.g.,	[1,	5,	6,	15,	17,	24‐29]).	
The	general	rate	model	for	chromatography	used	here	consists	of	three	parts:	a	mass	
balance	over	the	column	bed,	a	mass	balance	over	the	particle	and	a	description	of	the	
adsorption	kinetics.	
The	first	part	 is	the	mass	balance	of	BSA	over	the	column	bed.	The	space	variable	 is	
represented	by	z	varying	from	0	to	L	as	indicated	in	Figure	6.1.	The	concentration	of	
BSA	in	the	bed	changes	due	to	convection,	mass	transfer	to	the	particles	through	the	
stagnant	film	layer	surrounding	the	particles,	and	dispersion.	 	
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The	mass	balance	is	defined	as:	
axial:	 డ௖డ௧ ൅
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ఌ೐
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radial:	 డ௖డ௧ ൅
௨
ఌ೐
డ௖
డ௭ ൅
ଵିఌ೐
ఌ೐ ݇௙ܽ ቀܿ െ ܿ௣൫ܴ௣൯ቁ ൌ
ଵ
௭
డ
డ௭ ቀܦ௅ݖ
డ௖
డ௭ቁ	 (6.1b)	
In	 Equation	 6.1	 c	 equals	 the	 concentration	 of	 BSA	 in	 the	 liquid,	 u	 the	 superficial	
velocity	 in	 the	bed	 (flow	rate	divided	by	cross‐sectional	area	of	 the	bed),	εe	 the	bed	
porosity,	kf	the	mass	transfer	coefficient	from	liquid	to	particle,	a	the	specific	surface	
area	of	 the	particles	 (3/Rp	 for	 spherical	particles,	with	Rp	 the	particle	 radius),	cp(Rp)	
the	 BSA	 concentration	 at	 the	 interface	 between	 particle	 and	 liquid,	 and	 DL	 the	
dispersion	coefficient.	
To	complete	the	mass	balance,	 two	boundary	conditions	are	defined	at	the	 inlet	and	
outlet	of	the	column:	
ݖ ൌ 0						ݑ	∙ܿ௜௡ ൌ ݑ ∙ ܿ െ ߝ௘ܦ௅ డ௖డ௭	 (6.2a)	
ݖ ൌ ܮ					 డ௖డ௭ ൌ 0	 (6.2b)	
In	Equation	6.2a	cin	is	the	inlet	concentration.	
There	are	 two	differences	between	the	axial	and	radial	model	equations.	The	first	 is	
that	 in	an	axial	 flow	column,	 the	velocity	u	 inside	 the	column	 is	constant,	while	 in	a	
radial	flow	column	the	velocity	depends	on	the	position	in	the	bed.	Since	the	values	for	
kf	 	and	DL	also	depend	on	the	 liquid	velocity,	 these	parameters	are	not	constants	 for	
the	radial	flow	model.	Second,	the	dispersion	term	changes	to	cylindrical	coordinates	
for	a	radial	flow	column.	
The	second	part	of	the	model	is	the	mass	balance	of	BSA	over	the	particle.	For	porous	
particles	 a	 concentration	profile	 exists	 inside	 the	particle.	 The	 space	 variable	 in	 the	
particle	is	r	which	runs	from	0	in	the	centre	to	Rp	at	the	outer	radius.	BSA	diffuses	into	
the	particle	and	is	adsorbed	on	the	surface	of	the	pores.	The	mass	balance	therefore	
consists	of	an	accumulation	term,	an	adsorption	term	and	a	diffusion	term.	
ߝ௣ డ௖೛డ௧ ൅ ൫1 െ ߝ௣൯
డ௤
డ௧ ൌ ܦ௘௙௙
ଵ
௥మ
డ
డ௥ ቀݎଶ
డ௖೛
డ௥ ቁ	 (6.3)	
In	 Equation	 6.3,	 εp	 equals	 the	 particle	 porosity,	 q	 the	 amount	 of	 adsorbed	 BSA	 per	
particle	solid	volume,	and	Deff	the	effective	diffusion	coefficient.	
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The	boundary	conditions	belonging	to	Equation	6.3	are	as	follows:		
ݎ ൌ ܴ௣ 			డ௖೛డ௥ ൌ ݇௙൫ܿ െ ܿ௣൯	 (6.4a)	
ݎ ൌ 0					 డ௖೛డ௥ ൌ 0	 (6.4b)	
The	 third	part	 of	 the	model	describes	 the	 adsorption	kinetics	between	BSA	and	 the	
VHH	or	any	other	target	molecule	and	ligand.	For	this	model,	Langmuir	kinetics	were	
assumed:	
డ௤
డ௧ ൌ ݇௔ܿ௣ሺݍ௠௦ െ ݍሻ െ ݇ௗݍ.	 (6.5)	
In	Equation	6.5,	q	is	defined	as	the	amount	of	BSA	adsorbed	per	particle	solid	volume,	
and	qms	 is	 therefore	 defined	 as	 the	maximum	 adsorption	 capacity	 per	 particle	 solid	
volume.	 Usually	 the	 maximum	 adsorption	 capacity	 qm	 is	 given	 in	 amount	 of	 BSA	
adsorbed	per	column	volume.	From	qm,	qms	can	be	calculated	as	follows:	
ݍ௠௦ ൌ ௤೘ሺଵିఌ೐ሻሺଵିఌ೛ሻ	 (6.6)	
The	initial	conditions	for	Equations	6.1,	6.3,	and	6.5	are:		
at		ݐ ൌ 0			ܿ ൌ 0; ܿ௣ ൌ 0; ݍ ൌ 0.	 (6.7)	
6.3.3.2 Parameters	
For	the	calculation	of	 the	mass	 transfer	coefficient	kf	 the	Wilson‐Geankoplis	relation	
was	used	[30]:	
݇௙ ൌ ௌ௛	஽೘ଶோ೛ 	 (6.8)	
݄ܵ ൌ ଵ.଴ଽఌ೐ ܴ݁
ଵ ଷൗ ܵܿଵ ଷൗ ,	 (6.9)	
with	ܴ݁ ൌ 2ܴ௣ ߩݑ ߟ⁄ 	and	ܵܿ ൌ ߟ/ሺߩܦ௠ሻ	 (6.10a‐b)	
In	 Equations	 6.8	 through	 6.10,	 Sh	 equals	 the	 Sherwood	 number,	Dm	 the	 molecular	
diffusivity	of	BSA,	Re	the	Reynolds	number,	Sc	the	Schmidt	number,	ρ	the	density	and	
η	 the	 viscosity	 of	 the	 solution.	 The	 BSA	 solution	 is	 assumed	 to	 have	 the	 same	
properties	as	pure	water.	
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For	 the	 calculation	 of	 the	 axial	 dispersion	 coefficient	 DL	 the	 following	 relation	
proposed	by	Chung	and	Wen	[31]	was	used:	
ܦ௅ ൌ ௨௅௉௘,	with	 (6.11)	
ܲ݁ ൌ ௅ఌ೐ଶோ೛ ሺ0.2 ൅ 0.011ܴ݁
଴.ସ଼ሻ.	 (6.12)	
where	Pe	 equals	 the	Peclet	number.	The	effective	diffusion	coefficient	Deff	 inside	 the	
porous	particle	is	estimated	as	follows	[28,	29]:	
ܦ௘௙௙ ൌ ఌ೛஽೘ఊ 	 (6.13)	
where	 γ	 equals	 the	 particle	 tortuosity.	 The	 values	 for	 the	 input	 parameters	 are	
summarized	in	Table	6.1.	The	molecular	diffusion	coefficient	and	the	molecular	weight	
of	 BSA	 were	 taken	 from	 [32].	 The	 values	 for	 the	 rate	 constants	 for	 the	 adsorption	
kinetics	ka	and	kd	were	estimated	based	on	data	provided	by	BAC	BV	(Naarden,	The	
Netherlands).	 The	 value	 for	 the	 particle	 tortuosity	 γ	was	 taken	 from	 the	 paper	 by	
Barrande	and	co‐workers	[33]	for	SP	Sepharose	Fast	Flow.	The	particle	porosity	εp	for	
BSA	was	 estimated	 to	 be	 0.8.	 The	 bed	 thickness	was	 chosen	 6	 cm	 and	 volume	 2	 l,	
because	 these	 dimensions	 represent	 a	 commercially	 available	 lab‐scale	 radial	 flow	
column.	With	 the	 parameters	 stated	 in	 Table	 6.1,	 the	 axial	 flow	 column	 is	 20.6	 cm	
wide	and	6	cm	high.	The	width	and	height	of	 the	 radial	 flow	column	depend	on	 the	
ratio	α	between	the	outer	and	inner	radius	of	the	column.	For	α	equal	to	2,	the	width	is	
24	cm	and	the	height	5.9	cm;	for	α	equal	to	5	the	column	is	15	cm	wide	and	11.8	cm	
high.	
Table	6.1.	Values	of	model	input	parameters.	
Name	 Value	 Unit	 Name	 Value	 Unit	
cin	 1	 kg/m3	 qm	 20	 kg/m3	
Dm	 5.9×10‐11	 m2/s	 Rp	 45×10‐6	 m	
ka	 0.3	 m3/(kg	s)	 V	 2×10‐3	 m3	
kd	 5×10‐4	 1/s	 εe	 0.4	 ‐	
L	 6×10‐2	 m	 εp	 0.8	 ‐	
MWBSA	 67	 kg/mol	 γ	 1.32	 ‐	
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6.3.3.3 Model	simulation	
The	 equations	 given	 in	 Sections	 6.3.3.1	 and	 6.3.3.2	 were	 implemented	 in	 the	
mathematical	 modeling	 software	 gPROMS	 (Process	 Systems	 Enterprise	 Limited,	
London).	To	solve	 the	equations	 the	backward	 finite	difference	method	was	applied	
with	 100	 discretization	 points	 over	 the	 column	 bed.	 To	 solve	 the	 equations	 for	 the	
particle,	the	centered	finite	difference	method	was	used	with	20	discretization	points.	
6.4 Results	and	discussion	
6.4.1 Volume	and	velocity	in	a	radial	bed	
The	design	of	 a	 radial	 flow	column	 implies	 a	 velocity	and	 resin	 volume	distribution	
over	the	bed	thickness.	The	cumulative	resin	volume	for	a	radial	bed	as	a	function	of	
axial	or	radial	position	z	in	the	bed	is	shown	in	Figure	6.3a.	Of	course,	for	an	axial	bed	
the	cumulative	resin	volume	is	directly	proportional	to	the	bed	thickness.	
The	 superficial	 velocity	u	at	 each	 position	 z	 and	 the	 average	 velocity	 ݑത	 at	 a	 known	
volumetric	flow	rate	Φ	in	the	radial	bed	can	be	calculated	with:	
ݑ ൌ ఃଶగሺ௥మି௭ሻுೝ	;	 (6.14)	
ݑത ൌ ఃଶగுೝ
୪୬	ሺఈሻ
௅ 	.	 (6.15)	
To	 evaluate	 the	 influence	 of	α,	 the	 ratio	 between	 the	 outer	 and	 inner	 radius	 of	 the	
column	(r2/r1),	on	the	velocity	profile	along	the	radial	bed,	we	defined	a	dimensionless	
superficial	 velocity.	This	 is	 the	actual	 superficial	 velocity	at	 each	point	on	 the	 radial	
bed,	u,	 divided	 by	 the	 superficial	 velocity	 in	 an	 axial	 bed	with	 equal	 flow	 rate,	 bed	
thickness	and	volume,	uax	 (equal	 to	Φ/(πra2)).	The	average	dimensionless	superficial	
velocity	of	a	radial	flow	column	can	be	calculated	with:	
௨ഥ
௨ೌೣ ൌ
ଵ
ଶ
ఈାଵ
ఈିଵ 	݈݊ሺߙሻ	 (6.16)	
This	average	dimensionless	velocity	of	a	radial	flow	column	as	a	function	of	α	is	given	
in	Figure	6.3b.	A	radial	column	with	α	=	1	(both	r2	and	r1	are	very	large	compared	to	
their	difference)	 is	basically	an	axial	system;	therefore,	the	dimensionless	superficial	
velocity	at	α	=	1	is	necessarily	1.	The	average	velocity	increases	significantly	when	α	is	
increased.	The	dimensionless	velocity	profile	as	a	function	of	the	position	in	the	bed	
(z/L)	 is	 shown	 in	 Figure	 6.3c.	 From	 the	 dimensionless	 superficial	 velocity	 profile	
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against	 the	 relative	 cumulative	 resin	 volume,	 the	 cumulative	 volume	 at	 each	 point	
along	the	radial	bed	divided	by	the	total	volume,	it	is	clear	that	for	the	largest	portion	
of	the	resin	in	the	radial	bed	the	velocity	is	lower	than	the	average	velocity	(see	Figure	
6.3d).	The	larger	the	ratio	between	the	outer	and	inner	radius,	the	smaller	the	amount	
of	resin	at	which	the	velocity	is	higher	than	the	average	velocity	in	the	bed.	However,	
when	the	ratio	increases,	the	average	velocity	also	increases	at	equal	flow	rate	and	the	
high	velocity	at	the	outlet	may	be	detrimental	to	the	resin.	
	
Figure	6.3.	Volume	distribution	and	superficial	velocity	in	axial	(solid)	and	radial	flow	columns	(dashed	for	
α	=	2	and	dotted	 for	α	=	5).	a)	Dimensionless	cumulative	volume	of	resin	as	a	 function	of	 the	axial/radial	
position	in	the	bed	(z/L);	b)	average	dimensionless	superficial	velocity	(ū/uax)	as	a	function	of	the	ratio	α	
between	outer	and	 inner	radius	of	a	radial	 flow	column;	c)	dimensionless	superficial	velocity	(u/uax)	as	a	
function	 of	 the	 dimensionless	 position	 in	 the	 bed	 (z/L),	 grey	 lines	 indicate	 average	 velocity;	 d)	
dimensionless	 superficial	 velocity	 (u/uax)	 as	 a	 function	 of	 cumulative	 resin	 volume,	 grey	 lines	 indicate	
average	velocity.	The	radial	position	variable	runs	from	the	outer	cylinder	to	the	inner	cylinder	as	in	Figure	
6.1.	
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6.4.2 Experimental	comparison	axial	and	radial	flow	chromatography	
A	small‐scale	axial	flow	column	of	5	cm	bed	thickness	was	compared	to	the	micro‐RFC	
column	 with	 equal	 bed	 thickness.	 For	 the	 micro‐RFC	 column,	 the	 ratio	 α	 can	 be	
calculated	by	dividing	the	inlet	surface	area	by	the	outlet	surface	area,	which	is	equal	
to	r2	divided	by	r1	when	translated	to	a	 full‐scale	radial	 flow	column.	For	 the	micro‐
RFC	 column,	 the	 value	 for	 α	 equals	 1.83.	 The	 adsorption,	 washing	 and	 desorption	
stage	 of	 the	 chromatography	 process	 are	 shown	 in	 Figure	 6.4.	 To	 compensate	 for	
differences	in	tubing	and	adapter	volumes	between	the	two	experiments,	the	point	at	
which	the	BSA	concentration	drops	due	to	washing	is	taken	as	a	reference	to	overlay	
the	chromatograms.	For	both	columns,	the	average	superficial	velocity	was	equal.	The	
results	 shown	 in	 Figure	 6.4	 indicate	 that	 the	 velocity	 profile	 inside	 the	 radial	 flow	
column	 does	 not	 have	 an	 influence	 on	 the	 BSA	 concentration	 at	 the	 outlet	 of	 the	
column.	
	
Figure	6.4.	BSA	concentration	as	a	function	of	outlet	volume	for	a	micro‐RFC	column	with	liquid	flow	from	
large	to	small	surface	area	(inward	flow;	solid	grey)	and	for	an	axial	flow	column	(dashed	black)	of	5	cm	bed	
thickness.	 Superficial	 velocity	 was	 set	 at	 111	 cm/h	 (1.5	 ml/min	 for	 the	 radial	 flow	 column),	 BSA	 inlet	
concentration	1	mg/ml.	Adsorption	and	wash	with	10	mM	PBS	pH	7.4,	desorption	with	0.1	M	glycine/HCl	
pH	3.	
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6.4.3 Rate‐limiting	steps	in	affinity	chromatography	
Theoretically,	 the	difference	 in	mass	 transfer	 coefficient	between	 inlet	 and	outlet	 of	
the	micro‐RFC	column	is	in	the	order	of	only	10%	based	on	Equations	6.8	and	6.14.	In	
the	 case	 of	 porous	 particles,	 the	mass	 transfer	 to	 the	 particle	 is	most	 likely	 not	 the	
limiting	factor.	For	the	model	simulations	this	can	be	verified	by	calculating	the	Biot	
number	Bi,	which	is	the	ratio	between	external	and	internal	mass	transfer:	
ܤ݅ ൌ ௞೑ோ೛஽೐೑೑	 (6.17)	
For	the	parameter	set	in	Table	6.1	Bi	is	22	for	the	axial	flow	column	and	between	18	
and	39	for	the	radial	flow	column	at	a	ratio	of	2.	These	numbers	confirm	that	external	
mass	transfer	is	not	the	rate‐limiting	step.		
Diffusion	inside	the	particles	is	usually	very	slow	with	effective	diffusion	coefficients	
up	to	100	times	 lower	than	the	free	diffusion	coefficient	of	the	solute	[28].	Equation	
6.13	 implies	 that	 Deff	 is	 estimated	 to	 be	 εp/γ	 =	 0.61	 times	 Dm,	 the	 free	 diffusivity.	
Kaczmarski	and	co‐workers	have	fitted	their	model	to	find	a	value	for	Deff		and	found	a	
value	 that	 was	 30	 times	 smaller	 than	Dm	 [28].	 Also	 other	 authors	 they	 referred	 to	
found	 lower	 values	 for	 Deff.	 It	 is	 therefore	 more	 likely	 that	 the	 value	 for	 Deff	 was	
overestimated	with	Equation	6.13	than	it	was	underestimated.	This	would	result	in	an	
even	higher	value	of	Bi,	and	a	strengthening	of	our	conclusion.		
One	can	use	the	Damköhler	number	to	estimate	whether	the	adsorption	step	is	rate‐
limiting.	The	Damköhler	number	for	the	adsorption	step	Daa	is	the	ratio	between	the	
adsorption	rate	and	intraparticle	diffusion:	
ܦܽ௔ ൌ ௞ೌ௖೛ோ೛మ஽೐೑೑ 	 (6.18)	
With	the	parameters	from	Table	6.1,	Daa	equals	9.7	at	cp	equal	to	0.5	cin	and	19.4	at	cp	
equal	 to	 cin.	 This	 indicates	 that	 the	 process	 is	mostly	 not	 limited	 by	 the	 adsorption	
kinetics,	but	is	limited	by	intraparticle	diffusion.	This	is	even	more	so	when	indeed	the	
value	for	Deff	is	underestimated.	Only	in	the	case	of	very	low	solute	concentrations	in	
the	order	of	0.05	kg/m3,	adsorption	kinetics	may	become	limiting.	
A	difference	in	adsorption	behaviour	between	the	radial	and	axial	flow	column	is	thus	
not	expected,	since	the	rate‐limiting	steps	take	place	inside	the	particles	which	do	not	
differ	between	the	two	systems.	
Chapter	6	
96	
6.4.4 Theoretical	comparison	axial	and	radial	flow	chromatography	
6.4.4.1 Breakthrough	curves	and	concentration	profiles	for	porous	particles	
The	simulation	results	for	the	adsorption	of	a	solute	in	an	axial	and	radial	flow	column	
with	porous	adsorbent	particles	are	shown	in	Figure	6.5.	In	the	model	the	effect	of	the	
ratio	between	the	outer	and	inner	radius	of	the	radial	flow	column	can	be	estimated	
by	 varying	 it	 over	 a	 wide	 range.	 Similar	 to	 the	 experiments	 and	 expectations,	 the	
simulation	 shows	 that	 there	 is	 only	 a	 small	 difference	 between	 the	 axial	 and	 radial	
flow	 column	 in	 terms	 of	 solute	 breakthrough,	 as	 shown	 in	 Figure	 6.5a	 and	 b.	 Even	
when	 the	ratio	 is	as	high	as	10,	only	a	small	difference	 is	observed,	albeit	always	 in	
favour	of	the	radial	flow	column.	However,	inside	the	column	the	concentration	profile	
is	 different	 for	 each	 ratio	 (see	 Figure	 6.5c).	 This	 is	mainly	 due	 to	 the	 resin	 volume	
distribution	and	thus	the	adsorption	capacity	distribution	in	the	radial	bed	(see	Figure	
6.3).	At	the	inlet	of	the	radial	flow	column	more	solute	can	be	bound	than	at	the	outlet.	
This	effect	is	even	more	apparent	at	higher	ratios	between	the	outer	and	inner	radii.	
To	further	illustrate	that	the	differences	in	profiles	are	due	to	the	distribution	of	resin	
over	the	column,	the	concentration	profile	is	also	plotted	against	the	cumulative	resin	
volume	in	Figure	6.5d.	Related	to	the	resin	volume	all	concentration	profiles	more	or	
less	coincide.		
Based	 on	 Figure	 6.5c	 it	may	 seem	 beneficial	 to	 use	 a	 radial	 flow	 column	 and	 use	 a	
shorter	 bed	 thickness.	 The	 comparison	 is,	 however,	 based	 on	 equal	 bed	 thickness.	
With	different	bed	thickness,	 the	curve	for	the	axial	 flow	column	would	also	change,	
again	resulting	in	a	coinciding	breakthrough	curve.	
6.4.4.2 Non‐porous	particles	or	membranes	
Because	 the	 rate	 of	 the	 chromatography	 process	 is	 controlled	 by	 intraparticle	
diffusion,	it	is	interesting	to	compare	the	systems	with	a	process	that	is	controlled	by	
external	mass	 transfer,	 like	 a	 stack	 of	membranes	or	 a	 bed	of	 non‐porous	particles.	
Because	of	 the	velocity	profile	over	 the	radial	bed,	 the	mass	transfer	coefficient	kf	 is	
not	constant	over	 the	bed.	For	 the	parameter	set	of	Table	6.1,	 the	axial	 flow	column	
has	a	kf	value	of	1.5×10‐5	m/s.	For	a	radial	flow	column	with	ratio	2,	the	value	varies	
from	1.4×10‐5	m/s	to	1.8×10‐5	m/s	and	for	a	column	with	ratio	5	from	1.3×10‐5	m/s	to	
2.7×10‐5	m/s.	The	 lowest	 value	 for	kf	 is	 found	at	 the	outer	 radius	of	 the	 radial	 flow	
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column	where	the	velocity	is	lowest,	the	highest	value	is	found	at	the	inner	radius	at	
the	highest	velocity.	
	
Figure	6.5.	a)	Breakthrough	 curve	 for	 axial	 and	 radial	 flow	 columns;	 b)	 zoomed‐in	 breakthrough	 curve	
indicated	with	 the	dashed	rectangle	 in	a);	 c)	 concentration	profile	along	 the	axial	and	radial	 flow	column	
bed	as	a	 function	of	position	along	 the	bed	(z/L);	d)	concentration	profile	along	 the	axial	and	radial	 flow	
column	bed	as	a	function	of	dimensionless	cumulative	resin	volume.	Column	volume	(2	l),	bed	thickness	(6	
cm)	and	flow	rate	(superficial	velocity	in	axial	flow	column	is	150	cm	h‐1,	~833	ml/min)	were	equal	for	axial	
and	radial	flow	and	radial	flow	was	directed	inward.	Legend:	axial	(solid),	radial	flow	α	=	2	(dashed),	α	=	5	
(dotted)	and	α	=	10	(dash‐dotted)	and	times	10	minutes	(A),	30	minutes	(B)	and	50	minutes	(C).	
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For	non‐porous	particles	or	a	membrane	the	adsorption	capacity	of	BSA	is	much	lower	
than	 for	 porous	 particles	 because	 of	 the	 lower	 surface	 area	 per	 unit	 resin	 or	
membrane	volume.	In	addition,	in	contrast	to	our	system,	the	adsorption	kinetics	may	
be	limiting.	This	can	be	estimated	with	a	modified	Damköhler	number:	
ܦܽ௔′ ൌ ௞ೌ௖∗ோ೛௞೑ 	 (6.19)	
When	 c*	 equals	 cin,	Daa'	would	be	0.9	 for	 an	 axial	 flow	 column	with	 the	parameters	
from	Table	6.1.	For	a	radial	flow	column	with	ratio	2,	Daa'	would	lie	between	0.8	and	
1.0	 for	c*	equal	 to	cin.	At	 lower	concentrations	of	c*,	 the	value	 for	Daa'	 is	even	 lower.	
These	low	values	indicate	that	not	mass	transfer,	but	adsorption	is	limiting	here.	This	
is	the	same	situation	as	found	in	membrane	chromatography	[34].	Lowering	the	value	
for	Rp	does	not	improve	the	system,	because	this	would	increase	the	value	for	kf	(see	
Equation	 6.8)	 cancelling	 out	 any	 change	 in	Rp.	 The	 value	 for	 c*	 can	 be	 increased	 by	
increasing	 the	value	 for	cin,	 but	 this	would	only	 increase	 the	Damköhler	number	 for	
the	last	part	of	the	chromatography	process	since	at	the	start	c*	is	lower	than	cin.	The	
value	 for	 ka	 should	 then	 be	 increased	with	 at	 least	 one	 order	 of	 magnitude,	 which	
would	 no	 longer	 resemble	 a	 realistic	 process.	 Therefore,	 we	 can	 conclude	 that	 for	
practical	 cases	 an	 axial	 and	 radial	 flow	 chromatography	 column	 operated	 at	 equal	
column	volume	and	flow	rate	yield	almost	 identical	breakthrough	curves,	regardless	
of	the	specific	packing	used	inside	the	columns.	
6.4.4.3 Pressure	drop	
An	aspect	that	is	often	mentioned	as	an	advantage	of	the	radial	flow	configuration	is	a	
lower	 pressure	 drop	 compared	 to	 axial	 flow.	 The	 pressure	 drop	 over	 a	
chromatography	column	has	two	contributions:	the	pressure	drop	over	the	resin	bed	
and	the	pressure	drop	over	the	hardware	such	as	tubing	and	frits.	The	latter	can	only	
be	determined	when	the	complete	design	of	the	hardware	is	known,	but	is	expected	to	
be	similar	in	both	axial	and	radial	systems.	
The	pressure	drop	over	the	resin	bed	can	be	estimated.	For	a	bed	of	porous	media	the	
Kozeny‐Carman	 equation	 is	 used	 to	 calculate	 the	 pressure	 drop	 over	 the	 axial	 flow	
column:	
߂ ௔ܲ௫௜௔௟ ൌ ଵହ଴ఎ஽೛మ
ሺଵିఌ೐ሻమ
ఌ೐య
ఃೌೣ೔ೌ೗
గ௥ೌ మ ܮ	;	 (6.20a)	
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When	Equation	6.20a	is	converted	to	a	derivative	of	pressure	P	over	z	and	integrated	
from	0	to	L,	the	following	equation	can	be	derived	for	the	radial	flow	column:	
߂ ௥ܲ௔ௗ௜௔௟ ൌ ଵହ଴ఎ஽೛మ
ሺଵିఌ೐ሻమ
ఌ೐య
ఃೝೌ೏೔ೌ೗
ଶగுೝ ݈݊ሺߙሻ.	 (6.20b)	
In	these	equations,	ΔP	equals	the	pressure	drop	over	the	axial	or	radial	 flow	column	
and	 Dp	 the	 particle	 diameter	 of	 the	 resin.	 The	 flow	 rate	 of	 an	 axial	 flow	 column	
compared	 to	 a	 radial	 flow	 column	when	 the	 pressure	 drop,	 bed	 thickness	 and	 bed	
volume	are	kept	the	same	is	defined	as:	
ఃೌೣ೔ೌ೗
ఃೝೌ೏೔ೌ೗ ൌ
ଵ
ଶ
ఈାଵ
ఈିଵ 	݈݊ሺߙሻ.	 (6.21)	
From	 Equation	 6.21	 it	 is	 clear	 that	 at	 equal	 pressure	 drop,	 bed	 thickness	 and	 bed	
volume,	the	flow	rate	for	an	axial	flow	column	is	higher	than	for	a	radial	flow	column.	
The	ratio	between	axial	and	radial	flow	rate	at	equal	pressure	drop	is	exactly	equal	to	
the	 dimensionless	 average	 velocity	 in	 a	 radial	 flow	 column	 (see	 Equation	 6.16).	 In	
other	words,	the	higher	average	superficial	velocity	in	the	radial	flow	column,	as	also	
indicated	 in	 Figure	 6.3b,	 increases	 the	 pressure	 drop.	 Therefore,	 the	 potential	
advantage	of	using	a	radial	flow	column	mainly	lies	in	the	possibility	to	use	lower	bed	
thickness	without	obtaining	an	impractical	‘pancake’	shape.	
6.4.5 Inward	or	outward	flow	
6.4.5.1 Experimental	comparison	inward	and	outward	flow	
Inward	 flow	 is	 the	 convention	 for	 radial	 flow	 chromatography,	 but	 outward	 flow	 is	
also	possible.	The	micro‐RFC	column	was	used	to	evaluate	whether	the	flow	direction	
has	an	influence	on	the	breakthrough	curve	for	BSA	on	the	affinity	resin.	In	Figure	6.6	
the	outlet	concentration	of	the	radial	flow	column	is	plotted	against	the	outlet	volume	
for	 both	 inward	 (down)	 and	 outward	 (up)	 flow.	 The	 adsorption,	 washing	 and	
desorption	 stage	of	 the	 chromatography	process	are	 shown	 in	 the	graph.	There	 is	 a	
slight	difference	at	the	washing	and	desorption	stages	where	outward	flow	seems	to	
be	advantageous.	However,	by	changing	the	flow	direction,	the	tubing	volumes	before	
and	after	 the	column	were	also	changed.	The	 inlet	and	outlet	port	of	 the	radial	 flow	
column	 differ	 in	 volume,	 so	 the	 differences	 observed	 are	 probably	 not	 significant.	
Therefore,	 there	 does	 not	 seem	 to	 be	 a	 significant	 difference	 between	 inward	 and	
outward	flow	for	a	radial	flow	system	with	this	experimental	setup.	
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Figure	6.6.	BSA	concentration	as	a	function	of	outlet	volume	for	a	micro‐RFC	column	with	liquid	flow	from	
large	to	small	surface	area	(solid	grey)	and	from	small	to	large	surface	area	(dashed	black).	Flow	velocity	
was	set	at	111	cm/h	(1.5	ml/min),	BSA	inlet	concentration	1	mg/ml.	Adsorption	and	wash	with	10	mM	PBS	
pH	7.4,	desorption	with	0.1	M	glycine/HCl	pH	3.	
6.4.5.2 Theoretical	comparison	inward	and	outward	flow	
Inward	 flow	 would	 theoretically	 be	 beneficial	 compared	 to	 outward	 flow,	 because	
there	is	a	large	surface	area	and	low	velocity	at	the	inlet	and	a	small	surface	area	and	
high	velocity	at	the	outlet.	This	effect	could	aid	in	the	adsorption	efficiency.	In	Section	
6.4.5.1	we	could	not	observe	any	significant	differences	 in	 the	experiments,	but	 it	 is	
expected	that	if	there	is	a	difference,	the	ratio	between	outer	and	inner	radius	would	
be	a	parameter	in	this.	
The	only	difference	between	inward	and	outward	flow	in	the	mathematical	model	 is	
the	expression	for	u,	 the	velocity	 inside	the	column,	because	 it	runs	from	r1	 to	r2	 for	
outward	flow.	Equation	6.14	then	becomes:	
ݑ ൌ ఃଶగሺ௥భା௭ሻு	 (6.22)	
The	 breakthrough	 curves	 for	 ratios	 2	 and	 10	 with	 inward	 and	 outward	 flow	 are	
plotted	 in	Figure	6.7a	 and	Figure	6.7b.	 From	 these	 curves	 it	 is	 evident	 that	 there	 is	
only	 a	 slight	 difference	 between	 inward	 and	 outward	 flow	 for	 ratio	 2,	 but	 that	 this	
difference	 becomes	 significantly	 larger	 for	 ratio	 10.	 Especially	 at	 the	 early	 stage	 of	
breakthrough	this	effect	is	clearly	visible.	Inward	flow	yields	a	sharper	breakthrough	
front	than	outward	flow,	which	corresponds	to	the	expected	benefits	of	using	this	flow	
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direction.	The	small	difference	between	flow	directions	 for	a	ratio	of	2	explains	why	
no	 significant	 difference	 was	 observed	 in	 the	 experimentally	 determined	
breakthrough	curves	shown	in	Figure	6.6.	
	
Figure	 6.7.	 a)	 Breakthrough	 curve	 for	 radial	 flow	 columns	 with	 inward	 flow	 (solid)	 and	 outward	 flow	
(dashed);	 b)	 zoomed‐in	 breakthrough	 curve	 indicated	 with	 the	 dashed	 rectangle	 in	 a);	 c)	 concentration	
profile	 along	 the	 radial	 flow	 column	 bed	 as	 a	 function	 of	 position	 along	 the	 bed	 (z/L);	 d)	 concentration	
profile	along	radial	flow	column	bed	as	a	function	of	dimensionless	resin	volume.	Column	volume	2	l,	bed	
thickness	6	cm	and	flow	rate	~833	ml/min	(superficial	velocity	in	similar	axial	flow	column	is	150	cm/h).	
Legend:	inward	flow	(solid),	outward	flow	(dashed),	α	=	2	(black)	and	α	=	10	(grey),	and	times	10	minutes	
(A)	and	45	minutes	(B).	
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When	the	concentration	profile	 is	plotted	as	a	function	of	the	position	along	the	bed	
(Figure	 6.7c),	 there	 are	 large	 differences	 between	 ratio	 2	 and	 10	 and	 inward	 or	
outward	flow.	This	is,	similar	to	the	results	shown	in	Figure	6.5,	mainly	as	a	result	of	
the	 resin	 volume	 distribution	 as	 shown	 in	 Figure	 6.7d.	 The	 main	 differences	 are	
observed	in	the	last	10%	of	the	resin	bed	volume,	where	in	the	case	of	inward	flow	the	
liquid	 velocity	 is	 high	 and	 remaining	 bed	 thickness	 long	 and	 for	 outward	 flow	 the	
liquid	velocity	is	low,	but	remaining	bed	thickness	short.	
From	the	 results	obtained	with	 the	simulations	as	shown	 in	Figure	6.7	we	conclude	
that	 inward	 flow	 is	 slightly	advantageous	 compared	 to	outward	 flow	 for	 radial	 flow	
chromatography.	With	inward	flow,	the	solute	entering	the	column	has	a	longer	time	
to	diffuse	and	adsorb	than	when	the	flow	direction	is	reversed,	resulting	in	a	slightly	
improved	 breakthrough	 curve	 and	 hence	 adsorption	 capacity.	 The	 effect	 of	 flow	
direction	 increases	 as	 the	 ratio	 between	 outer	 and	 inner	 radius	 of	 the	 column	 is	
increased.	
6.4.6 Column	dimensions	
Neither	 the	 experimental	 results	 in	 Section	 6.4.2,	 nor	 the	 model	 calculations	 in	
Sections	 6.4.3	 and	 6.4.4	 indicate	 any	 significant	 difference	 in	 adsorption	 efficiency	
between	 an	 axial	 and	 radial	 flow	 column	 for	 the	 adsorption	 process	 investigated.	
However,	the	main	advantage	of	radial	flow	chromatography	is	the	possibility	to	scale	
up	 in	 column	height	 instead	 of	 diameter.	 For	 an	 axial	 flow	 column	bed	 thickness	 is	
equal	 to	 column	 height,	 excluding	 the	 hardware.	 The	 bed	 thickness	 is	 usually	
restricted	to	approximately	20	cm	for	soft	resins	such	as	the	Sepharose	4	FF	used	in	
this	research.	
In	Figure	6.8	the	column	width	and	height	(not	to	be	confused	with	bed	thickness)	is	
plotted	 as	 a	 function	 of	 column	 volume	 for	 an	 axial	 flow	 column	 and	 radial	 flow	
columns	with	 ratios	 2,	 5	 and	 10.	 The	 bed	 thickness	 is	 20	 cm	 for	 all	 columns.	 For	 a	
radial	flow	column	setting	the	bed	thickness	sets	the	width	of	the	column,	regardless	
of	 the	 resin	 volume.	 A	 higher	 ratio	 between	 outer	 and	 inner	 radius	 results	 in	 a	
narrower	and	taller	column.	The	plots	indicate	that	for	small‐scale	chromatography	an	
axial	flow	column	is	less	wide	than	a	radial	flow	column.	This	results	from	the	‘empty’	
space	of	the	inner	cylinder	of	the	radial	flow	column.	However,	as	the	volume	of	the	
resin	bed	increases,	so	does	the	width	of	the	axial	flow	column	and	at	a	certain	column	
volume	it	becomes	wider	than	a	radial	flow	column.	Compared	to	a	radial	flow	column	
with	ratio	2,	an	axial	flow	column	is	wider	when	its	resin	bed	volume	exceeds	100	l.	
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For	 ratios	 5	 and	 10,	 the	 points	 of	 intersection	 are	 39	 and	 31	 litre	 respectively.	 The	
radial	flow	columns	are	obviously	taller	than	the	axial	flow	columns,	but	it	is	easier	to	
transport	 a	 tall	 and	narrow	 column	 to	 a	 clean	 room	 than	a	wide	and	 short	 column.	
Assuming	that	column	seals	and	flanges	are	cost‐driving,	a	narrow	column	should	also	
be	 less	 expensive.	 If	 the	 bed	 thickness	 is	 decreased	 for	 the	 radial	 flow	 column,	 the	
resin	volume	at	which	the	radial	flow	column	is	less	wide	than	an	axial	flow	column,	is	
of	 course	 even	 lower.	 However,	 at	 a	 certain	 point	 problems	with	 the	 resin	 packing	
may	arise	due	to	the	height	of	the	radial	flow	column,	and	the	system	is	better	split	up	
into	two	columns.	
	
Figure	 6.8.	 Column	 dimensions	 for	 an	 axial	 flow	 column	 (solid)	 and	 radial	 flow	 columns	 with	 ratio	 2	
(dashed),	5	(dotted)	and	10	(dash‐dotted)	at	20	cm	bed	thickness;	a)	column	width	as	a	function	of	column	
volume;	b)	column	height	as	a	function	of	column	volume.	
6.4.7 Case	study	
As	a	case	study	we	take	a	15‐l	axial	flow	column	of	20	cm	bed	thickness	(to	avoid	large	
pressure	drops)	 and	a	 radial	 flow	 column	of	 equal	 volume,	but	6	 cm	bed	 thickness.	
These	columns	represent	commercially	available	columns.	A	scaled	representation	of	
the	 two	 columns	 is	 shown	 in	 Figure	 6.9.	 The	 flow	 rate	 is	 set	 at	 10	 l/min	 for	 both	
columns	and	the	other	parameters	are	set	equal	to	those	mentioned	in	Table	6.1.	The	
resulting	breakthrough	curves	are	shown	in	Figure	6.10.	
Even	though	the	bed	thickness	is	much	shorter	for	the	radial	flow	column	compared	to	
the	 axial	 flow	 column,	 the	 breakthrough	 curves	 cannot	 be	 distinguished	 from	 each	
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other.	A	narrow,	tall	radial	flow	column	can	therefore	replace	a	wide,	short	axial	flow	
column	without	a	significant	change	in	adsorption	performance.	
	
Figure	6.9.	Scaled	 representation	of	 an	axial	 flow	column	with	20	 cm	bed	height	 (left)	 and	a	 radial	 flow	
column	with	6	cm	bed	height,	ratio	2	(right);	both	columns	have	a	volume	of	15	l.	
	
Figure	6.10.	a)	Breakthrough	curves	for	an	axial	flow	column	of	20	cm	bed	thickness(solid	grey	line)	and	
radial	 flow	 column	 of	 6	 cm	 bed	 thickness	 (α	 =	 2;	 dashed	 black	 line);	 b)	 zoomed‐in	 breakthrough	 curve	
indicated	 with	 the	 dashed	 triangle	 in	 a).	 The	 bed	 volume	 is	 15	 l	 and	 flow	 rate	 10	 l/min	 in	 both	
configurations.	
6.5 Conclusions	
Both	 a	 practical	 and	 theoretical	 comparison	 between	 axial	 and	 radial	 flow	
chromatography	were	made	based	on	 the	 affinity	 adsorption	of	BSA.	When	 the	bed	
volume,	bed	 thickness	and	 flow	rate	are	kept	equal,	 the	breakthrough	curves	of	 the	
two	configurations	coincide.	Usually	lab‐scale	experiments	are	performed	using	axial	
flow	 chromatography.	 The	 results	 obtained	 in	 this	 research	 suggest	 that	 these	 lab‐
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scale	 results	 can	 also	 be	 used	 to	 scale	 up	 to	 a	 radial	 flow	 column.	 However,	 some	
differences	may	become	apparent	when	a	high	ratio	between	outer	and	inner	radius	
of	the	radial	flow	column	(>10)	is	used.	
In	theory,	the	radial	flow	column	has	a	lower	flow	rate	at	a	pre‐defined	pressure	drop	
than	 the	equivalent	axial	 flow	column	at	 equal	bed	 thickness	and	volume.	However,	
the	theory	only	takes	into	account	the	particle	bed,	other	components	of	the	column	
such	as	frits	may	give	a	different	result.	
The	 radial	 flow	 column	 has	 potential	 at	 large‐scale	 applications,	where	 a	 short	 bed	
thickness	 can	 be	 combined	 with	 a	 large	 inlet	 surface	 area.	 For	 pressure‐sensitive	
resins,	an	axial	flow	column	is	scaled	up	in	diameter,	while	the	radial	flow	column	can	
be	scaled	up	vertically.	This	allows	for	the	large‐scale	radial	flow	column	to	be	easier	
to	handle	than	the	equivalent	axial	flow	column,	although	the	resin	packing	may	limit	
the	 height	 of	 the	 radial	 flow	 column.	 On	 a	 smaller	 scale,	 the	 axial	 flow	 column	 is	
probably	the	best	option.		
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Chapter	7	
General	Discussion	
	
7.1 Introduction	
This	 thesis	 provides	 an	 overview	 of	 different	 aspects	 involved	 in	 the	 isolation	 of	
proteins	 present	 at	 low	 concentrations	 in	 larger	 feed	 streams,	 using	 affinity	
chromatography	with	immobilised	ligands.	In	Chapter	2,	the	technique	was	tested	on	
whey	as	a	representative	feedstock.	The	results	indicate	that	the	ligands	are	selective	
and	that	a	significant	increase	in	target	protein	concentration	can	be	achieved	during	
desorption.	 However,	 traces	 of	 other	 components	may	 end	 up	 in	 the	 final	 product.	
This	is	not	necessarily	a	problem	for	many	applications;	but	for	others	it	may	require	
some	additional	purification.	
Good	characterization	of	the	affinity	ligand	is	important	because	it	provides	insight	in	
the	 process	 design	 as	 illustrated	 in	 Chapter	 3.	 The	 thermodynamics	 of	 the	 binding	
between	 affinity	 ligand	 and	 target	 are	 complex.	 The	 information	 obtained	 from	
thermodynamic	measurements	at	varying	temperature	and	pH	can	be	used	to	identify	
whether	adsorption	is	favourable	at	the	pH	and	temperature	of	the	feedstock,	and	also	
how	desorption	can	best	be	carried	out.	
Many	different	stationary	phases	exist	for	immobilization	of	the	affinity	ligand.	Several	
commercially	available	porous	particles	have	been	investigated	in	Chapters	4	and	5.	In	
Chapter	6	 radial	 flow	chromatography	was	presented	and	discussed	as	a	possibility	
for	scaling	up	affinity	chromatography.	
In	 this	 chapter,	we	will	 further	 elaborate	 on	 other	 types	 of	 stationary	 phases.	Non‐
porous	 particles	 and	 membranes	 may	 provide	 solutions	 to	 some	 issues	 related	 to	
porous	 particles,	 but	 why	 are	 these	 not	 widely	 used?	 And	 can	 magnetic	 particles	
provide	fast	isolation	of	minor	proteins,	by	avoiding	diffusion	limitation?	We	will	try	
to	 identify	 the	 pros	 and	 cons	 of	 different	 stationary	 phases	 compared	 to	 the	
conventional	 bed	 of	 porous	 particles.	 In	 the	 final	 part	 of	 this	 discussion	we	 give	 an	
overview	 of	 the	 future	 prospects	 of	 affinity	 chromatography	 for	 minor	 protein	
separation	and	isolation	in	the	food	industry.	
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7.2 	Stationary	phases	
7.2.1 Porous	versus	non‐porous	particles	in	packed	bed	chromatography	
In	 this	 thesis	we	 focused	on	 the	use	of	 a	 column	packed	with	porous	particles	onto	
which	the	VHH	ligand	is	immobilized.	Porous	particles	exhibit	a	large	area	to	volume	
ratio,	 because	 they	 have	 a	 large	 inner	 surface	 area.	 As	 a	 result	 of	 the	 large	 specific	
surface	area,	these	particles	can	generally	be	quite	large	(in	the	order	of	100	µm)	and	
still	exhibit	high	adsorption	capacity.	However,	when	the	pores	of	the	particles	are	too	
narrow	 for	 the	 target	 protein	 to	 enter,	 this	 advantage	 is	 lost.	 The	 pores	might	 also	
become	 clogged	 with	 other	 components	 in	 the	 process	 liquid,	 such	 as	 large	 or	
aggregated	proteins,	or	fat	globules.	In	many	cases,	the	diffusion	of	the	target	protein	
into	 the	 particle	 is	 the	 rate‐limiting	 step	 in	 the	 adsorption	 process	 (and	 out	 of	 the	
particle	 in	 case	 of	 the	 desorption	 process).	 Several	 authors	 have	 investigated	 and	
visualized	the	diffusion	of	proteins	into	porous	particles	(e.g.,	[1,	2]).		
To	 circumvent	 the	 problems	 of	 diffusion	 and	 clogging,	 why	 not	 use	 non‐porous	
alternatives?	A	possibility	could	be	to	use	a	non‐porous	particle	in	a	packed	bed.	The	
theoretical	maximum	adsorption	capacity	of	a	non‐porous	particle	 can	be	estimated	
with	the	following	equation:	
ݍ௠ ൌ ሺ1 െ ߝ௘ሻ ଺஽೛
ெௐ೟
஺೟ேಲೡ	 (7.1)	
In	 this	 equation,	 qm	 equals	 the	 maximum	 adsorption	 capacity	 per	 unit	 packed	 bed	
volume,	 εe	 the	 porosity	 of	 the	 packed	 bed,	Dp	 the	 diameter	 of	 the	 particle,	MWt	 the	
molecular	weight	of	the	target	molecule,	At	 the	area	occupied	by	the	target	molecule	
and	NAv	 equals	Avogadro’s	number.	With	 this	equation	complete	surface	coverage	 is	
assumed.	BSA	measures	approximately	4	by	14	nm	[3],	which	means	it	would	occupy	
at	least	44	nm2.	Its	molecular	weight	is	approximately	67	kDa.	With	porous	particles	a	
qm	of	20	mg/ml	can	be	reached	for	BSA	affinity	chromatography	(see	Chapters	2	and	
5).	Assuming	a	bed	porosity	of	0.35,	a	non‐porous	particle	should	be	smaller	than	485	
nm	in	diameter	to	have	the	same	capacity.	
The	 pressure	 drop	 over	 an	 axial	 packed	 bed	 can	 be	 calculated	 with	 the	 Kozeny‐
Carman	equation:	
߂ܲ ൌ ଵହ଴ఎ஽೛మ
ሺଵିఌ೐ሻమ
ఌ೐య ݑܮ	 (7.2)	
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In	 this	 equation,	 ΔP	 equals	 the	 pressure	 drop	 over	 the	 packed	 bed,	 η	 the	 liquid	
viscosity,	 u	 the	 superficial	 velocity	 in	 the	 bed	 (flow	 rate	 divided	 by	 cross‐sectional	
area)	and	L	the	length	of	the	bed.	For	a	bed	length	of	20	cm	and	a	superficial	velocity	
of	150	cm/h	a	bed	of	485	nm	particles	will	yield	a	pressure	drop	exceeding	6500	bar.	
As	a	comparison,	a	bed	of	100	µm	particles	would	yield	a	pressure	drop	of	only	0.1	
bar.	 Packing	 non‐porous	 particles	 into	 a	 conventional	 column	 is	 therefore	 not	 an	
option	 for	 large‐scale	 applications.	 Other	 ways	 of	 contacting	 the	 particles	 and	 the	
process	liquid	should	therefore	be	found,	for	example	with	magnetic	particles.		
7.2.2 Magnetic	particles	
7.2.2.1 High	gradient	magnetic	separation	
Small,	 non‐porous	 particles	 may	 be	 used	 in	 batch	 adsorption	 in	 a	 stirred	 vessel	 to	
circumvent	 the	 high	 pressure	 drop.	 Since	 the	 adsorption	 is	 limited	 by	 either	
adsorption	 or	 mass	 transfer,	 and	 the	 particles	 are	 mixed	 intimately	 with	 the	 feed,	
equilibrium	can	be	reached	quickly.	Even	though	only	one	equilibrium	stage	exists	per	
stirred	vessel,	it	could	be	feasible	with	strong	and	selective	adsorption.	It	is	however	
important	to	recover	the	particles	used	for	the	adsorption,	which	can	be	difficult	with	
small	 particles.	 To	 solve	 this	 issue,	 several	 groups	 have	 investigated	 high	 gradient	
magnetic	 fishing	 (HGMF)	 or	 high	 gradient	 magnetic	 separation	 (HGMS)	 for	 affinity	
purification	(e.g.,	 [4‐9]).	HGMS	makes	use	of	a	magnetic	 field	 to	capture	magnetic	or	
magnetizable	particles.	This	method	is	for	example	used	in	waste	water	treatment	and	
steel	production	[10].	
Recently,	the	application	of	HGMS	has	found	interest	for	the	separation	of	proteins	in	
biotechnology.	Adsorption	here	usually	 takes	place	 in	a	stirred	vessel	 (or	a	series	of	
vessels)	 filled	with	 the	process	 liquid	and	magnetic	 (or	magnetizable)	particles	 that	
have	 an	 affinity	 for	 the	 component	 of	 interest.	 These	 particles	 can	 be	 several	
nanometres	in	diameter,	or	even	porous,	so	adsorption	capacity	does	not	have	to	be	
limiting.	Many	reports	on	the	production	of	magnetic	particles	for	affinity	separation	
can	be	found	in	literature	(e.g.,	[5‐7,	9,	11‐23]).	
After	adsorption,	the	magnetic	particles	are	filtered	out	of	the	process	liquid	using	an	
external	magnetic	field	or	with	a	magnetized	filter	made	of	steel	mesh.	Washing	and	
desorption	 can	 take	 place	 in	 the	 magnetic	 filter	 after	 which	 the	 particles	 may	 be	
returned	to	the	stirred	vessel	yielding	a	semi‐continuous	system	as	shown	in	Figure	
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7.1.	However,	 it	 is	not	possible	to	filter	out	and	recover	all	magnetic	particles	 in	one	
step	[9,	24].	Recovery	of	all	particles	is	especially	important	for	regeneration,	but	also	
for	cleaning	purposes	and	especially	if	the	process	liquid	has	further	use,	for	example	
as	a	food.	
	
	
	
Figure	7.1.	Diagram	of	semi‐continuous	HGMS.	
The	desorption	 is	again	 important	 since	 the	void	space	between	 the	particles	 in	 the	
magnetic	filter	is	high.	Batch	desorption	in	a	stirred	vessel	is	unfavourable	because	it	
will	 not	 yield	 significant	 concentration	 of	 the	 target	 component.	 Several	 stages	 of	
desorption	would	be	 required	 to	 fully	 regenerate	 the	adsorbent	particle	making	 the	
process	 inefficient.	 HGMF	 or	 HGMS	 may	 be	 a	 useful	 separation	 process	 for	 the	
laboratory,	but	 it	 is	not	yet	 feasible	 for	 larger	scale	affinity	purification	processes	 in	
the	food	or	biotechnology	industry.	
7.2.2.2 Magnetically	stabilized	fluidized	bed	
Magnetically	 stabilized	 fluidized	 beds	 (MSFB)	 are	 columns	 containing	
magnetic/magnetizable	particles	which	are	kept	in	place	by	a	magnetic	field	[25‐40].	
These	 columns	 can	be	viewed	as	 an	 alternative	 for	 expanded	bed	 adsorption	 (EBA)	
where	the	particles	are	hydrodynamically	stabilized	due	to	their	size	and	density	and	
have	 a	more	or	 less	 fixed	position	 in	 the	bed	 [41‐45].	When	 the	particles	 can	move	
freely	 through	 the	 bed,	 it	 is	 called	 a	 fluidized	 bed.	 In	 Figure	 7.2	 the	 different	
configurations	 are	 shown	 schematically.	 Stabilization	 is	 necessary	 to	 prevent	 early	
and	shallow	breakthrough.	In	EBA	restrictions	apply	to	the	flow	velocity,	which	may	
not	exceed	the	terminal	settling	velocity	of	the	lightest	particles.	In	an	MSFB	this	flow	
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velocity	may	be	higher	due	to	the	magnetic	field	applied.	For	MSFB	it	is	also	possible	
to	 force	 the	particles	 to	 flow	counter‐current	 to	the	 feed	 flow	allowing	a	continuous	
system	when	multiple	MSFBs	 for	 adsorption,	washing	 and	 desorption	 are	 placed	 in	
series	 [27].	 Finally,	 one	 can	 stabilize	 a	 packed	 bed	 of	 non‐magnetic	 particles	 with	
magnetic	particles	 [32].	 In	 that	case,	 the	magnetic	particles	do	not	play	a	role	 in	the	
actual	separation	process.	
In	MSFBs	 the	magnetic	 field	strength	applied	 is	crucial.	 If	 the	 field	 is	 too	strong,	 the	
magnetic	 particles	 will	 start	 to	 form	 chains	 in	 the	 bed.	 This	 greatly	 reduces	 the	
efficiency	 of	 the	bed	 [46].	 If	 the	 field	 is	 not	 strong	 enough,	 particles	 break	 through.	
Because	of	 the	 large	magnetic	 fields	 required	and	 the	difficulty	 to	maintain	a	 stable	
bed,	an	MSFB	is	not	a	feasible	large‐scale	process	for	the	near	future.		
	
Figure	 7.2.	 Schematic	 representation	 of	 an	 axial	 packed	 bed	 (a),	 a	 fluidized	 bed	 (b),	 an	 expanded	 bed	
stabilized	 by	 size	 (c),	 and	 a	 magnetically	 stabilized	 fluidized	 bed	 (d).	 For	 the	 axial	 and	 magnetically	
stabilized	bed	both	upward	and	downward	flow	are	possible.	
7.2.3 Membranes	
In	membrane	affinity	adsorption,	the	feed	stream	is	led	through	a	membrane	or	along	
it	 (cross‐flow).	The	affinity	 ligands	are	 located	 in	 the	pores	of	 the	membrane.	When	
the	 feed	 stream	 flows	 through	 the	membrane	 pores,	 the	 target	 protein	 comes	 into	
close	 contact	 with	 the	 ligand,	 which	 reduces	 diffusion	 limitation.	 These	 pores	 are	
much	larger	than	the	pores	in	porous	particles,	which	enables	convective	flow	through	
the	membrane.	This	convection	is	seen	as	a	main	advantage	of	membrane	adsorption,	
since	mass	transfer	is	not	limited	by	pore	diffusion	as	in	porous	particles.	Because	of	
the	fast	mass	transfer,	the	kinetics	of	adsorption	can	become	limiting.	
The	 best	 known	 configurations	 are	 sheet	 membranes	 and	 hollow	 fibres	 [47‐58].	 A	
major	 problem	 with	 single	 sheet	 membranes	 is	 the	 variation	 in	 thickness	 and	
a)	 b) c) d) 
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porosity.	 Even	 small	 variations	 may	 lead	 to	 less	 performance	 caused	 by	 uneven	
permeation	rates.	 It	 is	 therefore	better	 to	use	 thicker	membranes,	or	stacks	of	 them	
[48].	Thicker	membranes	or	stacked	membranes	will	increase	the	pressure	drop,	but	
it	generally	remains	lower	than	for	porous	particles	at	equal	superficial	velocity	and	
bed	height.	Since	the	feed	usually	has	to	pass	through	the	membrane	pores,	the	system	
can	 become	 easily	 plugged	 or	 fouled	 by,	 for	 example,	 fat	 globules	 or	 protein	
aggregates.	This	would,	however,	also	be	true	for	packed	beds	of	particles.	
7.2.3.1 Adsorption	capacity	of	membranes	
Membranes	 seem	 to	 compare	 quite	 well	 to	 the	 conventionally	 used	 packed	 bed	 of	
porous	 particles.	 However,	 a	 membrane	 has	 a	 low	 surface	 area	 to	 volume	 ratio	
compared	 to	 porous	 particles.	 When	 very	 large	 molecules	 or	 particles	 have	 to	 be	
purified,	the	surface	area	available	for	adsorption	may	be	low	for	a	porous	particle	as	
well:	the	component	simply	cannot	enter	the	pore	as	it	is	too	big.	This	can	for	example	
be	the	case	for	DNA	purification	or	viral	clearance.	
There	 are	 not	 many	 affinity	 membranes	 commercially	 available	 as	 opposed	 to	 the	
widely	used	porous	particles.	A	 few	 ion	exchange	membranes	are	available,	 such	as	
the	Mustang	Q	and	S	membranes	from	Pall	with	a	dynamic	adsorption	capacity	of	60	
mg/ml	 membrane	 volume	 at	 10%	 breakthrough	 for	 BSA	 [59].	 This	 should	 be	
compared	 to	 the	porous	cellulose	particles	 from	Pall,	Q	and	S	Hypercel	 resin,	which	
exhibit	a	dynamic	adsorption	capacity	at	10%	breakthrough	of	up	to	198	mg/ml	resin	
volume	 [60].	 A	 Sartobind	 Q	 ion	 exchange	 unit	 (Sartorius	 Stedim	 Biotech,	 Aubagne	
France,	 [61])	 can	 adsorb	 approximately	 29	mg	 BSA/ml	membrane	 volume	 in	 total.	
The	adsorption	 capacity	may	be	 further	 improved	by	 increasing	 the	 specific	 surface	
area	 of	 the	 membrane	 for	 example	 by	 grafting	 polymers	 to	 the	membrane	 surface	
(e.g.,	 [62]).	 However,	 these	 surface	 modifications	 may	 result	 in	 diffusion	 limitation	
once	more.	
7.2.3.2 Potential	for	membrane	chromatography	
The	main	advantage	of	membrane	chromatography	 is	 the	 low	pressure	drop	at	high	
flow	 velocities.	 When	 the	 target	 molecule	 is	 very	 large,	 the	 adsorption	 capacity	 of	
membranes	 can	 be	 higher	 than	 for	 porous	 particles.	 Membranes	 are	 said	 to	 be	
cheaper	to	produce	than	porous	particles	and	may	therefore	be	suitable	for	disposable	
systems	which	avoid	the	need	of	extensive	washing,	regeneration	and	validation	of	the	
General	Discussion	
115	
chromatography	 bed.	 However,	 disposable	 systems	 are	 probably	 not	 suitable	 for	
affinity	chromatography,	since	the	affinity	ligands	would	be	discarded	as	well,	leading	
to	 higher	 costs.	 In	 addition,	 for	 large‐scale	 processes,	 disposable	 systems	 are	 not	
feasible	due	to	sustainability	considerations.	
For	 large‐size	 components,	 such	 as	 DNA	 and	 viruses,	 membranes	 are	 probably	 a	
better	 choice	 than	 porous	 beads.	 For	 single	 proteins	 and	 smaller	 components,	 the	
choice	between	membranes	and	beads	has	to	be	determined	for	each	specific	process.	
Larger	flow	rates	can	be	used	for	membrane	adsorption,	but	too	high	flow	rates	can	
result	in	poor	adsorption	due	to	adsorption	limitation.		
7.2.3.3 Mixed‐matrix	membrane	adsorbers	
Mixed‐matrix	 membrane	 adsorbers	 consist	 of	 grinded	 or	 otherwise	 small	 porous	
particles	which	are	 immobilized	 in	a	membrane‐like	porous	structure,	developed	by	
Avramescu	 and	 co‐workers	 [63‐65]	 (see	 Figure	 7.3).	 The	 particles	 (usually	 ion	
exchangers)	 are	 used	 to	 adsorb	 the	 target	 component;	 the	 membrane	 does	 not	
contribute	to	the	separation	itself	but	serves	as	a	matrix.	This	type	of	membrane	can	
be	 used	 in	 both	 sheet	 and	 hollow	 fibre	 configurations.	 The	 porous	 particles	 may	
improve	 the	 adsorption	 capacity	 of	 the	 system	 when	 it	 is	 compared	 to	 a	 regular	
membrane.	 The	 length	 of	 diffusion	 is	 shorter	 than	 for	 full‐sized	 porous	 particles.	
However,	the	void	space	per	unit	of	membrane	volume	is	considerable,	approximately	
75%,	and	thus	 the	capacity	per	unit	volume	 is	again	 lower	 than	 for	a	packed	bed	of	
porous	particles.	
	
Figure	7.3.	 Cross‐section	 SEM	 photographs	 of	 ion‐exchange	mixed‐matrix	membranes.	 A)	magnification	
750x,	size	bar	indicates	20	μm;	B)	magnification	2000x,	size	bar	indicates	10	μm.	Picture	reproduced	from	
[63]	with	permission	from	Elsevier.	
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7.2.4 Monoliths	
Monolithic	columns	are	also	referred	to	as	continuous	beds.	Monolithic	columns	are	
comparable	 to	 packed	 beds,	 but	 they	 consist	 of	 only	 one	 ‘particle’.	 There	 are	many	
ways	 to	 produce	monolithic	 columns	 (see	 e.g.,	 [66]	 and	 [67]).	 It	 is	 also	 possible	 to	
produce	so‐called	structured	monoliths	with	uniform	channels.	Monoliths	composed	
from	cryogels	(the	gel	is	formed	at	a	very	low	temperature,	in	which	ice	crystals	act	as	
porogens)	can	be	dried	and	reused	[67].	Monoliths	can	be	 formed	 into	 fibres,	which	
can	be	placed	in	parallel.	Monolithic	disks	[68]	resemble	membranes,	but	are	thicker.	
By	forming	tubes,	a	radial	flow	monolith	can	be	produced,	by	which	scale‐up	can	take	
place	by	increasing	the	length	of	the	tube.	
Monoliths	 can	 have	 a	 large	 surface	 area	 when	 they	 have	 micropores	 as	 well	 as	
macropores	 allowing	 for	 liquid	 convection.	 They	 may	 therefore	 have	 a	 larger	
adsorption	capacity	than	membranes,	but	lower	than	porous	beads	when	proteins	and	
small‐sized	 molecules	 are	 concerned.	 The	 target	 component	 moves	 to	 the	 affinity	
ligand	 mainly	 through	 convection,	 which	 makes	 this	 process	 faster	 than	 processes	
with	porous	beads.		
Due	to	the	larger	pores,	the	pressure	drop	along	a	monolithic	column	is	lower	than	in	
a	conventional	column.	However,	when	the	height	or	thickness	increases,	the	pressure	
drop	 naturally	 increases	 as	 well.	 The	 process	 can	 be	 scaled	 up	 by	 increasing	 the	
diameter	for	axial	flow,	or	height	for	radial	flow.	As	in	all	chromatography	processes	
with	 a	 large	 diameter,	 care	must	 be	 taken	 to	 accomplish	 uniform	 flow	 through	 the	
column	[56,	66,	69‐71].	
As	with	any	type	of	affinity	adsorbent,	the	monolith	has	a	limited	life	time.	For	porous	
particles	 this	 is	 usually	between	100	and	200	 cycles.	The	packed	bed	of	particles	 is	
then	emptied	and	filled	with	fresh	particles.	However,	the	monolith	has	to	be	tightly	
attached	 to	 the	 walls	 of	 its	 casing,	 because	 otherwise	 liquid	 would	 preferably	 flow	
along	 the	walls	 instead	of	 through	 the	monolith	(i.e.,	 channelling).	Therefore,	once	a	
column	 is	 filled	 with	 monolith,	 it	 cannot	 be	 easily	 replaced	 without	 replacing	 the	
entire	module.	It	may	be	advantageous	to	use	a	radial	flow	module,	where	attachment	
of	the	monolith	is	required	to	the	top	and	bottom	of	the	module	instead	of	the	outer	
wall.	
At	 this	 moment	 it	 is	 not	 possible	 to	 produce	 large	 scale	 monoliths;	 the	 largest	
monolith	available	from	BIA	Separations	(Villach,	Austria)	is	8	l	[72].	The	question	is	
whether	effort	should	be	put	in	trying	to	make	larger	monolithic	adsorption	devices.	It	
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is	 probably	 more	 interesting	 to	 use	 smaller	 scale	 monolithic	 devices	 in	 parallel	 to	
obtain	the	required	capacity.	However,	for	large	scale	systems	this	is	probably	not	an	
efficient	method	of	operation.	
7.2.5 Summary	stationary	phases	
In	Table	7.1	an	overview	of	the	most	important	advantages	and	disadvantages	of	the	
stationary	phases	for	affinity	chromatography	are	summarized.	To	make	a	decision	on	
the	 stationary	 phase	 suitable	 for	 a	 small	 or	 large‐scale	 affinity	 chromatography	
process,	Table	7.2	can	be	used.	For	each	stationary	phase	a	small	sub‐table	indicates	
its	 general	 applicability	 for	 affinity	 chromatography	 depending	 on	 target	molecular	
weight	and	process	scale.	
Table	 7.1.	 Overview	 of	 important	 advantages	 and	 disadvantages	 of	 stationary	 phases	 for	 affinity	
chromatography	
Stationary	phase	 Advantages	 Disadvantages	
Porous	particles	
(packed	bed)	
+ highest	capacity	up	to	medium‐MW	
targets	
+ concentrated	product	
+ easily	available	and	flexible	
‐ intraparticle	diffusion	limitation	
‐ bed	height	limitation	→	scale‐up	
‐ filtration	required	for	particulate	
matter	
Non‐porous	particles
(batch	or	small	bed)	
+ suitable	for	high‐MW	targets	
+ suitable	for	particulate	matter	
+ no	diffusion	limitation	
‐ limited	adsorption	capacity	
‐ low	final	product	concentration	
‐ high	pressure	drop	when	packed	
Membranes	 + mass	transfer	through	convection	
+ low	pressure	drop	at	high	flow	rates	
+ possibility	for	disposable	systems	
‐ adsorption	kinetics	may	become	
limiting	
‐ limited	adsorption	capacity	
‐ limited	availability	
Monoliths	 + mass	transfer	through	convection	
and	possibly	(limited)	diffusion	
+ low	pressure	drop	at	high	flow	rates	
+ potentially	higher	capacity	than	
membranes	
‐ adsorption	kinetics	may	become	
limiting	
‐ tight	attachment	to	casing	required	
‐ currently	only	small	volumes	(<	8	l)	
available	
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Table	7.2.	Applicability	 of	 stationary	 phases	 based	 on	 process	 scale	 (lab,	 pilot	 or	 industrial)	 and	 target	
molecular	weight	(low	for	sugars	and	peptides;	medium	for	proteins;	high	for	DNA	or	viruses).	Dark	grey	
indicates	that	the	stationary	phase	is	first	choice,	lighter	grey	second	choice.	
porous	particles	 	 membrane	
MWtarget	 lab	 pilot	 industry	 	 MWtarget	 lab	 pilot	 industry	
low	 	 	 	 	 low	 	 	 	
medium	 	 	 	 	 medium	 	 	 	
high	 	 	 	 	 high	 	 	 	
	 	 	 	 	 	 	 	 	
non‐porous	particles 	 monolith
MWtarget	 lab	 pilot	 industry	 	 MWtarget	 lab	 pilot	 industry	
low	 	 	 	 	 low	 	 	 	
medium	 	 	 	 	 medium	 	 	 	
high	 	 	 	 	 high	 	 	 	
7.3 Future	of	minor	protein	separation	in	the	food	industry	
Affinity	separation	has	a	reputation	of	being	expensive.	As	shown	in	Chapters	2	and	5,	
the	adsorption	capacity	of	BSA	to	the	VHH	affinity	resin	is	around	20	mg/ml.	With	this	
capacity,	a	column	of	at	least	50	l	is	required	to	produce	1	kg	of	product.		
7.3.1 Adsorption	capacity	
It	 is	 common	 to	 describe	 the	 adsorption	 capacity	 of	 an	 adsorbent	 in	 terms	 of	 the	
dynamic	or	static	adsorption	capacity	at	a	relatively	high	target	concentration.	In	the	
case	of	dedicated	product	streams,	such	as	fermentation	broths	for	the	production	of	
monoclonal	 antibodies,	 the	 target	 concentration	 is	 indeed	 high.	However,	 for	minor	
component	separation,	the	adsorption	capacity	at	that	concentration	in	the	fluid	may	
be	 much	 lower	 than	 the	 adsorption	 capacity	 mentioned	 by	 the	 manufacturer.	 Of	
course	the	number	of	ligands	available	plays	a	role,	but	the	equilibrium	constant	is	at	
least	as	important.	When	the	adsorption	is	very	strong,	almost	horizontal	adsorption	
isotherms	are	measured	and	even	for	low	concentrations	a	considerable	capacity	may	
be	reached.	This	is	illustrated	in	Figure	7.4	where	a	Langmuir	adsorption	isotherm	is	
assumed:	
ݍ ൌ ௤೘௄ೌ௖ଵା௄ೌ௖ ൌ
௤೘௖
௄೏ା௖	 (7.3)	
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In	 Equation	 7.3,	 q	 equals	 the	 equilibrium	 adsorption	 capacity,	 qm	 the	 maximum	
adsorption	capacity,	Ka	the	adsorption	equilibrium	constant	(adsorption	rate	constant	
divided	by	desorption	rate	constant)	and	c	the	target’s	equilibrium	concentration,	Kd	is	
the	desorption	equilibrium	constant	(1/Ka).	
The	dependence	of	the	adsorption	isotherm	on	Ka	is	illustrated	in	Figure	7.4a.	A	value	
of	109	M‐1	for	the	equilibrium	constant	is	very	high	but	possible	for	antibody‐antigen	
adsorption.	For	the	immobilized	affinity	ligand	we	investigated	in	this	thesis	we	found	
a	value	of	1.37×106	M‐1	(see	Chapter	2),	which	is	close	to	the	dash‐dotted	line	in	Figure	
7.4.	A	lower	value	of	Ka	results	in	a	lower	adsorption	capacity	for	components	present	
at	 low	 concentrations.	 In	 Figure	 7.4b	 the	 influence	 of	 the	 Ka	 value	 on	 the	 relative	
adsorption	capacity	is	indicated	for	target	concentrations	ranging	between	0.1	and	10	
µM.	This	graph	again	shows	that	having	a	ligand	with	a	high	value	of	Ka	is	crucial	for	
optimal	adsorption	from	a	feed	with	a	low	concentration	of	the	target	component.	
After	 adsorption,	 the	 product	 needs	 to	 be	 released	 from	 the	 affinity	 resin.	 High	Ka	
values	usually	result	in	harsh	conditions	for	desorption,	for	example	by	using	low	pH	
buffers	or	high	salt	concentrations.	This	may	eventually	lead	to	product	degradation,	
depending	on	the	stability	of	the	product	in	the	desorption	buffer	and	the	use	of	large	
amounts	of	buffer	resulting	in	large	waste	streams.	Besides,	the	harsh	conditions	may	
decrease	the	life	time	of	the	affinity	resin	and	the	ligands.		
	
Figure	7.4.	a)	Relative	adsorption	capacity	as	a	 function	of	 the	concentration	of	 the	 target	component	at	
equilibrium	 constant	 (Ka)	 values	 of	 105	 M‐1	 (solid),	 106	 M‐1	 (dash‐dotted),	 107	 M‐1	 (dashed)	 and	 109	 M‐1	
(dotted);	 b)	 relative	 adsorption	 capacity	 as	 a	 function	 of	 equilibrium	 constant	 Ka	 at	 equilibrium	 target	
concentrations	of	10	nM	(solid),	0.1	µM	(dash‐dotted),	1	µM	(dashed)	and	10	µM	(dotted).	
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It	may	be	possible	to	increase	the	target	concentration	before	the	adsorption	step	by	
for	 example	 ultrafiltration.	 Prior	 to	 applying	 the	 feed	 to	 a	 chromatography	 column	
with	porous	particles,	the	feed	is	usually	filtered	using	a	microfilter	to	remove	larger	
impurities	 which	 reduce	 the	 performance	 of	 the	 adsorption	 process	 and	 have	 a	
negative	effect	on	the	resin	life	time.	Subsequent	ultrafiltration	could	then	be	used	to	
concentrate	 the	 target.	 However,	 ultrafiltration	 of	 complete	 large	 streams	 for	 the	
isolation	 of	 just	 minor	 components	 is	 a	 costly	 operation;	 it	 also	 increases	 the	
concentration	of	 other	 components	which	may	 interfere	with	 the	ultrafiltration	and	
the	 adsorption	 process.	 For	 feeds	 that	 would	 be	 used	 for	 other	 purposes	 after	 the	
adsorption	(e.g.,	milk,	or	in	the	case	of	scavenging	processes),	it	would	not	be	feasible	
to	use	ultrafiltration.	
7.3.2 Buffer	usage	
Research	on	affinity	 chromatography	 in	 literature	usually	 focuses	on	 the	adsorption	
phase	and	only	 sometimes	discusses	 the	desorption	 step.	The	washing	 step	 is	 often	
ignored,	 even	 though	 the	 amounts	 of	 buffer	 required	 can	 be	 quite	 large	 [73].	 In	
Chapter	 4	 the	 lowest	 amount	 of	wash	 buffer	 required	 to	 drop	 to	 10%	of	 the	 initial	
protein	concentration	was	3	column	volumes	when	using	pure	protein	solution	as	a	
feedstock.	 In	 Chapter	 2	 both	 pure	 protein	 solutions	 and	 whey	 were	 used	 as	 a	
feedstock.	 For	 the	 pure	 protein	 solutions,	 the	 wash	 volume	 was	 approximately	 5	
column	volumes,	for	whey	it	was	10	column	volumes.	For	an	industrial‐sized	column	
10	 column	 volumes	 of	 buffer	 require	 very	 large	 storage	 tanks	 and	 good	 waste	
management.	The	large	wash	volumes	probably	rise	from	the	slow	diffusion	inside	the	
porous	 beads.	 Since	 disposing	 the	 resin	 is	 not	 an	 option	 because	 of	 the	 high	 resin	
costs,	 resins	 have	 to	 be	 improved	 to	 minimize	 washing.	 Macroporous	 particles,	
membranes	and	monoliths	would	probably	require	lower	wash	volumes,	but	will	have	
less	 favourable	 adsorption	 capacities.	 Carful	 design	 of	 the	 pores,	 ensuring	 that	 the	
pores	are	wide	and	short	enough	to	avoid	diffusion	limitation,	is	important.	
7.3.3 Resin	costs	and	life	time	
The	 affinity	 ligands	 investigated	 in	 this	 thesis	 have	 a	 current	 cost	 price	 that	 is	
approximately	equal	to	the	cost	price	of	the	bare	activated	resin	onto	which	it	has	to	
be	immobilized	(personal	communication	with	BAC	BV	(Naarden,	The	Netherlands)	in	
2010).	 That	 means	 that	 half	 of	 the	 total	 resin	 costs	 is	 due	 to	 the	 ligand,	 which	 is	
already	 a	 significant	 improvement	 compared	 to	 the	 price	 of	monoclonal	 antibodies.	
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Lab‐scale	quantities	of	activated	resin	are	approximately	3	times	more	expensive	than	
a	similar	ion	exchanger	[74].	
As	 discussed	 in	 Chapter	 5,	 a	 significant	 portion	 of	 the	 ligand	 applied	 during	 the	
immobilisation	does	not	end	up	on	or	in	the	resin,	but	approximately	50%	stays	in	the	
solution.	We	 performed	 the	 experiments	 in	 Chapter	 5	 using	 the	 standard	 protocols	
and	optimization	is	still	possible,	for	example	by	changing	the	ligand	concentrations.	
More	striking	is	the	fraction	of	immobilized	ligand	that	is	functional	in	the	adsorption	
process:	maximum	25%.	Multiplying	 these	numbers	 indicate	 that	only	12.5%	of	 the	
ligand	 present	 initially	 is	 used	 in	 the	 final	 process.	 If	 we	 have	 to	 purify	 a	 minor	
component	with	a	concentration	of	1	µM	and	a	Ka	value	of	106	M‐1	we	can	see	in	Figure	
7.4b	that	only	50%	of	the	maximum	adsorption	capacity	can	be	used	when	the	resin	is	
fully	 saturated.	 This	 drops	 the	 ligand	 usage	 to	 6.25%	 of	 the	 ligand	 purchased.	 This	
shows	large	potential	for	the	technology	to	be	improved.	It	is	therefore	crucial	that	the	
immobilization	of	ligands	is	optimized	such	that	the	loss	of	functional	ligand	is	further	
minimized.	
Since	 the	 affinity	 resin	 is	 relatively	 expensive,	 it	 is	 necessary	 to	 reuse	 it	 as	 often	 as	
possible.	 Regeneration	 and	 cleaning‐in‐place	 methods	 have	 to	 be	 optimized.	
Unfortunately,	 these	 steps	 take	 a	 considerable	 amount	 of	 time	 in	 the	 total	 process	
cycle,	in	which	the	column	cannot	be	used	for	purification.	In	addition,	affinity	ligand	
may	be	hydrolyzed.	To	maximize	the	productivity,	it	may	be	worthwhile	to	have	two	
columns	which	 can	operate	 in	 turn,	which	 is	 quite	 common	 in	 industrial	 processes.	
The	final	value	of	the	minor	component	determines	whether	the	costs	are	acceptable	
or	not.	
7.3.4 Process	example	
In	this	thesis	we	investigated	important	aspects	in	the	separation	of	low‐concentrated	
protein	 using	 affinity	 chromatography.	 The	 combination	 of	 the	 findings	 in	 the	
preceding	 chapters	 provides	 a	 basis	 for	 the	 design	 of	 a	 large‐scale	 process,	 for	
example	in	the	food	industry.	A	hypothetical	process	provides	insight	into	the	actual	
feasibility	 of	 protein	 isolation	 using	 affinity	 chromatography	 with	 the	 current	
knowledge	and	materials	available.	
Whey	 is	 a	 good	 example	 of	 a	 food	 industry	 side	 stream	 that	 contains	 valuable	
components.	 For	 this	 example	 we	 assume	 that	 we	 want	 to	 isolate	 a	 protein	 with	
similar	properties	as	BSA,	present	at	a	concentration	of	0.1	g/L.	A	total	of	10	m3	whey	
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has	to	be	processed	per	hour,	and	the	adsorption	stage	may	not	take	longer	than	12	
hours.	
In	 Chapter	 4	we	 found	 that	 the	NHS	 Sepharose	4	 FF	 resin	 (GE	Healthcare,	Uppsala,	
Sweden)	was	one	of	the	best	resins	available	amongst	the	resins	tested.	The	maximum	
adsorption	capacity	of	 this	 resin	was	21.6	mg	BSA	per	ml	packed	resin	 (Chapter	2).	
Using	the	isotherm	from	Chapter	2,	we	can	calculate	that	the	maximum	capacity	at	the	
feed	concentration	of	0.1	g/L	 is	14.5	mg/ml	resin.	Each	hour	a	 total	of	1	kg	product	
(10	m3/h	with	 a	 concentration	 of	 0.1	 g/l)	 is	 applied,	 so	 12	 kg	 for	 each	 batch	 of	 12	
hours.	Full	saturation	of	the	column	with	this	product	concentration	would	require	a	
resin	volume	of	828	l.	
However,	full	saturation	does	not	yield	the	highest	productivity	(see	Chapter	2).	The	
productivity	will	 depend	 on	 the	 breakthrough	 curve,	which	 depends	 on	 the	 column	
design.	We	 assume	 a	 similar	 breakthrough	 curve	 as	 found	 for	 the	 isolation	 of	 BSA	
from	 0.12	mg/ml	 pure	 BSA	 solution	 using	 a	 0.93‐ml	 column	 in	 Chapter	 2.	 The	 bed	
height	and	residence	time	will,	of	course,	not	be	the	same	for	the	large‐scale	process.	
The	highest	productivity	with	the	lab‐scale	column	was	reached	at	33%	breakthrough,	
when	a	total	of	approximately	10	mg	of	BSA	was	adsorbed.	At	33%	breakthrough	12	
mg	 of	 BSA	 was	 applied,	 so	 around	 17%	 of	 product	 was	 lost	 in	 the	 flow‐through.	
According	to	the	isotherm,	the	maximum	equilibrium	capacity	would	have	been	14.2	
mg	 for	 this	 column,	 so	 approximately	 70%	 of	 the	 available	 capacity	was	 utilized	 at	
33%	 breakthrough.	 In	 other	 words,	 we	 need	 approximately	 45%	 extra	 capacity	
compared	 to	 full	 saturation,	 so	 a	 column	 of	 1.2	 m3	 instead	 of	 828	 l.	 For	 washing,	
desorption	 and	 regeneration	 at	 least	 24	 column	 volumes	 are	 required	 (Chapter	 2),	
which	 is	 approximately	 30	 m3	 of	 buffer.	 When	 the	 same	 flow	 rate	 is	 used	 as	 for	
adsorption,	these	steps	would	add	3	hours	to	the	process	time.	In	total,	we	would	be	
able	to	isolate	83%	of	the	product	present	in	the	feed	(17%	would	be	lost	in	the	flow‐
through),	which	is	10	kg	product	in	15	hours.	
The	recommended	superficial	velocity	for	the	NHS	Sepharose	resin	is	150	cm/h.	For	a	
flow	rate	of	10	m3/h	a	flow‐through	area	of	6.7	m2	is	required,	which	is	a	diameter	of	
2.9	 m.	 For	 a	 1.2‐m3	 column,	 the	 bed	 height	 would	 be	 18	 cm.	 Because	 of	 its	 soft	
structure	the	bed	height	or	thickness	is	restricted	to	approximately	30	cm.	Based	on	a	
maximum	 bed	 length	 of	 30	 cm	 instead	 of	 maximum	 superficial	 velocity,	 the	 axial	
column	would	be	2.26	m	wide,	 resulting	 in	 a	 velocity	 of	 250	 cm/h.	 Columns	with	 a	
width	of	up	to	2	m	are	readily	available,	above	~2.5	m	packing	of	the	resin	and	sealing	
of	 the	 column	may	become	difficult.	A	wide	 axial	 flow	column	can	be	 replaced	by	 a	
General	Discussion	
123	
radial	flow	column	(Chapter	6).	Using	a	more	rigid	particle	could	offer	an	increase	in	
bed	 length	 and	 liquid	 velocity.	 However,	 the	 drawbacks	 would	 be	 an	 increase	 in	
pressure	drop	and	a	shallower	breakthrough	curve.	
A	1.2‐m3	radial	flow	column	with	a	ratio	of	2	between	outer	and	inner	cylinder	and	a	
bed	thickness	of	18	cm	would	be	72	cm	wide	and	3.9	m	high.	The	average	superficial	
velocity	 inside	 the	 column	would	 be	 slightly	 higher	 than	 150	 cm/h:	 156	 cm/h	 (see	
Chapter	6).	Radial	flow	columns	with	these	dimensions	are	currently	not	available	and	
problems	may	arise	when	packing	resins	to	such	a	height.	With	a	bed	thickness	of	30	
cm	and	a	ratio	of	2,	the	radial	flow	column	would	be	1.2	m	wide	and	1.4	m	high	with	
an	average	superficial	velocity	of	260	cm/h.	A	radial	flow	column	of	these	dimensions	
is	commercially	available.	 Increasing	the	ratio	between	outer	and	inner	cylinder	will	
decrease	the	width	and	increase	the	height	and	average	velocity.	
As	observed	 in	 the	 resin	comparison	 in	Chapter	4,	 an	 increase	of	 the	 liquid	velocity	
leads	 to	 a	 decrease	 of	 the	 dynamic	 binding	 capacity.	 For	 the	 Big	 Beads	 resin	 (GE	
Healthcare,	 Uppsala,	 Sweden)	 the	 dynamic	 binding	 capacity	 at	 10%	 breakthrough	
drops	 from	 4.8	 mg/ml	 resin	 to	 2.34	 mg/ml	 resin	 when	 increasing	 the	 superficial	
velocity	 from	 150	 cm/h	 to	 300	 cm/h.	 For	 sake	 of	 simplicity,	 we	 assume	 that	 this	
reduction	 decreases	 linearly	 with	 increasing	 velocity	 over	 this	 range	 and	 that	 the	
same	 reduction	 holds	 for	 the	 dynamic	 binding	 capacity	 at	 33%	 breakthrough.	 An	
increase	in	superficial	velocity	from	150	cm/h	to	250	cm/h	would	then	decrease	the	
dynamic	 capacity	 by	 a	 factor	 1.6,	 leading	 to	 only	 6.3	 kg	 of	 product.	 Of	 course	 the	
column	 volume	 could	 be	 increased,	 but	 this	 would	 again	 lower	 the	 velocity	 and	
increase	the	costs.	
By	 improving	 the	 efficiency	 of	 ligand	 immobilization	 (see	 Chapter	 5)	 the	 overall	
capacity	of	the	resin	may	be	increased.	This	would,	for	example,	limit	the	increase	in	
resin	 volume	 required	 due	 to	 higher	 liquid	 velocities.	 It	 may	 also	 be	 possible	 to	
improve	the	adsorption	capacity	of	membranes	and	monoliths,	although	care	must	be	
taken	 that	 adsorption	 kinetics	 do	 not	 become	 limiting.	 However,	 it	 does	 not	 seem	
likely	 that	sufficient	capacity	can	be	obtained	with	membranes	and	monoliths,	 since	
the	surface	area	available	for	adsorption	will	still	be	lower	than	for	porous	beads.	An	
ideal	stationary	phase	should	have	a	good	balance	between	macropores,	or	void	space	
between	particles,	for	convective	mass	transfer,	and	micropores	for	increased	surface	
area	 taking	 into	 account	 the	 rate	 of	 adsorption.	 The	 stationary	 phase	 should	 be	
designed	taking	into	account	the	size	and	nature	of	the	target	component	and	would	
therefore	not	be	a	“one‐size‐fits‐all”	type.	
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Another	 improvement	 for	 the	 process	 other	 than	 improving	 the	 stationary	 phase	
would	be	a	different	method	for	desorption.	In	total	10	column	volumes,	 in	this	case	
well	 over	 10	m3,	 of	 acidic	desorption	buffer	 is	 required	 for	 only	 a	 few	kilograms	of	
product.	We	found	that	temperature	has	a	limited	effect	on	the	bond	between	BSA	and	
the	ligand	(see	Chapter	3),	but	careful	design	of	the	ligand	may	provide	other	options.	
7.4 Conclusions	
Highly	 selective	 ligands	 are	 indispensable	 for	 the	 separation	 and	 isolation	 of	minor	
proteins.	Because	of	the	low	concentration	of	these	proteins,	the	specificity	is	crucial	
for	adsorption	and	concentration	of	the	protein.	The	availability	of	affinity	 ligands	is	
highly	 improved	by	using	recombinant	proteins	produced	by	for	example	yeast	cells	
[75‐77].	
This	 thesis	 shows	 that	 there	 are	 many	 aspects	 involved	 in	 protein	 isolation	 using	
affinity	 chromatography.	 The	 concentration	 of	 the	 minor	 protein	 as	 well	 as	 the	
adsorption	 strength	 of	 the	 affinity	 ligand	 are	 of	 importance	 for	 the	 purification	
process.	Even	though	many	different	adsorbents	have	been	invented,	none	seem	to	be	
able	 to	 compete	with	 the	packed	bed	of	porous	beads	 just	 yet.	Many	attempts	have	
been	 made	 to	 improve	 mass	 transfer,	 but	 it	 is	 important	 to	 note	 that	 adsorption	
kinetics	can	become	limiting	as	well.	
Seemingly	 non‐interesting	 parts	 of	 the	 separation	 process,	 such	 as	 ligand	
immobilization,	column	washing	and	desorption,	are	of	importance	to	determine	the	
feasibility	 of	 affinity	 separation	 on	 a	 large	 scale.	 Ligand	 functionality	 after	
immobilization	 has	 to	 be	 improved	 to	 improve	 the	 economic	 feasibility	 of	 affinity	
separation,	but	we	showed	that	there	also	is	potential	for	that.	A	challenge	lies	ahead	
to	find	adsorbents	with	high	adsorption	capacity	that	are	not	significantly	limited	by	
diffusion	and	exhibit	 low	pressure	drops.	Until	now,	affinity	 separation	 seems	 to	be	
limited	 to	 highly	 valuable	 products,	 but	 we	 here	 proved	 that	 there	 are	 many	
possibilities	 for	 improvement	 which	 may	 eventually	 lead	 to	 a	 wide‐spread	 use	 of	
affinity	separations	in	the	food	industry.	
	 	
General	Discussion	
125	
References	
1.	 Hubbuch,	 J.,	 et	 al.	 2002.	 Dynamics	 of	 protein	 uptake	 within	 the	 adsorbent	
particle	 during	 packed	 bed	 chromatography.	 Biotechnology	 and	
Bioengineering,	80(4):	p.	359‐368.	
2.	 Stone,	 M.C.	 and	 G.	 Carta.	 2007.	 Patterns	 of	 protein	 adsorption	 in	
chromatographic	 particles	 visualized	 by	 optical	 microscopy.	 Journal	 of	
Chromatography	A,	1160(1‐2):	p.	206‐214.	
3.	 Peters	 Jr,	 T.	 1995.	 2	 ‐	 The	 albumin	 molecule:	 its	 structure	 and	 chemical	
properties,	in	All	About	Albumin.	Academic	Press:	San	Diego.	p.	9‐II.	
4.	 Hubbuch,	 J.J.,	et	al.	2001.	High	gradient	magnetic	separation	versus	expanded	
bed	adsorption:	a	first	principle	comparison.	Bioseparation,	10(1):	p.	99‐112.	
5.	 Hubbuch,	 J.J.	 and	 O.R.T.	 Thomas.	 2002.	 High‐gradient	 magnetic	 affinity	
separation	 of	 trypsin	 from	 porcine	 pancreatin.	 Biotechnology	 and	
Bioengineering,	79(3):	p.	301‐313.	
6.	 Heebøll‐Nielsen,	 A.,	 et	 al.	 2004.	 Superparamagnetic	 adsorbents	 for	 high‐
gradient	magnetic	fishing	of	lectins	out	of	legume	extracts.	Biotechnology	and	
Bioengineering,	87(3):	p.	311‐323.	
7.	 Heebøll‐Nielsen,	 A.,	 et	 al.	 2004.	 Superparamagnetic	 cation‐exchange	
adsorbents	for	bioproduct	recovery	from	crude	process	liquors	by	high‐gradient	
magnetic	fishing.	Separation	Science	and	Technology,	39(12):	p.	2891‐2914.	
8.	 Meyer,	A.,	et	al.	2005.	Demonstration	of	a	strategy	for	product	purification	by	
high‐gradient	 magnetic	 fishing:	 recovery	 of	 superoxide	 dismutase	 from	
unconditioned	whey.	Biotechnology	Progress,	21(1):	p.	244‐254.	
9.	 Franzreb,	 M.,	 et	 al.	 2006.	 Protein	 purification	 using	 magnetic	 adsorbent	
particles.	Applied	Microbiology	and	Biotechnology,	70(5):	p.	505‐516.	
10.	 Yavuz,	 C.T.,	 et	 al.	 2009.	 Magnetic	 separations:	 from	 steel	 plants	 to	
biotechnology.	Chemical	Engineering	Science,	64(10):	p.	2510‐2521.	
11.	 Halling,	P.J.	and	P.	Dunnill.	1980.	Magnetic	supports	 for	 immobilized	enzymes	
and	bioaffinity	adsorbents.	Enzyme	and	Microbial	Technology,	2(1):	p.	2‐10.	
12.	 Goetz,	V.,	M.	Remaud,	and	D.J.	Graves.	1991.	A	novel	magnetic	silica	support	for	
use	 in	 chromatographic	 and	 enzymatic	 bioprocessing.	 Biotechnology	 and	
Bioengineering,	37(7):	p.	614‐626.	
13.	 Prioult,	G.,	 et	al.	2000.	Rapid	purification	of	nisin	Z	using	 specific	monoclonal	
antibody‐coated	magnetic	 beads.	 International	 Dairy	 Journal,	 10(9):	 p.	 627‐
633.	
14.	 Tong,	 X.D.,	 B.	 Xue,	 and	 Y.	 Sun.	 2001.	 A	 novel	magnetic	 affinity	 support	 for	
protein	 adsorption	 and	 purification.	 Biotechnology	 Progress,	 17(1):	 p.	 134‐
139.	
15.	 Heebøll‐Nielsen,	 A.	 2002.	 High	 Gradient	 Magnetic	 Fishing:	 support	
functionalisation	 and	 application	 for	 protein	 recovery	 from	 unclarified	
bioprocess	liquors.	PhD	Thesis.	Technical	University	of	Denmark:	Biocentrum‐
DTU.	172p.	
16.	 Bucak,	 S.,	 et	 al.	 2003.	 Protein	 separations	 using	 colloidal	 magnetic	
nanoparticles.	Biotechnology	Progress,	19(2):	p.	477‐484.	
17.	 Heebøll‐Nielsen,	A.,	S.F.L.	Justesen,	and	O.R.T.	Thomas.	2004.	Fractionation	of	
whey	proteins	with	high‐capacity	 superparamagnetic	 ion‐exchangers.	 Journal	
of	Biotechnology,	113(1‐3):	p.	247‐262.	
Chapter	7	
126	
18.	 Moeser,	 G.D.,	 et	 al.	 2004.	 High‐gradient	 magnetic	 separation	 of	 coated	
magnetic	nanoparticles.	AIChE	Journal,	50(11):	p.	2835‐2848.	
19.	 Ding,	 Y.	 and	 Y.	 Sun.	 2005.	 Small‐sized	 dense	magnetic	 pellicular	 support	 for	
magnetically	 stabilized	 fluidized	 bed	 adsorption	 of	 protein.	 Chemical	
Engineering	Science,	60(4):	p.	917‐924.	
20.	 Basar,	 N.,	 et	 al.	 2007.	 Lysozyme	 purification	 with	 dye‐affinity	 beads	 under	
magnetic	 field.	 International	 Journal	 of	 Biological	Macromolecules,	 41(3):	 p.	
234‐242.	
21.	 Chen,	L.,	et	al.	2007.	Isolation	of	lactoferrin	from	acid	whey	by	magnetic	affinity	
separation.	Separation	and	Purification	Technology,	56(2):	p.	168‐174.	
22.	 Hoshino,	A.,	et	al.	2007.	Separation	of	murine	neutrophils	and	macrophages	by	
thermoresponsive	magnetic	 nanoparticles.	 Biotechnology	 Progress,	 23(6):	 p.	
1513‐1516.	
23.	 Tuzmen,	 N.,	 et	 al.	 2010.	 Development	 of	 the	magnetic	 beads	 for	 dye	 ligand	
affinity	 chromatography	 and	 application	 to	magnetically	 stabilized	 fluidized	
bed	system.	Process	Biochemistry,	45(4):	p.	556‐562.	
24.	 Šafařík,	 I.,	 L.	 Ptáčková,	 and	 M.	 Šafaříková.	 2001.	 Large‐scale	 separation	 of	
magnetic	bioaffinity	adsorbents.	Biotechnology	Letters,	23(23):	p.	1953‐1956.	
25.	 Rosensweig,	R.E.,	Process	for	operating	a	magnetically	stabilized	fluidized	bed,	
1978,	Exxon	Research	&	Engineering	Co.:	United	States.	
26.	 Sada,	E.,	 et	al.	 1981.	Performance	of	 fluidized‐bed	reactors	utilizing	magnetic	
fields.	Biotechnology	and	Bioengineering,	23(11):	p.	2561‐2567.	
27.	 Siegell,	J.H.,	J.C.	Pirkle,	and	G.D.	Dupre.	1984.	Cross‐flow	magnetically	stabilized	
bed	 chromatography.	 Separation	 Science	 and	 Technology,	 19(13‐1):	 p.	 977‐
993.	
28.	 Burns,	M.A.	and	D.J.	Graves.	1985.	Continuous	affinity	chromatography	using	a	
magnetically	stabilized	fluidized	bed.	Biotechnology	Progress,	1(2):	p.	95‐103.	
29.	 Burns,	 M.A.	 and	 D.J.	 Graves.	 1987.	 Application	 of	 magnetically	 stabilized	
fluidized	beds	to	bioseparations.	Reactive	Polymers,	Ion	Exchangers,	Sorbents,	
6(1):	p.	45‐50.	
30.	 Lochmuller,	 C.H.	 and	 L.S.	Wigman.	 1987.	Affinity	 separation	 in	magnetically	
stabilized	 fluidized	 beds:	 synthesis	 and	 performance	 of	 packing	 materials.	
Separation	Science	and	Technology:	p.	2111‐2125.	
31.	 Siegell,	 J.H.	 1987.	 Liquid‐fluidized	 magnetically	 stabilized	 beds.	 Powder	
Technology,	52(2):	p.	139‐148.	
32.	 Chetty,	 A.S.	 and	 M.A.	 Burns.	 1991.	 Continuous	 protein	 separations	 in	 a	
magnetically	 stabilized	 fluidized	 bed	 using	 nonmagnetic	 supports.	
Biotechnology	and	Bioengineering,	38(9):	p.	963‐971.	
33.	 Liu,	 Y.A.,	 R.K.	 Hamby,	 and	 R.D.	 Colberg.	 1991.	 Fundamental	 and	 practical	
developments	of	magnetofluidized	beds:	a	 review.	 Powder	 Technology,	 64(1‐
2):	p.	3‐41.	
34.	 Noble,	R.D.,	 et	 al.,	Stationary	magnetically	 stabilized	 fluidized	bed	 for	protein	
separation	 and	 purification,	 1992,	 The	 University	 of	 Colorado	 Foundation,	
Inc.:	United	States.	
35.	 Goto,	 M.,	 T.	 Imamura,	 and	 T.	 Hirose.	 1995.	 Axial	 dispersion	 in	 liquid	
magnetically	stabilized	fluidized	beds.	Journal	of	Chromatography	A,	690(1):	p.	
1‐8.	
General	Discussion	
127	
36.	 Fee,	C.J.	1996.	Stability	of	the	 liquid‐fluidized	magnetically	stabilized	 fluidized	
bed.	AIChE	Journal,	42(5):	p.	1213‐1219.	
37.	 Seibert,	 K.D.	 and	 M.A.	 Burns.	 1998.	 Effect	 of	 hydrodynamic	 and	 magnetic	
stabilization	 on	 fluidized‐bed	 adsorption.	 Biotechnology	 Progress,	 14(5):	 p.	
749‐755.	
38.	 Böhm,	 D.	 and	 B.	 Pittermann.	 2000.	Magnetically	 stabilized	 fluidized	 beds	 in	
biochemical	 engineering	 ‐	 investigations	 in	 hydrodynamics.	 Chemical	
Engineering	&	Technology,	23(4):	p.	309‐312.	
39.	 Hou,	Y.Y.	 and	R.A.	Williams.	 2002.	Magnetic	 stabilisation	of	a	 liquid	 fluidised	
bed.	Powder	Technology,	124(3):	p.	287‐294.	
40.	 Tong,	X.D.	and	Y.	Sun.	2003.	Application	of	magnetic	agarose	support	in	liquid	
magnetically	 stabilized	 fluidized	 bed	 for	 protein	 adsorption.	 Biotechnology	
Progress,	19(6):	p.	1721‐1727.	
41.	 Chase,	 H.A.	 and	 N.M.	 Draeger.	 1992.	 Affinity	 purification	 of	 proteins	 using	
expanded	beds.	Journal	of	Chromatography	A,	597(1‐2):	p.	129‐145.	
42.	 Chase,	H.A.	and	N.M.	Draeger.	1992.	Expanded‐bed	adsorption	of	proteins	using	
ion‐exchangers.	Separation	Science	and	Technology,	27(14):	p.	2021	‐	2039.	
43.	 Hjorth,	 R.	 1997.	Expanded‐bed	 adsorption	 in	 industrial	 bioprocessing:	 recent	
developments.	Trends	in	Biotechnology,	15(6):	p.	230‐235.	
44.	 Anspach,	 F.B.,	 et	 al.	 1999.	Expanded‐bed	 chromatography	 in	primary	protein	
purification.	Journal	of	Chromatography	A,	865(1‐2):	p.	129‐144.	
45.	 Hubbuch,	 J.,	 J.	 Thömmes,	 and	 M.‐R.	 Kula.	 2005.	 Biochemical	 engineering	
aspects	 of	 expanded	 bed	 adsorption.	 Advances	 in	 Biochemical	
Engineering/Biotechnology,	92:	p.	101‐123.	
46.	 Franzreb,	 M.,	 et	 al.	 2001.	 Liquid‐phase	 mass	 transfer	 of	 magnetic	 ion	
exchangers	in	magnetically	influenced	fluidized	beds:	I.	DC	fields.	Reactive	and	
Functional	Polymers,	46(3):	p.	247‐257.	
47.	 Brandt,	 S.,	 et	 al.	 1988.	Membrane‐based	 affinity	 technology	 for	 commercial	
scale	purifications.	Nature	Biotechnology,	6(7):	p.	779‐782.	
48.	 Suen,	S.‐Y.	and	M.R.	Etzel.	1992.	A	mathematical	analysis	of	affinity	membrane	
bioseparations.	Chemical	Engineering	Science,	47(6):	p.	1355‐1364.	
49.	 Josic,	 D.,	 et	 al.	 1992.	High‐performance	membrane	 chromatography	of	 serum	
and	plasma	membrane	proteins.	 Journal	of	Chromatography	A,	590(1):	p.	59‐
76.	
50.	 Tennikova,	 T.B.	 and	 F.	 Svec.	 1993.	 High‐performance	 membrane	
chromatography:	 highly	 efficient	 separation	 method	 for	 proteins	 in	 ion‐
exchange,	 hydrophobic	 interaction	 and	 reversed‐phase	 modes.	 Journal	 of	
Chromatography	A,	646(2):	p.	279‐288.	
51.	 Roper,	 D.K.	 and	 E.N.	 Lightfoot.	 1995.	 Separation	 of	 biomolecules	 using	
adsorptive	membranes.	Journal	of	Chromatography	A,	702(1‐2):	p.	3‐26.	
52.	 Thömmes,	J.	and	M.R.	Kula.	1995.	Membrane	chromatography	‐	an	integrative	
concept	 in	 the	 downstream	 processing	 of	 proteins.	 Biotechnology	 Progress,	
11(4):	p.	357‐367.	
53.	 Sridhar,	 P.	 1996.	 Design	 of	 affinity	 membrane	 bioseparations.	 Chemical	
Engineering	and	Technology,	19(5):	p.	398‐404.	
54.	 Charcosset,	 C.	 1998.	 Review:	 Purification	 of	 proteins	 by	 membrane	
chromatography.	 Journal	of	Chemical	Technology	&	Biotechnology,	71(2):	p.	
95‐110.	
Chapter	7	
128	
55.	 Klein,	 E.	 2000.	 Affinity	membranes:	 a	 10‐year	 review.	 Journal	 of	 Membrane	
Science,	179(1‐2):	p.	1‐27.	
56.	 Zou,	H.,	Q.	Luo,	and	D.	Zhou.	2001.	Affinity	membrane	chromatography	for	the	
analysis	and	purification	of	proteins.	 Journal	 of	 Biochemical	 and	Biophysical	
Methods,	49(1‐3):	p.	199‐240.	
57.	 Ghosh,	 R.	 2002.	 Protein	 separation	 using	 membrane	 chromatography:	
opportunities	and	challenges.	 Journal	 of	Chromatography	A,	 952(1‐2):	 p.	 13‐
27.	
58.	 Charcosset,	 C.	 2006.	 Membrane	 processes	 in	 biotechnology:	 an	 overview.	
Biotechnology	Advances,	24(5):	p.	482‐492.	
59.	 Pall	 Corporation.	Mustang®	membrane	 chromatography	 starter	 kits.	 [cited:	
2012,	March	5th].	Available	from:	http://www.pall.com.	
60.	 Pall	 Corporation.	 Q	 and	 S	 HyperCel™	 sorbents.	 [cited:	 2012,	 March	 5th].	
Available	from:	www.pall.com.	
61.	 Sartorius	 Stedim	 Biotech.	 Sartobind®	 ion	 exchange	MA	 units.	 [cited:	 2012,	
March	5th].	Available	from:	www.sartorius‐stedim.com.	
62.	 Gebauer,	K.H.,	J.	Thommes,	and	M.R.	Kula.	1997.	Breakthrough	performance	of	
high‐capacity	 membrane	 adsorbers	 in	 protein	 chromatography.	 Chemical	
Engineering	Science,	52(3):	p.	405‐419.	
63.	 Avramescu,	 M.‐E.,	 Z.	 Borneman,	 and	 M.	 Wessling.	 2003.	 Mixed‐matrix	
membrane	 adsorbers	 for	 protein	 separation.	 Journal	 of	 Chromatography	 A,	
1006(1‐2):	p.	171‐183.	
64.	 Avramescu,	M.‐E.,	Z.	Borneman,	and	M.	Wessling.	2003.	Dynamic	behavior	of	
adsorber	membranes	for	protein	recovery.	Biotechnology	and	Bioengineering,	
84(5):	p.	564‐572.	
65.	 Avramescu,	 M.‐E.,	 et	 al.	 2003.	 Preparation	 of	 mixed	 matrix	 adsorber	
membranes	 for	protein	 recovery.	 Journal	 of	Membrane	 Science,	 218(1–2):	 p.	
219‐233.	
66.	 Zou,	 H.,	 et	 al.	 2002.	Monolithic	 stationary	 phases	 for	 liquid	 chromatography	
and	capillary	electrochromatography.	Journal	of	Chromatography	A,	954(1‐2):	
p.	5‐32.	
67.	 Jungbauer,	 A.	 and	 R.	 Hahn.	 2004.	 Monoliths	 for	 fast	 bioseparation	 and	
bioconversion	 and	 their	 applications	 in	 biotechnology.	 Journal	 of	 Separation	
Science,	27(10‐11):	p.	767‐778.	
68.	 Tennikova,	 T.B.	 and	 R.	 Freitag.	 2000.	An	 introduction	 to	monolithic	 disks	 as	
stationary	 phases	 for	 high	 performance	 biochromatography.	 Journal	 of	 High	
Resolution	Chromatography,	23(1):	p.	27‐38.	
69.	 Josic,	 D.	 and	 A.	 Buchacher.	 2001.	 Application	 of	 monoliths	 as	 supports	 for	
affinity	chromatography	and	fast	enzymatic	conversion.	Journal	of	Biochemical	
and	Biophysical	Methods,	49(1‐3):	p.	153‐174.	
70.	 Frey,	D.D.	and	X.	Kang.	2005.	New	concepts	in	the	chromatography	of	peptides	
and	proteins.	Current	Opinion	in	Biotechnology,	16(5):	p.	552‐560.	
71.	 Kecili,	 R.,	 et	 al.	 2007.	 Purification	 of	 penicillin	 acylase	 through	 a	 monolith	
column	 containing	 methacryloyl	 antipyrine.	 Separation	 and	 Purification	
Technology,	55(1):	p.	1‐7.	
72.	 BIA	 Separations.	 2012.	 CIM®	 cGMP	 Columns.	 [cited:	 2012,	 March	 22nd].	
Available	from:	http://www.biaseparations.com.	
General	Discussion	
129	
73.	 Aldington,	 S.	 and	 J.	 Bonnerjea.	 2007.	 Scale‐up	 of	 monoclonal	 antibody	
purification	processes.	Journal	of	Chromatography	B,	848(1):	p.	64‐78.	
74.	 GE	 Healthcare	 Life	 Sciences.	 2012.	 Price	 list	 IEX	 Sepharose	 FF	 and	 NHS	
Sepharose	 FF.	 [cited:	 2012,	 March	 8th].	 Available	 from:	
www.gelifesciences.com.	
75.	 Frenken,	 L.G.J.,	 et	 al.	 2000.	 Isolation	of	antigen	 specific	Llama	VHH	antibody	
fragments	and	their	high	level	secretion	by	Saccharomyces	cerevisiae.	Journal	of	
Biotechnology,	78(1):	p.	11‐21.	
76.	 Muyldermans,	 S.	 2001.	 Single	 domain	 camel	 antibodies:	 current	 status.	
Reviews	in	Molecular	Biotechnology,	74(4):	p.	277‐302.	
77.	 Harmsen,	M.	and	H.	De	Haard.	2007.	Properties,	production,	and	applications	of	
camelid	 single‐domain	 antibody	 fragments.	 Applied	 Microbiology	 and	
Biotechnology,	77(1):	p.	13‐22.	
	
	
	 	
Chapter	7	
130	
	
	131	
Summary	
	
Many	product	 or	 even	waste	 streams	 in	 the	 food	 industry	 contain	 components	 that	
may	 have	 potential	 for	 e.g.	 functional	 foods.	 These	 streams	 are	 typically	 large	 in	
volume	 and	 the	 components	 of	 interest	 are	 only	 present	 at	 low	 concentrations.	 A	
robust	 and	 highly	 selective	 separation	 process	 should	 be	 developed	 for	 efficient	
isolation	 of	 the	 components.	 Affinity	 chromatography	 is	 such	 a	 selective	 method.	
Ligands	immobilized	to	a	stationary	phase	(e.g.,	a	resin	or	membrane)	are	used	to	bind	
the	component	of	interest.	Affinity	chromatography	is,	however,	a	costly	process,	due	
to	the	batch‐wise	operation,	the	large	amount	of	solvents	required	and	the	high	costs	
of	 the	 ligands	 and	 stationary	 phases.	 Therefore,	 its	 current	 use	 is	mainly	 limited	 to	
lab‐scale	purifications	and	pharmaceutical	applications.	
The	aim	of	 this	 research	was	 to	 investigate	 the	potential	of	affinity	chromatography	
for	 the	 isolation	 of	 minor	 protein	 in	 the	 food	 industry.	 The	 discovery	 of	 the	 VHH	
ligand,	 based	 on	 the	 binding	 domain	 of	 a	 llama	 antibody,	 has	 led	 to	 a	 new	 class	 of	
highly	 selective	 ligands,	 which	 can	 be	 produced	 on	 a	 large	 scale.	 We	 studied	 the	
chromatography	 process	 to	 measure	 productivity,	 but	 also	 to	 develop	 a	 rational	
protocol	 for	decisions	on	suitable	stationary	phases	and	process	configurations.	The	
research	presented	in	this	thesis	provides	insights	in	the	opportunities	and	challenges	
for	large‐scale	affinity	chromatography.	
The	 isolation	 of	 protein	 using	 affinity	 chromatography	 requires	 several	 stages:	
adsorption,	 washing,	 and	 desorption.	 In	 Chapter	 2,	 we	 studied	 these	 stages	 for	 the	
isolation	of	bovine	serum	albumin	(BSA)	from	pure	BSA	solutions	with	high	and	low	
concentration	 and	 from	 actual	 feedstock,	 in	 this	 case	 cheese	 whey.	 A	 small‐scale	
packed	 bed	 column	 was	 used	 to	 investigate	 the	 yield	 and	 productivity.	 BSA	 was	
retrieved	in	highly	pure	and	concentrated	form	in	the	desorption	stage.	Furthermore,	
we	found	that	the	productivity	of	the	system	strongly	depended	on	the	point	at	which	
the	adsorption	stage	is	terminated.	
Acids	 or	 salts	 are	 commonly	 used	 to	 disrupt	 the	 bond	 between	 ligand	 and	 target	
protein	 during	 desorption.	 This	 results	 in	 the	 use	 of	 large	 quantities	 of	 chemicals,	
whilst	 the	 potential	 of	 other	 methods	 for	 desorption,	 such	 as	 an	 increase	 in	
temperature,	is	not	fully	explored.	In	Chapter	3	we	measured	the	thermodynamics	of	
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the	 adsorption	 reaction	 between	 BSA	 and	 the	 VHH	 ligand	with	 isothermal	 titration	
calorimetry	 (ITC).	 Temperature	 and	 pH	 were	 varied	 to	 find	 other	 conditions	 for	
desorption.	 A	 buffer	with	 high	 pH	 could	 be	 used	 for	 desorption,	 and	 an	 increase	 of	
temperature	seemed	to	weaken	 the	bond	between	protein	and	 ligand.	However,	 the	
acidic	buffer	would	in	this	case	still	be	most	effective.	
Apart	from	the	bond	between	ligand	and	target	protein,	the	stationary	phase	to	which	
the	 ligand	 is	 immobilised	 plays	 a	 key	 role	 in	 the	 chromatography	 process.	 Many	
supports	are	available,	of	which	we	investigated	a	selection	of	resins	for	packed	bed	
chromatography	 in	 Chapter	 4.	 We	 found	 that	 some	 resins	 were	 unsuitable	 for	 our	
process	 due	 to	 their	 low	 adsorption	 capacity.	 A	 ranking	 and	weighing	method	was	
presented	 to	 determine	 the	 optimal	 resin	 depending	 on	 the	 requirements	 of	 the	
process.	
An	 important	 issue	we	 found	 for	all	 the	 resins	 investigated,	was	 the	 low	adsorption	
capacity	 compared	 to	 other	 types	 of	 adsorptive	 chromatography	 processes,	 such	 as	
ion	exchange	chromatography.	Therefore,	we	studied	the	immobilization	of	the	ligand	
to	 three	 resins	 in	more	 detail	 in	 Chapter	 5.	 The	 efficiency	 of	 ligand	 immobilization	
depended	 on	 the	 ligand	 concentration	 used	 in	 the	 immobilization	 procedure.	
However,	only	approximately	one	out	of	five	immobilized	ligands	was	able	to	bind	to	
the	 target.	 Improvement	 of	 ligand	 immobilization	 is	 therefore	 a	 potential	 route	 to	
increase	the	feasibility	of	affinity	chromatography	for	large‐scale	processes.			
Eventually	the	lab‐scale	process	has	to	be	scaled‐up	to	industrial	scale.	The	commonly	
used	axial	flow	column,	essentially	a	cylinder	filled	with	resin	through	which	the	feed	
flows	 in	 the	 axial	 direction,	 can	 have	 problems	 at	 scale‐up,	 because	 of	 increased	
pressure	drop	as	the	column	is	lengthened.	Therefore,	scale‐up	usually	takes	place	by	
widening	the	column.	Another	option	is	to	use	a	radial	flow	column,	in	which	the	resin	
is	 confined	 between	 two	 concentric	 cylinders	 and	 liquid	 flows	 from	 the	 outside	
inwards	 or	 from	 the	 inside	 outwards.	 The	 radial	 flow	 column	 can	 be	 scaled	 up	 in	
height	 instead	 of	 width.	 In	 Chapter	 6	 we	 compared	 axial	 and	 radial	 flow	 affinity	
chromatography	both	experimentally	and	theoretically.	We	found	that	the	differences	
in	performance	were	minimal,	because	the	process	was	limited	by	diffusion	inside	the	
resin	particle.	At	a	small	process	scale,	radial	flow	columns	are	impractical	in	terms	of	
size,	but	at	a	larger	process	scale	they	may	compete	with	axial	flow	columns	because	
of	their	smaller	foot	print	and	possibly	lower	construction	costs.	
Summary	
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The	 research	 in	 this	 thesis	 was	 focused	 on	 a	 defined	 ligand‐protein	 system	 and	
commercially	 available	 resins	 in	 packed‐bed	 configuration.	 The	 potential	 of	 other	
stationary	 phases,	 such	 as	 non‐porous	 (magnetic)	 particles,	 membranes	 and	
monoliths	was	therefore	discussed	in	Chapter	7.	We	found	that	currently	the	packed	
bed	of	porous	resin	beads	still	 seems	to	be	 the	most	suitable	configuration.	A	radial	
flow	 column	 with	 porous	 affinity	 resin	 is	 in	 theory	 capable	 of	 isolating	 a	 low‐
concentrated	 protein	 from	 a	 large	 feed	 of	 10	 m3/h.	 However,	 the	 relatively	 low	
capacity	of	the	resin,	the	limited	liquid	velocity,	as	well	as	large	buffer	usage	and	the	
current	costs	remain	important	issues	to	resolve	to	further	expand	the	opportunities	
of	affinity	chromatography	for	minor	protein	isolation.	
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Samenvatting	
	
In	de	 levensmiddelenindustrie	bevatten	product‐	of	 reststromen	vaak	hoogwaardige	
componenten	 die	 bijvoorbeeld	 een	 gezondheidsbevorderend	 effect	 hebben.	 Deze	
hoogwaardige	 componenten	 zijn	 vaak	 in	 kleine	 hoeveelheden	 aanwezig,	 terwijl	 de	
product‐	of	reststroom	vaak	erg	groot	is.	Om	deze	componenten	efficiënt	the	kunnen	
isoleren,	 is	 een	 robuust	 en	 zeer	 selectief	 scheidingsproces	 nodig,	 zoals	 affiniteits‐
chromatografie.	Voor	affiniteitschromatografie	worden	 liganden	geïmmobiliseerd	op	
een	stationaire	fase,	bijvoorbeeld	een	hars	of	een	membraan.	Deze	liganden	binden	de	
gewenste	component.	Affiniteitschromatografie	is	echter	een	kostbaar	proces,	omdat	
het	 batch‐gewijs	 uitgevoerd	 wordt,	 er	 grote	 hoeveelheden	 oplosmiddel	 of	 buffer	
gebruikt	worden	en	zowel	de	liganden	als	de	harsen	en	membranen	kostbaar	zijn.	Om	
deze	 redenen	 wordt	 affiniteitschromatografie	 vooral	 gebruikt	 op	 labschaal	 en	 voor	
farmaceutische	doeleinden.	
Het	 doel	 van	 dit	 onderzoek	 was	 om	 de	 mogelijkheden	 voor	 isolatie	 van	
laaggeconcentreerde	 eiwitten	 in	 de	 levensmiddelenindustrie	 met	 behulp	 van	
affiniteitschromatografie	te	analyseren.	De	ontdekking	van	het	VHH	ligand,	gebaseerd	
op	het	bindingsdomein	van	het	antilichaam	van	een	lama,	heeft	geleid	tot	een	nieuwe	
klasse	van	zeer	selectieve	liganden	die	op	grote	schaal	kunnen	worden	geproduceerd.	
We	hebben	de	productiviteit	van	het	chromatografieproces	geanalyseerd,	en	ook	een	
methode	ontwikkeld	om	een	keuze	te	kunnen	maken	tussen	verschillende	stationaire	
fasen	 en	 procesconfiguraties.	 Het	 onderzoek	 in	 dit	 proefschrift	 geeft	 inzicht	 in	 de	
mogelijkheden	en	uitdagingen	voor	affiniteitschromatografie	op	grote	schaal.	
Het	proces	van	eiwitisolatie	met	behulp	van	affiniteitschromatografie	bestaat	uit	drie	
fasen:	 adsorptie,	 wassen	 en	 desorptie.	 In	 Hoofdstuk	 2	 hebben	 we	 deze	 fasen	
onderzocht	voor	de	isolatie	van	runderalbumine	(BSA)	uit	pure	BSA	oplossingen	met	
hoge	 en	 lage	 concentratie,	 en	 uit	 kaaswei	 als	 voorbeeld	 voor	 een	 reststroom.	 We	
hebben	een	kleine	gepakte	kolom	gebruikt	om	de	opbrengst	en	productiviteit	van	het	
proces	 te	 bepalen.	 Aan	 het	 eind	 van	 het	 proces	werd	 een	 geconcentreerde	 en	 zeer	
zuivere	BSA	 oplossing	 verkregen.	De	 productiviteit	 van	 het	 proces	 bleek	 sterk	 af	 te	
hangen	van	het	moment	waarop	de	adsorptie‐fase	wordt	beëindigd.	
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In	de	meeste	gevallen	worden	voor	desorptie	zuren	of	zouten	gebruikt	om	de	binding	
tussen	 het	 ligand	 en	 het	 eiwit	 te	 verbreken.	 Hierdoor	 worden	 grote	 hoeveelheden	
chemicaliën	gebruikt.	Andere	opties	voor	desorptie,	zoals	bijvoorbeeld	het	verhogen	
van	 de	 temperatuur,	 zijn	 niet	 uitgebreid	 onderzocht.	 In	 Hoofdstuk	 3	 hebben	we	 de	
thermodynamica	van	de	bindingsreactie	tussen	BSA	en	het	VHH	ligand	als	functie	van	
temperatuur	en	pH	gemeten	met	behulp	van	isotherme	titratie	calorimetrie	(ITC).	Een	
basische	 buffer	 in	 combinatie	met	 een	 verhoogde	 temperatuur	 zou	 kunnen	worden	
gebruikt	 om	 de	 binding	 tussen	 BSA	 en	 het	 VHH	 ligand	 te	 verzwakken.	 Een	 zure	
desorptiebuffer	is	echter	effectiever.	
Naast	de	binding	tussen	ligand	en	BSA,	speelt	de	stationaire	fase	waarop	het	ligand	is	
geïmmobiliseerd	 een	 belangrijke	 rol	 in	 het	 chromatografieproces.	 In	 Hoofdstuk	 4	
hebben	 we	 verscheidene	 harsen	 voor	 gepakte	 bedden	 met	 elkaar	 vergeleken.	 Een	
aantal	 harsen	 bleek	 ongeschikt	 voor	 dit	 proces	 vanwege	 de	 lage	 bindingscapaciteit.	
Door	een	rangorde	aan	te	brengen	waarbij	een	gewicht	kan	worden	toegekend	aan	de	
verschillende	eigenschappen	van	de	harsen,	kan	een	keuze	worden	gemaakt	tussen	de	
harsen.	De	harsen	die	we	hebben	onderzocht,	hadden	allen	een	veel	lagere	bindings‐
capaciteit	 dan	 harsen	 voor	 andere	 typen	 chromatografie,	 zoals	 bijvoorbeeld	
ionenwisselingschromatografie.	
In	Hoofdstuk	5	hebben	we	de	 immobilisatie	van	 ligand	verder	bestudeerd	voor	drie	
commercieel	verkrijgbare	harsen.	De	efficiëntie	van	de	immobilisatie	bleek	afhankelijk	
van	de	gebruikte	ligandconcentratie	in	de	immobilisatie‐oplossing.	Echter,	slechts	één	
van	 de	 vijf	 geïmmobiliseerde	 liganden	 kon	 BSA	 binden.	 Het	 verbeteren	 van	 de	
bindingscapaciteit	 is	daarom	een	mogelijke	route	om	de	affiniteitschromatografie	op	
grote	schaal	breder	toe	te	kunnen	passen.	
Een	proces	op	 labschaal	 zal	 uiteindelijk	 opgeschaald	moeten	worden	 tot	 industriële	
schaal.	De	 gepakte	kolom,	 in	 feite	 een	 cilinder	 gevuld	met	hars	waar	de	vloeistof	 in	
axiale	 richting	doorheen	 stroomt,	 kan	problemen	 geven	bij	 opschaling.	Het	 grootste	
probleem	 is	de	verhoging	van	de	drukval	wanneer	de	kolom	 langer	wordt	gemaakt;	
daarom	wordt	 vaak	opgeschaald	 in	de	breedte.	 Een	 radiale	 kolom,	waarbij	 het	hars	
tussen	 twee	 concentrische	 cilinders	 wordt	 gepakt	 en	 de	 vloeistof	 van	 buiten	 naar	
binnen	of	van	binnen	naar	buiten	stroomt,	kan	in	dit	geval	uitkomst	bieden.	Dit	type	
kolom	 kan	 worden	 opgeschaald	 in	 hoogte	 zonder	 de	 drukval	 te	 verhogen.	 In	
Hoofdstuk	6	vergeleken	we	een	axiale	en	een	radiale	kolom,	zowel	theoretisch	als	met	
behulp	 van	 experimenten	 op	 labschaal.	 Beide	 kolommen	 presteren	 vrijwel	 gelijk,	
omdat	het	proces	gelimiteerd	is	door	de	diffusie	in	de	harsdeeltjes.	Op	kleine	schaal	is	
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een	radiale	kolom	niet	praktisch,	maar	op	grotere	schaal	(vanaf	enkele	tientallen	liters	
hars)	zou	dit	 type	kolom	een	goed	alternatief	kunnen	vormen	voor	de	axiale	kolom,	
vanwege	de	kleinere	footprint	en	mogelijk	goedkopere	constructie.	
Het	onderzoek	in	dit	proefschrift	was	gericht	op	een	specifiek	ligand‐eiwit	systeem	en	
commercieel	 verkrijgbare	harsen	 in	gepakte	bedden.	Andere	 stationaire	 fasen,	 zoals	
non‐poreuze	(magnetische)	deeltjes,	membranen	en	monolieten	werden	besproken	in	
Hoofdstuk	7.	Op	dit	moment	lijkt	een	gepakt	bed	van	poreuze	harsdeeltjes	nog	steeds	
de	meest	 geschikte	methode	 voor	 affiniteitschromatografie.	 Theoretisch	 gezien	 kan	
een	 gepakt	 radiaal	 bed	 een	 laaggeconcentreerd	 eiwit	 zuiveren	 uit	 een	 grote	 rest‐
stroom	van	10	m3/h.	De	 relatief	 lage	 capaciteit	 van	de	harsen,	 de	 beperkte	 stroom‐
snelheid,	de	benodigde	hoeveelheden	buffer,	en	de	huidige	kosten	blijven	belangrijke	
kwesties	 die	 opgelost	moeten	worden	 om	 affiniteitschromatografie	 voor	 de	 isolatie	
van	laaggeconcentreerde	eiwitten	breder	toepasbaar	te	maken.	
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